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Abstract
The role of optometry in the delivery of eye healthcare in the UK is well
recognised by the state and the British people. Optometry in Britain works
very closely with medicine and is steadily moving forward as a profession
complimentary to ophthalmology. However, with the exception of Ireland, the
role of optometry in the rest of the European Union is restricted by national
laws, decrees or acts like Actus Medicus to those professional activities
which are normally carried out by dispensing opticians in the UK.
From a British perspective there are no equivalent working optometrists in the
EU except in Ireland. British optometrists provide an increasing amount of
primary eye healthcare working closely with hospital based ophthalmologists
who provide secondary care. In the rest of the European Union primary eye
care is generally provided by practising ophthalmologists who refer patients to
hospitals or university clinics for secondary care.
With the growing elderly population and changing demography, the UK will
remain short of human resources for the management of sight threatening
conditions. It is not realistic to expect 750 British ophthalmologists to be
responsible for secondary eye care for the entire population of the UK
British standards in eye healthcare must be maintained and optometry in the
EU must be reformed effectively and improve to British standards before
freedom of movement is implemented under any EU legislation especially
under the new directive which would allow healthcare professionals to work
in the EU for 16 weeks without registration from the year 2005.
British optometrists with appropriate additional training could be given the
responsibility for the specific task of ophthalmic intervention to avoid
blindness and visual impairment and this would provide a pragmatic solution
to a human resources problem in the eye care field in the UK. Hopefully, such
a model would then be adopted by the future optometrists trained throughout
the European Union.
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by
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12
THE ROLE OF OPTOMETRY IN THE DELIVERY OF
EYE HEALTHCARE
IN THE EUROPEAN UNION
Chapter 1
Introduction, an Overview of Health Care and Historical Survey
of Eye Care Professions
1.1 Introduction
The World Health Organisation has estimated that about 80% of
global blindness is avoidable. It results from those conditions that could have
been prevented or controlled if the available knowledge and timely interventions
had been applied, (WHO, Fact Sheet 213, 2000). The WHO states that 'given the
scope of the problem, the time has come for a major focused and concerted
international effort to combat avoidable blindness'. The key elements in the
prevention, treatment and rehabilitation of avoidable blindness are the availability
of appropriately trained human resources, suitable technology and full support of
the state. However, the decision concerning the level of training and skills required
for different professionals remains a matter for the state and relevant
professional organisations.
The role of optometry in the delivery of eye health care in the United Kingdom is
well recognised by the state and the people. Optometry in the UK works very
closely with medicine and is steadily moving forward as a profession
complimentary to ophthalmology. The role of optometry in the rest of the
European Union, with the exception of Ireland, is restricted by national laws,
decrees and acts like Actus Medicus to those professional activities which are
normally carried out by dispensing opticians in the UK. British optometrists
provide an increasing amount of eye healthcare working closely with hospital
based ophthalmologists who provide secondary eye care.
With the growing elderly population and changing demography, the UK will
remain short of human resources for the management of sight threatening
conditions. British optometrists with appropriate additional training could be
given the responsibility for the specific task of ophthalmic intervention to avoid
blindness and visual impairment.
Before freedom of movement of optometrists within the EU is implemented
under any EU legislation, especially under the new European Commission
directive which would allow healthcare professionals to work in the EU for 16
weeks without any registration from 2005, optometry in the EU must be reformed
effectively and improve to British standards.
The purpose of this work is to evaluate the present role of optometry in the
delivery of eye health care in the United Kingdom and the rest of the European
Union and recommend a pragmatic solution.
1.1(a) An Overview of Health Care
The provision of preventive and curative health care for the
population within any administrative boundary or border can be defined as
an organised social system in which the state undertakes .responsibility for
the well being and welfare of all the inhabitants by providing access to
appropriate health care as and when necessary and ensuring that adequate
resources are allocated for this purpose.
It is also expected that the state assumes responsibility for overseeing the
provision of suitable professional education and training in skills relevant to
healthcare, enacts statutory rules and regulations to safeguard professional
standards for the protection of people and various healthcare providers, plans
adequate healthcare for all citizens and whenever necessary commissions
and authorises relevant research and related studies to ensure continuation of
the delivery of quality healthcare.
Public confidence in the healthcare professions in general depends upon
accessibility of affordable healthcare without delay, high standard of delivery
of healthcare and the level of quality of service provided. Public trust
in the optometric profession depends upon the quality of eye healthcare
services, the standard of delivery of eye healthcare and prevention of visual
impairment. However, the bureaucratic systems and their procedures, which
serve the state, allocate resources and implement healthcare policies, can
also affect the delivery of eye healthcare.
In the UK the 1983 Griffith Report delegated the Board of the NHS with the
following task: 'to ascertain how well the service is being delivered at local
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level by obtaining the experience and perceptions of patients and the
community: these can be derived from CHCs (Community Health Councils)
and by other methods, including market research and from the experience of
general practice and the community health service' (St Leger et al., 1992).
There are two important elements in the evaluation of healthcare, standard of
professional service and objectivity. Assessment of standard of service is
considered complete if evaluation is carried out against the stated aims. It is
comparative when professional services are proposed as an improvement on
the existing services and assessed accordingly. Within the framework of
objectivity are those evaluations which are independent of the judgment,
errors and prejudices of evaluators and those who commissioned them.
However, it is recognised that objectivity is a relative term and occasionally
an absolute objectivity may not be possible in some evaluations. Absolute
objectivity, nevertheless, remains an idealistic goal in healthcare. It can be
stated that total objectivity is dependent upon consensus decision making
in any evaluation and it is the collective responsibility of all concerned.
Consensus decision making refers to agreement of all those involved and
implies impartiality, a constituent element of objectivity. However, in the
context of evaluation of health impact assessment, it is stated by Milner et
al (2003) that 'it is important to guard against unrealistic expectations and
illusions of total objectivity and precision in the health impact assessment
process'.
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Considering that there is no single blueprint that will be appropriate for all
circumstances, total objectivity remains an idealistic goal for health policy
decision makers, howsoever unrealistic it may appear to those who may
regard such concepts as illusory. For the provision of effective
healthcare, several factors need to be assessed objectively. These include an
efficient and effective allocation and use of resources for the benefit of all
citizens especially those who are disadvantaged and therefore socially
vulnerable. It is necessary that local needs are always taken into account in
healthcare policy decisions.
For an efficient and effective assessment of healthcare services it is
sometimes necessary to obtain the expertise of individuals from different
disciplines which may include medical, allied healthcare and complimentary
professions, scientists, epidemiologists, physiologists, biologists,
statisticians, healthcare economists, sociologists, jurists, legal advisers,
information technologists and managers in healthcare work. It is also
necessary to seek and take into account the views and comments of the
recipients of healthcare services. In the context of specific healthcare,
evaluation can be defined as critical and objective assessment of the entire
professional services within the stated, projected and expected goals. Critical
assessment includes objectivity in healthcare priorities that are defined by
health-related evaluations. The concept that a disease may lead to disability
is an important element of critical analysis in healthcare. It can be argued
17
that healthcare expenditure is in fact healthcare investment. A system that
defines healthcare priorities has to include evaluation ofispecific services
e.g., availability of screening for ocular diseases like diabetic retinopathy and
glaucoma to prevent visual impairment and ensure effective interventions.
For an assessment of healthcare effectiveness it would be necessary to
examine the structure, pattern, procedures and outcome of specific
professional services.
The structure covers academic and professional training and appropriate
qualifications, geographical distribution of qualified professionals and the
number of establishments providing specific professional services and the
facilities and type of services provided. A quality control system, economics
of training and the actual provision of specific healthcare are also essential
parts of the structure.
An assessment of the above mentioned structure would cover organisation
of the professional services and, under the heading outcome, an evaluation
of the results of such services. Accreditation is a formalised procedure
designed for recognised disciplines and professions, individual
professionals, professional bodies and organisations by which an agreed
protocol and standard is deemed to have been met. Accreditation is a well
recognised and established social phenomena. For example, the right of
doctors, dentists and optometrists to practise in the United Kingdom has
been based upon registration with the General Medical Council, General
18
Dental Council and General Optical Council respectively. This signifies an
individual's ability to pass specific examinations at an agreed standard
before registration and practise is allowed.
Similarly, for example, medical schools following inspection of hospitals
have to decide which should be accredited for pre-registration training and
experience for medical graduates. Royal colleges provide their own
accreditation standard for post-graduate training. Quality assurance under an
agreed framework commits clinical and management staff to produce
a systematic and ongoing process of evaluating the standard of care and
service.
Health related issues in all the regions of the world are periodically reviewed by
the World Health Organisation (WHO), supported by epidemiological studies and
followed by appropriate recommendations. In 1978 worldwide primary healthcare
for all was recommended at the joint WHO/UNICEF conference held at Alma
Ata, following the adoption of a resolution by the World Health Assembly in 1977:
'Health for all by the year 2000' (Thylefors, 1998).
This ambitious resolution was adopted with the expectation that by the year 2000
all citizens should attain a level of health which would allow them to lead a
socially and economically productive life. The conference considered that
accessible healthcare was necessary in all the regions of the world. According
to a WHO working group quality assurance has four specific components,
quality professional performance, patient satisfaction with professional
services, efficient use of resources and risk management. The WHO European
targets for 'Health for All' (Target 31) have already stated that 'by 1990 all
member states should have built effective mechanisms for ensuring the quality
of patient care within their health care system'. The U( Government readily
accepted the principle of 'Health for All' (St Leger et al, 1992).
The WHO programmes for the prevention of blindness (PBL) and primary
healthcare started in 1978. It was in 1980 the WHO-PBL programme started
working on primary eye care as part of primary healthcare (Thylefors, 1998).
1.2	 The historical, social and professional background
of the Providers of Eye Health Care in Europe
Although currently in most countries of the European Union both
primary and secondary eye care is provided by ophthalmologists, in two
member states, namely the United Kingdom and the Republic of Ireland,
both primary and diagnostic eye care is shared between family physicians,
optometrists and ophthalmologists.
Family physicians in some EU countries provide a mixture of basic eye care,
screening for various eye diseases and referral for ophthalmological services.
However, in the UK and Ireland general medical practitioners very often
seek optometric clinical opinion prior to an ophthalmological referral.
Before the development of ophthalmology and optometry, health care
provided by physicians, apothecaries and the clergy would have included
some form of eye care based upon the available clinical information and
knowledge of the period.
20
1.2 (a) The Medical Profession in Medieval and 19th century
continental Europe
During the 12th century the clergy were prohibited by the
Church from practising both medicine and surgery. In 1139 at the
Ecumenical Council meeting of Lateran held in Lateran Palace in Rome, the
council prohibited monks from acting as physicians. In 1163 the Council of
Tours condemned the teaching and practising of medicine by the monks
(Millerson, 1964). In 1215, an ordinance from Pope Innocent the ifi (Papacy
1198-1216; died in 1216 because of malaria) forbade any surgical operation.
Pope John XXf (elected in 1276) was an ophthalmologist before becoming
Pope and also personal physician to Pope Gregory X in 1272. One of his
important works was Liber di Oculo (Concerning the Eye). His textbook
was in two parts, an introduction to the eye followed by descriptions of eye
diseases and their medical treatment. The work survived and a copy was found
amongst Michelangelo's papers. The book was a plagiarism of two earlier
textbooks (Blanchard, 1995). Supposedly, Pope John XXE discovered that
Glaucoma was a disease with a hard eye. In fact he was only referring to a
suppurative external disease with indurated lids called sclerophthalmia
(Blanchard, 1995).
Pope Boniface the VIII (Papacy 1294-1303; died in 1303) absolutely
forbade the practice of surgery. However, during the 13th century the
Cathedral of Notre Dam in Paris gained recognition as an independent
Universitas teaching medicine. Interestingly, physician and surgeon Guy
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de Chauliac (1300-1368), the author of Chirurgia Magna, acted as
physician to Pope Clement the VI (Papacy 1342-1352; died in 1352). In
the 12th and 13th centuries, Salerno, Pavia and Bologna were the earliest
universities in Europe to provide formal instructions in medicine.
Apprenticeship was required for licensing to practise medicine at Salerno
and Montpellier in the 13th century. At Padua a similar system was adopted
during the 16th century. In the following century the apprenticeship
system was also adopted at Leiden, followed by Austria and England
(Gottschalk et al, 1969). In 1503, Giovanni de Vigo (1450-1525) became
personal surgeon to Pope Julius II (Papacy 1503-13) . De Vigo wrote a surgical
textbook in Latin 'Practica Copiosa in Arte Chirurgia' which was completed in
1514. It was translated into English by Richard Traheron and printed by Edward
Whytechurch in 1543 ( Gurunluoglu et al, 2003).
In Paris an Academic Royale De Chirurgie was established in 1731 on the
initiative of Georges Mareschal, surgeon to Louis XV (Gottschalk et al, 1969).
The academy was dissolved in 1793 as a result of the French revolution. In
1843 the academy was revived by Auguste Berard as Societe Nationale de
Chirurgie. In 1935 it became Academic Nationale de Chirugie.
1.2 (b) The Medical Profession in Medieval and 19th
century England
The traders of foreign spices, pepperers and canvas dealers formed
the grocer's company of London in 1345. Another group of traders, the
apothecaries, amalgamated with the grocers while retaining their title.
In 1447 Henry the VI (1421-1471) granted the company exclusive rights to
inspect all spices and drugs sold in England.
In 1606 the grocers obtained a Royal Charter. The apothecaries decided to
form their own society and in 1617 succeeded in obtaining a separate charter.
An act of 1511 stated that all physicians, with the exception of those holding
degrees from Oxford and Cambridge, had to be licensed by the Church.
However in 1518, Thomas Linacre who was a personal physician to King
Henry the VIII and also to Cardinal Wolsey (chief adviser to Henry the VIII)
obtained permission from the King to form an elite group of physicians.
The body was named the 'Royal College of Physicians'. Linacre himself was
holder of an MD from the University of Padua. Membership was open to
Oxford and Cambridge medical graduates and also foreign medical degree
holders (Millerson, 1964).
The King's fear of the plague epidemic may have been a deciding factor in
his patronage of a well controlled group of physicians - the Royal College of
Physicians (Berlant, 1975; Carr-Saunders and Wilson, 1964).
By 1522, four years after the formation of the Royal College of Physicians,
university degrees were formally required as a necessary qualification for
licensing by the church for practising as a physician (Elliott, 1972).
The apothecaries after obtaining their own Charter in 1617, fought a series of
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legal battles with the physicians over their rights to provide medical advice
and prescribe drugs. The plague epidemic of 1665 in London provided the
apothecaries with an opportunity to practice almost unopposed because
most physicians had left London for the countryside to escape from the
great plague.
The Royal College of Physicians had the right to search the premises of
apothecaries in London for bad drugs and this right had been strengthened
in 1723. Early in the 18th century, a decision by the House of Lords allowed
apothecaries to charge for the drugs but not for the advice. However, after
the passing of Apothecaries Act of 1815 and following another court case,
the apothecaries were also allowed to charge for advice (Elliott, 1972).
Although the surgeons in England had already formed a group in 1435, the
Barber's company (established in 1308) also received a Royal charter in
1462. In 1421 an attempt on the part of the surgeons to unite with the
physicians had not been successful. In 1540, the surgeons reached an
agreement with the barbers to form a united company of barber-surgeons.
The social status of barbers was that of a craft guild. The membership of the
guild of barber-surgeons was not always exclusive and sometimes in
different areas members from the guild of apothecaries and even those from
non-medical and non-surgical occupations were accepted (Millerson, 1964).
By the 18th century, there were almost twenty times more barbers than
surgeons in the company, although most of the income for the company was
24
provided by the surgeons (Millerson, 1964). The alliance of the barbers and
the surgeons as a united company of barber-surgeons lasted for almost two
centuries and in 1745, after several unsuccessful attempts, a separate
company of surgeons was incorporated.
In 1796, because of a violation of the rules the company of surgeons lost it's
corporate status and a bill to re-incorporate the company was not successful.
In 1800, a royal charter of incorporation was granted establishing a Royal
College of Surgeons of London. In 1843 the college was renamed as the
Royal College of Surgeons of England. During the 18th century several
voluntary hospitals were formed in London: Westminster (1719), Guys
(1721) , St. George's (1733) , London (1740) and Middlesex (1749).
Medical Schools developed around these hospitals (Cameron, 1954).
However, St. Bartholomew's and St. Thomas's hospitals trace their origins
from the medieval times.
During the 17th and 19th centuries only the physicians were regarded as
members of a learned profession. The surgeons were considered craftsmen
and the apothecaries mere tradesmen (Wilcock, 1830, quoted by
Brotherston, 1971). The demarcation between the three was very rigid. In
the 18th century an apothecary could not secure the licence of the surgeon's
company unless membership from the society of apothecaries was first
withdrawn. Similarly, the members of the College of Surgeons and
licentiates of the society of apothecaries had to withdraw their membership
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from their respective college and society before they were allowed to qualify
as licentiates of the College of Physicians. It was socially acceptable that
the physicians, surgeons and apothecaries should have different social rank
and status (Brotherston, 1971).
Joseph Butler (1692-1752), who was a Bishop of the Church of England, held
rigid views on self interest, conscience and class. He held the view that the
architect of the universe had distributed men into different ranks and at the
same time united them into society. This rigid and influential view was
equally applicable to the medical profession and society in general.
Interestingly, in ancient Greece, the philosopher Aristotle (384-322 BC) had
already assigned a strictly subordinate place for artisans in his polis (Black,
1984). During the first half of the 19th century, debates for the unification of
apothecaries, surgeons and physicians met with resistance because of the
view that the practitioners of inferior order and rank were necessary for the
needs of the socially inferior classes (Brotherston, 1971).
In 1824 an outspoken journal of medical knowledge and opinion named The
Lancet was launched primarily to seek reform and to establish and promote
communication for a disunited medical profession in England.
In 1832 a Provincial Medical and Surgical Association was formed in the
historic city of Worcester by a group of provincial medical practitioners
(Elliott, 1972). The association moved to London in 1856 and was renamed
the British Medical Association.
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Quackery was widespread during this period with unqualified practitioners in
evidence throughout England. The Carmichael essays have reported that in
1839 an apothecary falsely advertised himself as a surgeon. The following was
copied from a placard suspended in the window of an apothecary shop in
Manchester 'Surgeon and Apothecary'.
'Prescriptions and family medicines accurately compounded Teeth
extracted at one shilling each. Women attended in labour at two shillings
and six pence each. Patent medicines and perfumery. Best London pickles,
Fish sauces, Bear's grease, Soda Water, Ginger Beer, Lemonade, Con greave
matches and Warren's blackening'.
The apothecary in question acknowledged that he had no right to describe
himself as a surgeon (McLachlan and McKeown, 1971). The Medical Act
of 1858 provided the three licensing bodies with recognition under the
framework of the newly created General Medical Council. The membership
of the General Medical Council included nominees from the Crown, the
representatives from the three licensing bodies namely the Royal College of
Physicians, the Royal College of Surgeons and the Society of Apothecaries,
the representatives from the universities and later representatives from the
profession itself. With regard to medical education the General Medical
Council had limited powers. The act of 1858 had not abolished the
apprenticeship system which was regarded by some as a waste of time in the
'drudgery of the apothecary's shop' (Cameron, 1954).
The act of 1858 had intended to limit the right to practice in the subject of
qualification only i.e. medicine and surgery. However, anybody holding a
qualification either as a licentiate physician or a qualification of the society
of apothecaries or the college of surgeons was free to practice either
medicine or surgery with a single qualification. In 1859 a licentiate of the
Society of Apothecaries was fined twenty shillings for describing himself
both a physician and surgeon. Later, enforcement of this rule was not
considered practical and the rule was not pursued (Cameron, 1954).
Following the act of 1858, Oxford, Cambridge and Durham universities,
the Royal College of Physicians, the Society of Apothecaries and the Royal
College of Surgeons unsuccessfully attempted to establish a single unifying
examination. In 1878 this plan was abandoned. Later, under the act of 1886,
dual qualification in medicine and surgery became necessary for registration
with the General Medical Council.
1.2 (c) Quackery in Health Care
The poor, destitute, desperate, socially deprived and ill-informed
have in all ages and all societies fallen victims to quackery. Prior to any
enforcement of state rules governing the practice of medicine and other
health care professions, quacks and charlatans would have flourished in all
civilisations. For example the law books of Yajnavallcaya from India
(around 1000 BC) stated that a qualified and competent doctor incurs no
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guilt if his patient dies, but a quack in such cases should be punished
(Basham, 1976). A medical manuscript of Susruta also from ancient India
stated that a physician should be sanctioned by the King; a quack doctor kills
people out of greed, because of the fault of the King, meaning that the state
had been negligent in enforcing proper rules (Basham, 1976).
In Rome under Felix Cornelius (79-82 BC) an unqualified physician was
liable to be arrested if, because of his fault, a patient died (Jakobovits, 1959).
According to Millerson (1964) by the end of the 15 th century, the medical
profession in Europe was 'in a deplorable state due to the large numbers of
untrained, unskilled practitioners and quacks'. An 18 th century poster in
London proclaimed:
'Dr Frederich undertakes to cure the Gout and Rheumatism, without any
return Likewise, cures the Y ellow Jaundice, Stiching in the side.
He likewise cures anybody who is bit by a Mad Dog No cure No pay
(Gottschalk et al, 1969).
During the early 18th century, doctors and lawyers were portrayed in the
literature as pettifoggers and quacks taking advantage of the population's
misery and misfortune. In England the Society of Apothecaries made efforts to
prohibit quacks from practising medicine, to raise the educational standards and
enhance the social and professional status of apothecaries. Because of opposition
from the physicians and surgeons and also chemists and druggists, the Society's
desire to seek the prohibition of medical practice by the untrained was not
successful. The apothecaries act of 1815 simply gave the Society powers to
organise and supervise apprenticeships, examinations and licensing, but did not
prohibit medical practice by the unqualified (Elliott, 1972). The society obtained
jurisdiction over England and Wales and worked out a system of examination
and awarded LSA, now LMSSA.
At a time when quackery was widespread and there was disorder in the provision
of medical service, the act of 1815 was the beginning of the organisation of
medical profession, properly manifesting itself in the subsequent act of 1858.
Throughout the middle ages and until the middle of the 19th century when the
General Medical Council was formed under the Medical Act of 1858, quacks
and charlatans had flourished. In 1858 the physicians, surgeons and apothecaries
were all combined to form a unified medical profession. One of the aims of the
the act was to enable the recipients of medical services to distinguish the
qualified medical practitioners from the unqualified.
The Provincial Medical and Surgical Association formed in 1832 appointed
a committee on medical ethics in 1849 and two years later, following a
report by its committee on quackery, another committee was appointed to
form a code of ethical laws (The British Medical Association Handbook of
Medical Ethics, 1980).
1.2 (d) Quackery in Eye Health Care
In the field of ophthalmology, there were no restrictions to prohibit
quacks from setting up as oculists. For example William Read (died 1715)
started his career as a tailor and subsequently became a successful quack
oculist. William Read had an opportunity to treat Queen Anne for which he
was knighted in 1705 (Porter, 1989).
During this period, under royal patronage, a quack named Joshua Ward
(1685-1761), describing himself as a physician, even managed to obtain a
personal exemption from being searched for medicines by the officials of
the Royal College of Physicians (Porter, 1989). An itinerant oculist named
John Taylor (1703-72), son of an apothecary from Norwich with regular
surgical education and MDs from Basle, Liege and Cologne was describing
himself as 'Ophthalmiator Pontifical Imperial and Royal' and claiming that
he had treated several members of the continental royal families (Porter,
1989). Taylor regarded ophthalmology as 'distinct and independent of every
other branch of physic', meaning the art of healing After moving into a new
town, Taylor's advertisements and handbills usually extended an invitation for a
public show of his ophthalmic expertise (Porter, 1989). In 1747 in Northampton
Taylor described himself as Oculist to the King of Great Britain and invited local
gentry to witness his method of restoring sight, to hear his lecture on the
'alterations of the eye' and to watch a dissection of the eye and an exhibition of
'all its various beauties displayed' (Porter, 1989).
1.3	 Historical and Social background of Optometry
1.3 (a) Development of optics and topics related to Optometry
and Ophthalmology
Philosophers and scientists in different civilisations and cultures had
shown keen interest in optics and vision which is evident from optical
theories and speculations. During the 6th century BC the Buddhist texts had
dealt with optical theories (Malik, 1921). Prior to Euclid (300 BC), Pliny
(23-79 AD), Ptolemy (150 AD) and Galen (131-210 AD); Empedocles (d. 430
BC), Plato (428-347 BC) and Aristotle (384-322 BC) had already speculated
about light and optics. Much later, Al-Hindi or Al-Kindi (800-873) and Alhazen
(965-1040 AD) made contributions in optics. Abelard (1079-1142) from Bath
supported Plato's works. A Franciscan monk, philosopher, scientist and Oxford
scholar Roger Bacon (1214-92) studied the works of Alhazen and others with
his teacher Robert Grosseteste (1175-1253) and made further contributions in
the field of optics. Bacon was also a recipient of a Doctor of Theology degree
from Paris. In his Opus Majus, Bacon recommended the use of a lens for old
people with poor or weak eyesight (Bridges, 1897-1900; Burke, 1929).
The Polish scientist Witelo (born 1230) experimentally determined the value
for the angle of refraction (Wiet et al, 1975). Leonardo da Vinci (1452-
1519) made further contributions in the field of refraction by attempting to
identify the lens and the cornea as the refracting components of the human
eye. Plater (born 1536) contributed in the field of ocular anatomy,
followed by Scheiner in 1619. During the 17th and 19th centuries notable
contributions were made in ocular anatomy and physiology :- Marione
(1620-1684), the blind spot of Mariotte; Meibom (1638-1700), Meibomian
glands in the lid; Zinn (1727-1759), suspensory ligament of the crystalline
lens; Descemet (1732-1810), Descemet's membrane of the cornea; Fontana
(1720-1805), spaces in the iris; Tenon (1724-1816), Tenon's capsule
surrounding the eye; Horner (1793-1853), Homer's muscle in the lid; Cloquet
(1790-1882), Cloquet's canal in the vitreous; Schlemm (1795-1858), Schlemm's
canal in the sclera; Henle (1809- 1885), Henle's layer in the retina; Bruch
(1819-1884), Bruch's membrane in the choroid; Brucke (1819-1892), Brucke's
fibres in the ciliary muscle; Bowman (1816-1892), Bowman's membrane in the
cornea and Muller, (1820-1864) Muller's fibres in the ciliary muscle.
Maurolyco (1495-1575) explained myopia and presbyopia and his work in
physiological optics was later incorporated by Johannes Kepler (1571-1630).
Kepler (1604) attempted to formulate general laws of refraction, improving on
Alhazen. Snell (1591-1626) worked on the laws of refraction and photometry.
In 1673, Descartes restated SnelPs laws. Grimaldi (1618-63) and Hook (1665)
worked on the theories of diffraction. In 1675, Roemer suggested that light had
finite velocity. In 1672, Isaac Newton published his first paper, reporting his
experiments with prisms, in the Philosophical Transactions of the Royal
Society, speculating on the arrangement of the spectrum.
In 1678, Huygens, differing with Newton, announced his theory at the
Academie des Sciences, publishing it in 1690 in Traite de la Lumiere.
Euler's work was published in 'Lettres a une princesse d'Allemagne' (1760-62)
supporting the wave theory of light. Boscovich (1711-87)•proposed his own
light theory. Joseph Priestley (1733-1804) published 'History and Present
state of discoveries relating to Vision, Light and Colours' in 1772; an 18th
century update.
Comte de Buffon (1707-88) experimented with sunrays. Pierre Bougner (1698-
1758) constructed a photometer and was able to show that light intensity was
inversely proportional to the square of the distance from its source. Snell (1591-
1626) had already implied this earlier. Lambert (1728-77) summarised the works
on photometry in 1760.
Scheiner's work in 1619 formed the basis of the construction of an optometer,
although da Vinci's simple concept antedates Scheiner. Despite the fact that de
La Hire (1640-1718) had constructed a simple optometer by 1696, Porterfield
(1696-1771) was first to use the term optometer. Thomas Young (1773-1829)
later developed the instrument. In 1737 Porterfield published his works on
physiological optics (Levene,1977).
Maurolyco (1495-1575) had already discussed myopia and presbyopia and in
1696 Hamberger explained the optics of hypermetropia. Janin (1731-99), a
French ophthalmologist had described three types of vision, myopia, presbyopia
and perfect vision. Hypermetropia was further explained by Wells(1757-1817)
and Ware (1756-1815). In 1623, Benito Daca de Valdes published his book on the
remedial use of spectacles. The three sections of his work covered the 'nature
and properties of eyes', 'remedies for the sight by means of glasses' and 'dialogue
between various persons and a master maker of spectacles'. In 1692, William
Molyneux had recognised that spectacles were 'for the help of the defective eye;
whether they be those of old men or those of pur-blind'. The term pur-blind to
describe myopia was also used in 1656 when Beal, in a letter, noted that his
brother Captain Richard Beal had observed that King Adolphus was short-sighted,
almost pur-blind (Levene,1977). Barrow (1630-77), Newton (1642-1727), Smith
(1689-1768), Bouguer (1698-1758) and L'Hopital (1661-1704) had made
contributions towards understanding astigmatism, prior to Thomas Young's
discovery and measurement of astigmatism described in his paper in 1800 on the
'Mechanism of the Eye'. In 1825, Airy also announced his independent discovery
and correction of astigmatism.
Von Helmholtz (1821-94) contributed in the field of physiological optics and is
usually credited with the invention of the ophthalmometer and the ophthalmoscope.
However, the Cambridge mathematician Babbage (1792-1871), the founder of the
British Association for the Advancement of Science in 1831, had already
constructed an ophthalmoscope four years earlier. The ophthalmometer had
already been described earlier by Ramsden (1735-1800). Leeuwenhoek
(1632-1723), Jurin (1684-1750), Albinus (1697-1770), Young (1773-1829),
Home (1756-1832), Bowman (1816-92) contributed towards understanding
the mechanism of accommodation. Hooke's (1679) method of testing visual
acuity involved measuring the minimum separable at a specified distance. The
first attempt to achieve uniformity in the determination of visual acuity was
published by Kuchler in 1843.
Around the same time as Kuchler (1811-73), Fronmuller (1809-89) published
his version of a trial set. In 1838, Cox had made his own trial set. However,
both Ramsden (1735-1800) and Cary (1759-1825) had already designed their
own trial sets earlier.
In 1872, Monoyer (1836-1912) had suggested the use of the term Dioptre and in
1875, the ophthalmological congress at Heidelberg approved the term, largely
due to the efforts of Donders (1818-1879), Nagel (1833-95), Javal (1839-1907)
and Wells (1824-79) (Levene,1977).
The early concepts of corneal neutralisation of Leonardo Da Vinci (1452-1519),
Descartes (1596-1650), Thomas Young, (1773-1829) and De La Hire (1640-1718)
contributed towards the later development of contact lenses. During the 19th
century, approximately sixty years after the appearance of the writings of Sir John
Hirschel (1829), the first contact lenses were made during 1887-89 by F.E.Muller,
an artificial eye maker and recipient of an honorary degree of Doctor of Medicine.
Other contributions in the contact lens field were made by Fick (1887), August
Muller (1889), Kalt (1888- presented by Panas before the Paris Academy of
Medicine) and Sulzer (1892).
An important development during the late 18th century was the invention of
bifocals, generally attributed to Benjamin Franklin (1784); other noteworthy
contributors from the same period were Sir Joshua Reynolds, Benjamin West,
Samuel Pierce and Peter Dollond.
References for all the above medieval scientists are from:- Bernal, (1969);
Gottschalk et al, (1969); Hirsch and Wick, (1968); Levene, (1977); Pareti, (1965)
and Wiet et al, (1975).
1.3 (b) Mention of Spectacles in European Literature, Paintings and
other Historical Evidence
Mention of spectacles in literature and depiction in paintings suggests
a rudimentary phase of optics in that period. In a Florentine manuscript (MS) from
1299 'Trettato del Govern° da Sandra di Pipozzo di Sandro Fiorentino' spectacles
(occhiali) were mentioned. Another MS from 1322 mentioned spectacles
(occlialium) in an inventory of personal items of the Bishop of Florence. In
another MS dated 1329 from Tuscany, a merchant complains of stolen goods
which included spectacles (ochialium). Spectacles were also mentioned by
the Italian poet Petrarch (1304-1374).
In a sermon dated 23 February 1305, Giordano da Rivalto stated that 'it was
not yet twenty years' since the art of 'occhiali' making was discovered i.e.
spectacles first appeared in Italy around 1286. Rosen (1953,1956) believed
that spectacles were invented in Italy by an unknown layman of Pisa during
the 13th century. However, spectacles are depicted in an Italian fresco dated
1352 by Tomasso da Modena showing Cardinal Ugo di Provenza in the Sala
del Capitolo at the Seminary of San Nicolo in Treviso; believed to be the
earliest painting depicting a pair of spectacles. Numerous subsequent
European paintings depict spectacles; France-1380, Germany-1404,
Prague-1471, Spain-1441 etc. In Germany in the songs of the Minnesingers
from 1260-1280 Die Brillen' were mentioned (Von Rohr,1923). A portrait
of Thomas More, Lord Chancellor during the reign of Henry the V111 and
beheaded for treason in 1535, also depicts a pair of spectacles.
During the 14th century spectacles were depicted in paper watermarks and in
the 15th century spectacles appeared as part of emblems. Also during the
15th century, spectacles were depicted in a sculpture from Dijon (France)
and Salisbury (England). Spectacles formed a part of the 16th century
heraldic coats of arms of Jacques Gallouchau, Canon of the Cathedral Church
of St. Martin in Tours (France) and also the coats of arms of a convent in south
France from the same period.
Spectacles were mentioned by Chaucer (1340-1400) in the 'Tale of Wyfe of
Bath' from the Canterbury Tales and by Lydgate (1370-1451) in his poem
Lykpenye. The English writers Hoccleve in 1414 and Thomas Newberry in
1563 mentioned spectacles in their works. Spectacles were also mentioned
in the works of William Shakespeare (1564-1616). The diary of Pepys
(1633-1703) contains his personal notes from January 1600 until May 1679
and mentions spectacles.
An anthology by Flick (1951) covers many references to spectacles in Europe
between the 14th and the 20th centuries. However, the earliest printed
illustration of spectacles appeared in the Nuremberg Chronicle from 1494.
1.3 (c) The Guilds of Spectacle Makers in Europe
It could be argued that in Europe the rudimentary phase of
professionalisation in optometry began with the formation of spectacle
makers guilds during the medieval period. Consistent with then prevailing
social attitudes the spectacle makers (predecessors of the present day
optometrists) were regarded as non-professional artisans.
Although early social guilds could be described as forerunners of the later
craft guilds, the rationalised appearance of such guilds incorporating several
features of the earlier collegia and confraternities emerged in Europe around
1100 AD. The craft guilds even described themselves as fraternities (Black,
1984). The medieval craft guilds differed considerably in size, wealth and
social status and sometimes the authorities in towns and cities determined the
permitted number (Black, 1984). It is noteworthy that Aristotle (384-322 BC)
in Greece had assigned a strictly subordinate place for artisans in his polis and
an almost similar social attitude had prevailed in medieval and later Europe.
An important reason for the development of craft guilds would have been a
desire to create an autonomous corporation on the part of some members of the
community of artisans. Economic motives had probably established priority over
other considerations, and by the end of the 13th century self regulating measures
taken by the corporations towards monopoly appeared as the promotion of
collective self interest for the guild members. The earliest spectacle makers guild
in Europe was formed in Venice in 1320 and by the mid 14th century another
one was formed in Antwerp in Belgium, followed by two others during the later
half of the 15th century, one in Nurnberg and the other in Regensberg (Dreyfus,
1988). In 1465 under King Louis the XI the spectacle makers were attached to
the guild of haberdashers and upholsterers. Spectacle makers in France were
not even considered worthy of an independent guild (Champness, 1952).
This trend continued in France since in 1581 under King Henry the III the
patent of membership was granted to the combined crafts of mirror makers,
toy makers and spectacle makers.
In England, for spectacle makers the most important event was the granting of
a royal charter of incorporation on 16 May 1629 by King Charles I and the
formation of the Worshipful Company of Spectacle Makers. Royal patronage
for spectacle makers was evident in the early 18th century; the name of
Edward Scarlett (1677-1743) is recorded as spectacle maker to King George
II (Champness, 1952).
1.3 (d) The abolition of guilds
The medieval jurists and the church regarded the guilds as voluntary
craft colleges, ignoring the mutual aid aspect. Because of economic and
political reasons the state and church were in agreement in not promoting the
guild concept. The rulers feared that the spreading of guild socialism and the
overall loyalty to the guilds may outweigh loyalty to the state. During the
13th century, Pope Innocent the IV (d. 1254) had defined the craft colleges
as voluntary and not obligatory, also declaring that the craftsmen were not
under any compulsion to join or enter guilds and were completely free to
leave at will.
During 1276 AD the artisans and craftsmen were generally considered
serfs and in order to seek dignity in society and raise their standing and
morale they often used examples of skills mentioned in Christianity.
Interestingly, in ancient Rome under Diocletian (284-305 AD) even medical
skills were considered inferior and mainly practised by former slaves of
Greek origin. Craftsmen believed that their entitlement to form guilds was in
pursuit of social justice. The Pope had accepted that with a minimum of
three members automatic recognition of a guild should follow, provided such
a formation was for a just cause which included defending justice and
preventing fraud. Whereas within the guild community their own rules
created a sense of economic security and social justice, the policies pursued
by merchant capitalists often created economic imbalance and led to
dissatisfaction within the brotherhood of the guild community.
The city authorities often revised the guild rules and even dissolved a guild
altogether for the protection of consumers, although in reality it was for
economic and political reasons. For comparison, in our times the political
and media obsession that professional autonomy, usually described as a
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monopoly, is not in the best interest of the consumer appears fairly similar to
the medieval political philosophy and social propaganda. The fact that
professional autonomy is based upon lengthy specialised training and skills is
often conveniently overlooked by the popular media in our times.
Medieval guilds in Europe were subjected to a mixture of Roman and Germanic
legal and state traditions. The city authorities used either tradition whenever it
suited them. There was, however, a traditional difference in Roman and
Germanic attitude towards guilds. Whereas the Roman tradition asserted the
authority of the state, the Germanic tradition mostly upheld the self-governing
rules of the guilds.
The Roman laws and traditions severely restricted the rights of people to form
Collegia which had to be approved by the state. By comparison, the Germanic
tradition accepted the formation of guilds as a matter of collective right of the
people and guild elections were simply ratified by the civic authorities.
Traditionally, anyone with a trade complaint went to the guild court but the jurists
gave the plaintiff a choice between the guild and city courts. This option
undermined the authority of the guild court within the guild community and
society at large.
Guilds did not feature in the medieval political system of many European states.
For example, the Italian writer Gianotti did not consider that craft guilds should
be allowed political citizenship. When Marsiglio (1275-1342) proposed better
participation of the guilds in civil life, his writings were declared heretical and he
was ex-communicated. The concept of co-sovereignty of the guilds with the state
threatened the paramountcy of the state and was an important factor in the
abolition of guilds. In England the guilds had been in decline since before 1750
and were legally abolished in 1835. However in 1832, shortly before the abolition
of guilds, a provincial medical and surgical association was formed which
became the British Medical Association in 1856.
Many of the guild ideals have survived in the form of trade unions,
co-operative movements and professional associations. In France the craft
guilds were abolished in 1791 as part of the revolutionary measure by the
republicans, although some less visible compagnonnages survived until the
19th century. In the 18 th century Germany various means were used to weaken
the guild system. In 1848 the German guilds attempted to create a national
organisation. However, by 1869 the guilds were abolished in Germany. The
guilds in Belgium and the Netherlands were abolished when these were under
French administration. In Spain and Portugal the privileged associations of
craftsmen were abolished during the revolutionary period of 1833-1840.
In Italy the guilds were abolished in 1864.
Some parts of Switzerland still have old guilds known as Zunfte or Gilds
without any special privileges. However, in Austria and Germany attempts
have been made to replace Zunfte with Innungen i.e. associations.
1.4 Development of optometric profession in Europe
1.4 (a) Optometry in Continental Europe in the late 19th and early
20th century
An optical school was established In Vienna in 1898 and in 1909 a
school of optics (Fachschule fur Optiker) was established in Mainz. By 1917
Jena school of optics was established although short courses were provided
in 1913 by Zeiss (Hofstetter, 1948). In 1924 under the medical laws of
France a Paris optician named Odin was accused of using a medical
instrument because he had used a retinoscope for the purposes of refractive
assessment objectively. Odin lost the case. In 1930, a Dutch optician named
Paul Bas from Amsterdam was arrested for practising refraction.
Subsequently judgement was given in his favour (Hofstetter, 1948). Optical
or optometric training of varying standards developed in continental Europe.
In our times some progress has been made for the provision of recognised
education in optometry in several countries of Europe. However, despite
geographical proximity, optometry in continental Europe in the early 20th
century did not develop on the lines of the United Kingdom.
1.4(b) Optometry in the United Kingdom until the late 19 th century
'A blessing to the aged' was the motto on the coat of arms of the
Worshipful Company of Spectacle Makers. However, the formation of craft
or spectacle maker's guilds did not imply or signify any professional status
for the artisan members. The period around the emergence of the Spectacle
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maker's guilds in England and the rest of Europe and prior to the formation
of the British Optical Association in 1895, laid the foundation for the future
development in the field of optometric profession. In England between the
17th and 19th centuries spectacles were supplied to the public either from a
spectacle maker's shop or by a peddler or as part of merchandise in a shop
selling a variety of goods.
Self selection of spectacles combined with some form of suitability test would
have been carried out by the purchaser and in some cases with the help of the
seller. The spectacle maker eventually evolved into spectacle fitter and supplier.
In 1756, at a court meeting of the Worshipful Company of Spectacle makers
held on 26 December, it was agreed that an applicant named John Berge be
apprenticed and bound to Peter Dollond (1730-1820) who was described as an
optician. This was the first use of the term optician in the company's records
(Champness, 1952; Barty-King,1986). After completing his apprenticeship,
John Berge stayed with Peter Dollond until 1791.
During the 18th and 19th
 centuries an attempt was made to determine refractive
errors on an individual basis due to the pioneering works of William Porterfield
(1696-1771), Ware (1756-1815), Thomas Young (1773-1829) and Wells (1824-
79), all of whom were physicians (Levene, 1977: Hirsch and Wick, 1968).
The construction of a simple optometer was carried out by De la Hire (1640-
1748), a mathematician.
Later, Thomas Young experimented with his optometer testing many people
including his instrument maker William Wollaston (1766-1829) who was also a
physician. However, the demand for spectacles was probably age related. During
the early 19th century a physiologist named Purkyne mentioned an acuity
apparatus which was made by an optician named Tauber.
Numerous developments took place between the 17 th and 19th centuries in
the field of physiological optics and optometric instrumentation, although
experiments were mostly part of a philosophical or scientific pursuit undertaken
by aristocrats, physicians, physicists, mathematicians, astronomers, theologians
etc. Around 1780, the newspaper advertisement of Gustavus Katterfelto claimed
expertise in various therapies including philosophical, mathematical and optical.
In his advertisements Ketterfelto stressed aristocratic connections mentioning
a duke, several lords, ladies and gentlemen of distinction (Porter, 1989).
In England during the 18th century, despite some resistance, the title 'dentist'
from French Dentiste' was adopted and similarly the shorter title optician
(from French opticien) replaced spectacle maker.
Taking into consideration relevant developments in the field of medicine and
dentistry in the 19th century, some opticians and spectacle makers in England
and continental Europe would probably have realised that formal training leading
to a socially acceptable and state recognised qualification and registration
and also a regular journal devoted to their speciality was necessary.
In the 19th
 century, medicine and ophthalmology did not recognise opticians
as professional people. In 1860, a clinical assistant named J. Soelberg Wells
from Moorfields Eye Hospital stressed the need for care in the choice of
spectacles and referred to 'unscientific opticians' (Mitchell,-1981a). During
this period people from different trades e.g. hawkers of pots and kettles and
even publicans were allowed to set up as opticians or spectacle peddlers
(Mitchell, 1981a).
The Worshipful Company of Spectacle Makers in England was approached
by some opticians to set up a course of instruction in optics leading to a
qualification, without any success. It was not surprising that on 2nd of April
1891 a journal appeared with the title 'The Optician' with the sub-title' The
Organ of the Optical, Mathematical, Philosophical, Electrical, and Photographic
Instrument Industries; and Review of the Jewellery and Allied Trades'. The
journal was produced by Messrs Hyatt-Woolf and Hayman from Fleet Street.
Charles Hyatt-Woolf was the editor although no mention was made of the
editor's name (Mitchell, 1981 b).
An editorial in August 1891 suggested certification for the opticians and
the subsequent correspondents included a surgeon oculist opposed to the
idea and especially to training in those areas requiring medical knowledge.
However, another medical correspondent, although agreeing with his
medical colleague, commented that some form of training was necessary.
The title of the journal was changed in 1917 to 'The Optician and Scientific
Instrument Maker and Journal of Optometry'. William Hardy joined 'The
Optician' in 1925 as assistant to Charles Hyatt-Woolf (Crundall, 1981).
By 1926 a sub-title 'The Optometrist and Optical Engineer' was adopted
which was later dropped.
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1.4 (c) Optometry in the United Kingdom after the late 19 th century
The British Optical Association was formed in 1895 and the first
examinations were conducted in 1896. In 1897 the Worshipful Company of
Spectacle Makers began considering the possibility of examinations and the
award of a company diploma. In March 1898 the SMC syllabus was published
and in November 1898 the first examinations of the company were held at the
Northampton Institute, the ancestor of the present day City University.
Following a meeting with the British Optical Association Council, the Spectacle
Makers Company added sight testing to its syllabus in 1904. This was an
important historic development for professional optometry.
After 275 years, a craft guild had not only survived in Europe but was
transformed into an examining body and had laid the foundations for
professional development for future optometrists and providers of eye
healthcare. Also in 1904 an optical association was formed in Scotland.
In 1906 a society of chemist-opticians was formed, followed by the beginnings
of the National Association of Opticians in 1910. Although in 1903 it was
announced in The Optician that regular classes in optical subjects were to
start at the Northampton Institute; shortly before the first examination of the
Spectacle Makers Company in November 1898 a course of instruction was
provided at the Institute with the Company's help and Lionel Laurance as
instructor. In 1905 an optical convention was held at Northampton Institute,
a definite landmark in the early process of consolidation for the optometric
profession.
By 1902 optics was taught at the College of Technology in Manchester. In the
mid 1920's the teaching of optics commenced at Bradford Technical College
(Pickwel1,1987) and by 1926 optics was also taught at Birmingham Technical
School. By the mid 1930's optics was taught at Cardiff and Edinburgh and by
1941 in Glasgow. The first full-time course in ophthalmic optics commenced
in 1904 at Northampton Polytechnic followed by another full-time course in
1928 at Manchester.
In 1905 a General Board of Opticians was formed in England with the
hope of attaining statutory registration. Because of a decision taken by the
Worshipful Company of Spectacle Makers to seek statutory registration
independently, some disagreement with the British Optical Association
followed and the board broke up.
William Hardy (editor of the Optician from 1938 until 1966) stated in 1981,
in the 90th
 anniversary issue of the Optician, that 'between 1895 and 1904
nine organisations--all, except one, newly formed--were claiming to be
representatives of opticians of the time, including jeweller and chemist
opticians. A Scottish Optical Association came on the scene in 1904 and
hard on its heels came the Institute of Ophthalmic Opticians, founded at a
meeting in the house of Lionel Laurence' (Hardy, 1981). In William Hardy's
historical article, although he mentions nine optical organisations, he does
not give their names.
However, the fact that between 1895 and 1904 several optical organisations
existed in the United Kingdom proves that there was widespread enthusiasm
for the future of the optometric profession. An important event for the future
of optometry was a court case in 1910 brought by a certain Miss Markham (a
student aged 23) against an optician named R. Thomas (a member of the
British Optical Association) from Manchester for failing to 'diagnose'
conical cornea, a condition she was suffering from when she had consulted
the defendant five times between 1907 and 1909. His defence was that
opticians do not diagnose disease. Counsel for the defence stated that the
action was in substance brought against 'an ordinary tradesman' and
optician who did not possess the skill of a distinguished Harley Street oculist
(Mitchell, 1981a). The court case was eventually decided in the plaintiffs
favour after a retrial. The court case, known as Markham vs. Thomas, was an
event which influenced the training and the mode of practice in the field of
optometry. The loss of the case prompted the British Optical Association to
introduce examinations in ocular disease.
Between 1905 and 1958 two attempts were made in the UK (1927 and 1936)
to secure statutory registration without success.
The Opticians Act of 1958 was a definite landmark for British optometry and
for the development of world optometry. The use of diagnostic drugs was
included in the act. It should be noted that the BOA examinations had included
the use of drugs in refraction as far back as 1924 (Mitchell, 1981a). The Society
of Chemist-Opticians, formed in 1906, may have influenced British optometry in
the use of diagnostic drugs. The responsibility for recognition of abnormal ocular
conditions i.e. of ocular and related pathological conditions in optometric practice
for the purposes of medical and ophthalmological referral was made a part of
statutory requirement under the Opticians Act of 1958.
With the aim of developing clinical practice in optometry, a Refraction
Hospital, ancestor of the present day Institute of Optometry, was formed in
1922 in London by the Institute of Ophthalmic Opticians. As previously
stated the Institute of Ophthalmic Opticians was formed in 1904. In 1928
two more Refraction Hospitals were formed, one in Leeds and the other in
Glasgow. However, these two institutions did not survive. In 1946 an
Association of Optical Practitioners was launched following the
amalgamation of the Institute of Ophthalmic Opticians and the Joint Council
of Qualified opticians.
The transformation of polytechnics into colleges of advanced technology in
1956 and into universities in the mid 1960's were significant developments
in the sphere of optometric education. Under the Opticians Act of 1958,
practice of optometry was regulated by the General Optical Council (GOC).
Registration with the GOC became a statutory requirement in order to
practice optometry or dispensing optics legally in the UK. To become
qualified as an optometrist an approved course of training had to be
completed. Since the mid 1960's a Bachelor of Science degree is gained
after three years of full time study (four years in the case of Glasgow
Caledonian). Currently the following British universities offer courses in
optometry, accredited by the GOC :-. Anglia Polytechnic University, Aston
University, Bradford university, Cardiff University, City University, Glasgow
Caledonian University, University of Manchester Institute of Science and
Technology and the University of Ulster. After graduation, a candidate must
complete a pre-registration year and qualifying examinations of the College
of Optometrists. The year involves full time training and experience of
practice, approved by the College of Optometrists, under the supervision of a
registered optometrist at a practice or a hospital.
With the transformation of the Worshipful Company of Spectacle Makers
into an examining body for optometrists during the end of the 19th century and
the early part of the 20th century, those only supplying or selling spectacles
formed a guild of dispensing opticians in 1925. The British Optical Association
had not considered that the dispensing aspect of optometry merited any
examination until 1928, when a separate section was introduced as part of the
optometric qualifying examination, which later also lead to a separate dispensing
associateship. In 1929, the guild of dispensing opticians and the British Medical
Association formed the National Ophthalmic Treatment Board (NOTB), in
order to provide a medical ophthalmic service to the public as against a
'non-medical' optometric service. The National Ophthalmic Treatment Board
was dissolved after 61 years.
Under the Opticians Act of 1958, the practice of dispensing optics was also
regulated by the General Optical Council. To become qualified as a dispensing
optician, an approved course of training had to be completed. Currently, there are
several ways to train as a dispensing optician. Dispensing optics students are
offered full time courses of three years duration (including pre-registration
year), day release courses of three years duration (linked to employment with a
qualified and registered dispensing optician or an optometrist) or distance
learning courses provided by the Association of British Dispensing Opticians..
Full time and day release courses are offered at the following institutions:-
Anglia Polytechnic University, Bradford and Ilkley Community College, City and
Islington College and Glasgow Caledonian University. A two- year full time or
three-year part time course is offered at City and Islington College with
biological sciences and clinical practice modules being taught by the department
of optometry and Visual Science at City University. A full time course in optical
management of three years duration, leading to a Bachelor of Science degree and
the Fellowship Diploma of the Association of British Dispensing Opticians
(ABDO) is also offered at the Anglia Polytechnic University.
Distance learning courses of three years duration are offered by the ABDO.
Distance learning students attend the ABDO College at Godmersham
(Canterbury), for two separate fortnights during each course year. The
pre-registration year is counted as part of the course.
1.4 (d) Professionalisation of optometry in the United Kingdom
It could be argued that the rudimentary phase of professionalisation in
British optometry began in 1629 with the formation of the Worshipful Company
of Spectacle Makers; the real process of professionalisation, however, began in
1895 with the formation of the British Optical Association, the penultimate phase
being the passing of the Opticians Act of 1958. With the transformation of the
colleges of advanced technology into universities in the mid 1960's, providing
optometric education with academic status, at least the structural aspects of the
professioinalisation process reached concluding stages. However, with
continuously changing characteristics the optometric profession is still evolving.
The functional aspects of the professionalisation process in optometry have
so far not reached the final stages.
It could be stated that in the United Kingdom the final phase of professionalisation
means the obtaining of a royal charter by a professional organisation, mainly in
the health care professions. A royal charter for a professional college in the
optometric profession was suggested by 1972 (Agarwa1,1972).
British optometry struggled for over 60 years before securing state recognition
in the form of statutory registration and an impressive legislation by any standard.
The Opticians Act of 1958 was comprehensive. However, the 'Report of the
Interdepartmental Committee on the Statutory Registration of Opticians'
(1952) under the chairmanship of Lord Crook, formed the basis of the Act
of 1958. Although the act was passed in 1958, the participation of ophthalmic
opticians in the National Health Service in 1946 had already advanced the
process of professionalisation in optometry, signifying state recognition of
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professional competence of the optometric profession. Since the fees for
sight testing were directly paid by the state and there was a provision for the
supply of spectacles with no charge to the patient, the inception of the NHS
provided an unique opportunity for further development to the optometric
profession in the UK, without parallel anywhere in the world, despite the
fact that the 'supplementary ophthalmic service' was intended only as an
interim measure until a full hospital service could be organised.
However, the supplementary service was allowed to continue and was later
replaced with the permanent General Ophthalmic Service, which is a
testimony of professional competence in the delivery of eye health care by
optometrists in the UK.
The amalgamation of the National Association of Opticians and the Institute
of Optical Science (formerly the Institute of Chemist-Opticians) in 1956 and
1962 respectively with the British Optical Association provided an
opportunity for consolidated development. However, a division in the mode
and style of optometric practice continued especially on the question of the
projected professional image. Many independent practitioners considered
that a commercial outlook did not promote a health care professional
image, either socially or inter-professionally. Issues like the display of
optometric appliances; the use of shared professional titles, descriptions
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and nomenclature; the continued existence of corporate bodies and
advertising divided the members opinions.
1.4 (e) The Scope of Optometric practice in the European Continent
With the exception of the UK and Ireland the scope of optometric
practice in most of the EU is not geared towards screening for ocular
conditions causing visual impairment or blindness (Table 1.1). However, in
the Netherlands an optometry degree course at the Hogeschool van Utrecht
was recently accepted by the General Optical Council for registration as
an optometrist in the United Kingdom. The titles optician and contact lens
specialist remain unprotected in the Netherlands, anybody can open an
optical establishment in the country and the contact lenses may be fitted in a
fish and chip shop (Grit, 2002). It should be stated that in the UK although
the titles ophthalmic optician and optometrist are protected under the present
laws, it is not clear whether the title optician is also protected.
An optometry degree course in Norway is developing on the lines of British
optometry and the Norway school has already invited the GOC as visitors for
comments and advice. Norway also allows the use of some diagnostic drugs e.g.
cycloplegics. Norway, although not in the EU, is mentioned in this work because
UK optometry was chosen as a model. However, the scope of professional
practice in optometry in most EU countries does not extend beyond objective and
subjective refraction (Table 1.2) and the use of fluorescein only (Table 1.1).
In most EU countries any kind of medical diagnosis and the use of diagnostic,
therapeutic or emergency drugs is not permitted legally.
The scope of optometric practice can be defined as professional activity
necessary for the provision of complete professional services. However, in most
European Union countries such activities are only partially permitted. Some
optometric procedures are carried out only in the absence of any specific laws
prohibiting such activities.
In some cases the laws which are considered either obsolete or unreasonable
are simply defied. For example, although the Italian laws dating from 1928
forbid Italian 'Otticos' from correcting astigmatism, the laws are ignored.
In some countries prescribing and dispensing of spectacles and fitting of
contact lenses to children is not permitted without a prior medical
examination and approval by a medical doctor. In the field of contact lenses
in some countries very specific rules are applicable(Table 1.3). For example
in Austria one of the particular requirements for contact lens fitters is that
permission from an ophthalmologist must be obtained prior to the fitting of a
first pair if there appears to be any contra-indication in the wearing of
contact lenses. In Finland the prescribing of spectacles and fitting of contact
lenses is not permitted by 'Optikkos' if there is any history of surgical
operation on the eyeball, if there is evidence of any eye disease and if visual
acuity can not be corrected to normal standard with spectacle lenses.
In France the 1945 and subsequent laws from 1952 and 1953 provide the
French Optician-lunetier the monopoly to dispense corrective lenses.
Although the use of the title Optometrist is an attempt on the part of French
Opticians to develop Optometry in France, several restrictions apply and the
scope of practice remains limited. For example, only medical practitioners
are permitted to use an apparatus to measure refraction. However, such
restrictions apply mainly in the use of auto-refractors. Although French
Opticians are permitted to carry out refraction for reimbursement by the
National Health Service (Securite-Sociale), a patient must have a medical
prescription or must state that new spectacles were needed because of loss or
breakage of the old ones. In Belgium the titles optician and optometrist are
not legally protected and a Royal decree, concerned with the profession of
healing arts excludes many professional activities in optometric practice.
The restrictions include the examination of the state of health, the detection
of diseases and deficiencies, establishing any diagnosis, the establishment or
the execution of the treatment of a pathological, physical or psychological
condition whether real or imagined.
However, like the most other EU countries, Optometrists/Opticians in
Belgium are allowed to perform objective and subjective refraction,
correction of visual defects and dispensing of optical appliances.
1.4 (1) The Scope of Optometric Practice in the United Kingdom
In the UK and Ireland, the scope of optometric practice includes
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primary and diagnostic eye care. For over 50 years optometrists in these
countries have been carrying out screening for ocular conditions causing
visual impairment or blindness.
As previously stated. the Markham v Thomas case of 1910 had highlighted
the need for training and examination in the recognition of ocular disease,
and by 1923 the council of the British Optical Association had included this
subject in the new Fellowship examinations.
In the following year the examinations had also included the 'effects of
mydriatics, miotics and cycloplegics' (Mitchell, 1981a). In 1947, the Eye
Services Committee, in its report to the Ministry of Health stated that 'it was
apparent that what had hitherto been described in a general way as "sight-
testing opticians" would in the permanent eye service expect to be given
responsibilities beyond the testing of vision' (Giles, 1952). Crook's report
(1952) recognised that an ophthalmic optician should be able to recognise or
detect an abnormal ocular condition for medical referral. The report stated
that 'the ophthalmic opticians must, of course, have knowledge of ocular
abnormalities, as they may in the course of their professional duties suspect
the presence of disease'.
Under the Opticians Act of 1958, optometrists are under statutory obligation
to recognise ocular abnormalities and take necessary further action i.e.
medical referral when necessary. The paragraphs 9(1) and 9(2) of the terms
of service for ophthalmic opticians in the National Health Service (General
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Ophthalmic Services) Regulations 1974 (as amended) stated that 'where an
ophthalmic medical practitioner or ophthalmic optician is of the opinion that
a patient whose sight he has tested `[9 (2) b]' shows on examination any
abnormality of the eye or otherwise requires treatment outside the scope of
the general ophthalmic services'; 'he shall so inform the patient's doctor'.
The statutory obligations, under the above regulations, were made identical
for both ophthalmic medical practitioners and optometrists and in order to
recognise any ocular abnormality it was necessary to carry out a complete
eye examination.
The General Optical Council notice N15 for the guidance of the profession
also stated that there was 'an obligation greater than that under National
Health Service (General Ophthalmic Services) regulations, which is only to
inform the person's general medical practitioner'. From the guidelines it was
inferred that the optometric professionals were expected to perform
appropriate diagnostic tests during the course of a routine eye examination,
as and when necessary. After performing diagnostic tests, optometrists were
expected to differentiate between those eye conditions which required
medical referral, and those which did not. The difference between
recognition or detection and diagnosis of ocular pathology, however, was
considered a matter of interpretation. It was also stated in 1952 in Crook's
report, that 'several witnesses representing medical and ophthalmological
organisations have informed us that there is no difference between the
detection and the diagnosis of ocular abnormality, the two processes
being inseparable'.
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Since the Crook's report of 1952, optometry in the UK has steadily moved
forward as a profession complimentary to ophthalmology. Under the revised
rules of the General Optical Council on referrals that came into force on
1 January 2000, optometrists are allowed to manage the eye conditions of
their patients, and only refer when clinically necessary. The General
Ophthalmic Services terms of service were similarly amended and
optometrists are required to refer patients 'when appropriate'. In 2001, the
College of Optometrists published a framework for optometric referrals. It
was stated in the framework that referral is intended to be for those
conditions (sight-threatening or health-threatening) that 'the optometrist
might expect to see deteriorate within the period of time before the patient's
next optometric visit' (Framework for Optometric Referrals, 2001). It was
further stated by the College that there are three categories of referral
decisions made by an optometrist: emergency referral, urgent referral and
routine referral. Optometrists are now encouraged by the General Optical
Council to work in close partnership with the Hospital Eye Service. Direct
optometric referral to Hospital Eye Service, as and when appropriate, now
falls within the scope of optometric practice in the UK.
1.4 (g) The titles used and status of Optometry in the European countries
Unlike medicine and dentistry, the status of optometry as a profession in
most EU countries does not exhibit any uniformity or harmony (Table 1.4).
However, there appears to be uniformity in the type of title used which is either
optician or other titles like Optiker, Optikko and Ottico, meaning optician in the
language of the country concerned.
The titles used in Germany protected by law are Augenoptiker or Augenop-
tikermeister which literally mean optician of the eyes or master-optician of
the eyes; almost a reminder of the social status bestowed by membership
of medieval craft-guilds and in a way consistent with the scope of practice
of optometry in the present day Germany. Although in Germany the title
Optometrist is also used, other titles and professional descriptions used by
German optometrists' include Diplom Ingenieur Fachhochsehule (School
Diploma in Engineering) or Augenoptikergeselle (Adviser Optician), Statlich
geprufter Augenoptiker (State examined Optician) or statlich anerkannter
Augenoptiker (State accepted Optician), signifying state recognition of the
optician. In Belgium the profession of optometry is practised with many
restrictions placed under the regulations of the Ministry of Middle classes
and by Royal decrees on the basis of the laws dating from 1964 and amended
in 1966, 1975 and 1988. These decrees have laid down the conditions for
the exercise of the profession of 'optician' in commercial and handicraft
enterprises, small and medium business and small industry. It would appear
from these Belgian Royal decrees referring to opticians in commercial and
handicraft setting etc. that some deeply rooted notions about spectacle
makers or sellers and the status of optics from the craft guilds of medieval
Europe still exist in the minds of lawmakers in Belgium and other EU
countries, hampering the process of professionalisation in optometry.
1.4 (h) The use of the title Optometrist in the United Kingdom
Within the optometric profession in the United Kingdom, a fair
proportion of the membership had favoured the title optometrist for several
decades. The argument being that the title optician was shared by the non-
optometric groups which included dispensing opticians and optical
manufacturers and therefore it created confusion and it was an obstacle to
further professionalisation. Also the literal meaning of the term optician was
maker and seller of optical instruments and spectacles. The title optician could
not have acquired a new 'exclusive definition' because it was shared by the
makers and sellers of spectacles. Interestingly in its report to the Ministry of
Health in 1947, the Eye Services Committee also noted that 'there should be
some clear distinction between "sight-testing opticians" who measure errors of
refraction and fit and supply glasses, and "dispensing opticians" whose function
consists in the fitting and supply of glasses prescribed by others' (Giles, 1952).
Although the Opticians Act of 1958 did not in any way specify the title
optometrist, it was erroneously assumed that a new legislation was required
for the use of this title.
It was further assumed that the use of the title optometrist was deprecated by
the General Optical Council and that it was not a protected title. On the
contrary, section 22 (1 b and 2 b) of the Opticians Act of 1958 had, by
implication, protected all those titles and descriptions meaning or implying
ophthalmic optician or dispensing optician (Lapsus Linguae, Lapsus Calami,
1976 b; Agarwa1,1979). However, in a symposium held in 1961 at the
International Ophthalmic Optical Congress in London, Dr. Sorsby, a medical
practitioner and also a member of the General Optical Council, stated that
he hoped British opticians would not adopt the term 'optometrist' because
interpreted it meant one who measures the eyes (Transactions of the
International Ophthalmic Optical Congress, 1961).
Merely on the grounds of literal interpretation, Dr Sorsby's comments were
not valid because with a similar analogy the term ophthalmology literally
meant the science of eyes and it did not describe the professional work of
an ophthalmologist as accurately as the title ophthalmic surgeon did.
Furthermore, the literal definition of a term may be different from the
professionally and socially accepted definition. For example, non-medical
personnel trained in psychology use the title psychologist, and those dispensing
hearing aids often describe themselves as audiologists; although it could be
argued that the correct titles are psychometrist and audiometrist, because other
titles etymologically similar to psychologist and audiologist e.g. cardiologist,
dermatologist, gynaecologist etc. are used by medically trained specialists
(Lapsus Linguae, Lapsus Calami, 1976 b).
Before the inclusion of the title optometrist in the new Health and Social
Security Act of 1984, frequent comments in the optometric press by some
members of the optometric profession in the United Kingdom rejected the title
optometrist, often in a non-constructive and illogical manner (Lapsus Linguae,
Lapsus Calami,1976 a and b, 1977; Agarwal, 1979). Some correspondents, for
whatever reason, even resented a change of title from ophthalmic optics to
optometry by the UK university departments (Anon, 1977). The young
optometrists decidedly favoured a change of title and in 1979 formed a
British Association of Young Optometrists.
Leaving aside any discussion on the etymology or philological derivation
and literal meaning of the terminology and professional titles related to
the eye, the term optometer was first used by William Porterfield (1696-
1771), subsequently the description optometry was used by Landolt in
1877, although Verschoor in 1865 had already used the description
'Optometers en Optometrie' (Levene, 1977).
However, the title optometrist was fully accepted in North America earlier
than in the United Kingdom. The impact of the Health and Social Security
Act of 1984 was evident in the UK optometric profession. In 1987 the
Association of Optical Practitioners changed its title to the Association of
Optometrists and also in 1987 the British College of Ophthalmic Opticians
(optometrists) became the British College of Optometrists. In 1995 the
College of Optometrists was incorporated by a Royal Charter. The AOP
publication 'Ophthalmic Optician' also changed its title to 'Optometry
Today'. The London Refraction Hospital, formed in 1922, also decided
to become the Institute of Optometry. Despite the adoption of the terms
optometry and optometrist, following the Health and Social Security Act of
1984, by the professional organisations, university departments and the
membership in general, in the official communications from the National
Health Service the title ophthalmic optician was still used, with the title
optometrist in brackets (FPN 534 HC (91) 11 WHC (91) 21, dated April
1991). Taking into consideration that an important factor in the process of
professionalisation is an exclusive identity, whether social, interprofessional
or statutory recognition; the title 'Opticians Register' gives an erroneous
impression of the lack of professional exclusiveness, since the professional
responsibilities of optometrists are certainly different from those of dispensing
opticians. The publication of separately bound registers by the General
Optical Council with the titles optometrists and dispensing opticians would
no doubt provide exclusive identities.
It should be noted that both medical and dental councils provide exclusive
identity in their registers and even the Health Professions Council (formerly
council for professions supplementary to medicine) publishes a separately
bound register for each profession. However, socially and inter-professionally,
British optometrists have succeeded in acquiring an exclusive identity in
recent years. It is significant that it was stated by the Irish health minister in
February 2003 that 'the Register of Ophthalmic Opticians is to be known as
the Register of Optometrists in response to the international acceptance of this
denomination' (Seanad Eireann, 2003).
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1.4 (i) Advertising and Corporate Practice in Optometry
in the United Kingdom
Presently advertising professional services is permitted by the
professional bodies and the state because of the general view that the quality
of the delivery of professional care is a separate issue and not relevant to
advertising. However, issues debated by optometrists and the professional
bodies in the United Kingdom during the early 20th century included
advertising and corporate practice in optometry.
Advertising of professional services and optometric appliances became an
issue during the early days of the British Optical Association. In 1897 an
optician named Barrett was expelled from the British Optical Association for
'appealing to the public in misleading advertisements in regard to the
association' (Mitchell, 1981a). Despite several warnings Barrett had continued
to advertise that he was the only optician in town licensed by the Board of
Trade etc. In 1921 the British Optical Association Council passed a resolution
that a new member will have to undertake, before the award of a professional
certificate, not to advertise 'free sight-testing'. By 1934 the councils of the
British Association and the Worshipful Company of Spectacle Makers had
issued a joint statement on the application of a code of ethics. Members were
not allowed to advertise 'ready to wear spectacles', free advice or free sight-
testing, any special method of sight-testing, any form of self testing or sight-
testing by post (Mitchell, 1981a). The Opticians Act of 1958 upheld these rules.
Ironically, fifty years later, under the Health and Social Security Act of 1984,
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some of these rules were deleted.
Historically, both political and professional environment had favoured
stringent restraints on healthcare providers. Healthcare professions developed
legal and ethical restrictions on advertising or other characteristics of
commercial practice. The exhibition and demonstration of appropriate
characteristics was expected from healthcare professions both socially and by
the state. Within the last two decades, many regulations have come under
scrutiny from the state proposing deregulation on the premise that they
inhibit free market healthcare delivery, keeping prices high and productivity
and innovation low. It was overlooked by the proponents of deregulation that
social expectations from healthcare professions are different when compared
with simple commerce. Opposition to deregulation is based on the grounds
that quality of care deteriorates in a commercial environment
Restrictions on commercial practice in optometry arose as a result of
professional purge of commercial elements in the early decades of last
century. In 1920, the British Optical Association Council expressed concern
when an unqualified person named Bloom with unqualified managers and a
chain of forty optical shops was advertising as 'the largest firm of opticians in
Britain'. Bloom was successfully prosecuted for fraud and was later convicted
and fined.
Report of the interdepartmental committee (Crook's Report, 1952) with Lord
Crook as chairman stated the views of the professional bodies that 'if opticians
wish to be regarded as professional men, they should not advertise at all' and
recommended that the 'General Optical Council should regard advertising as
one of the subjects demanding their urgent attention'. The Crook report also
noted that window displays 'would not be consistent with the development of
professional status'. Window displays of optometric appliances do not signify
specialised education or professional training (Lapsus Linguae, Lapsus
Calami, 1977). The continued existence of corporate bodies in optometry
brought divisions within the optometric community. It was felt by many
independent optometrists that corporate practice carried some definite
drawbacks. For example it was considered not possible for optometrists
delivering eye care in corporate employment to participate in professional
policy and decision making. It was feared that business and even
'professional' decisions of corporate bodies taken at board level by
commercial people and non-optometrists may affect the professional work
of an optometrist. The medical profession does not allow corporate
practice (Lapsus Linguae, Lapsus Calami, 1985). Lack of independent
professional identity in corporate practice was then considered a point
against the professionalisation process. In corporate practices, even if the
name of an employee providing professional service were displayed, the
public would still consider that they were the clients of the corporation,
despite the fact that an individual professional would have provided eye care
services. Although an individual optometrist would carry the legal
responsibility for his professional work, very often the recipients of
professional services with whatever kind of dissatisfaction would consider it
right to contact the business hierarchy of the company. It is one of the
characteristics of a true profession that the circumference of responsibility in
professional practice is not confined to mere legal obligations; moral, ethical
and social considerations being an integral part of professionalisation. In
corporate situations, there is an inherent danger of economic considerations
preceding other factors. Unlike the independent or partnership mode of
practice, an optometrist in corporate employment would not be allowed to
carry total responsibility by that corporation. Crook's report (1952) pointed
out that opticians working for corporate bodies 'could sometimes be subject
to conditions of employment not altogether compatible with professional
freedom, particularly in so far as the function of sight testing is concerned'.
It was also stated in Crook's report that 'new ophthalmic optical companies
should not in future be formed. Those already in existence should be
permitted to continue at the discretion of the General Optical Council and
'there should ultimately be no place for ophthalmic optical bodies corporate
in the future.'
It was further stated that ophthalmic and dispensing optical companies
should not carry on any business other than that of ophthalmic or of
dispensing optics, and in both cases a majority of the directors should be
registered optometrists or dispensing opticians. The council should
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maintain lists of such companies, from which they should have power to
remove offending companies. They should also have power to prevent a
disqualified optician from practising in the employment of a company. Lord
Crook's report also stated that 'the council should discourage opticians from
forming partnerships with people who are not registered opticians'.
1.5	 Summary
This chapter traces the origins and development of the profession of
optometry from the earliest times to the present day, looking at how the
process of professionalisation began in the UK, how it developed, and what
meaning it holds in present times. Significant events have been the
Markham vs. Thomas court case of 1911, the introduction of examinations
in ocular pathology by the British Optical Association, Lord Crook's report,
the passing of the Optician's Act of 1958 and university education in
optometry. Under the GOC revised rules on referrals that came into force on
1 January 2000, British optometrists are allowed to manage the eye
conditions of their patients and only refer when clinically necessary. In
2001, the College of Optometrists published a framework for optometric
referrals. The scope of eye health care work and regulatory status of
optometry in the UK today is compared with its scope and status in the
European Union.
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Use of Diagnostic
Drugs
Use of Fluorescein	 Referial to Medh..al 	 Diagnosis of OLular	 Monitoring of Ocular
Only	 Practitioner	 Pathology	 Pathology
X Belgium
* Hungary
XIreland
* Norway
* Poland
X Portugal
* Slovenia
X Spain
Eye examinations by optometrists and ocular pathology
X Austria	 •
* Croatia
* Czech Republic
XDenmark
X Finland
X France
XGermany
XGreece
X It*
XLuxembourg
X Netherlands
XSweden
j Switzerland
y United
" Kingdom
(optometrists)
• • 
•
•  
• •
• 
•  
• •
•
•  
• 
• •	 • 
•
•  
• •	 • 
• •	  
•  
• •	 •	 •
Key to Symbols:
X = European Union * = European Economic Area
* = EU Applicants j = Other
Table 1.1
Source: European Council of Optometry and Optics (1998)
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Scope of eye examinations by optometrists
Eye examinations by optometrists are either done within the law of the country or are not specifically prohibited by the law
Subjective Refiaction
	 Objective Refraction	 Use of Diagnostic Instruments 	 Prescription of Optical Appliances
• •	 •	 •X Austria
X Belgium
Croatia
-'- Czech Republic
.1`•
XDenmark
X Finland
xFrance
X Germany
X Greece
Hungary
X Ireland
X italY
x Luxembourg
X Netherlands
# Norway
Poland
X Portugal
* Slovenia
X Spain
XSweden
Switzerland
X United Kingdom
(optometrists)
• •	 •
•
• 40*	 •.* 
• •	 •	 • 
• •	 •	 •
• 4***	 •
• •	 •	 •
• •	 •	 • 
• •	 •	 • 
***	 •-**	 •**
• •	 •	 • 
• •	 •	 • 
• •	 •	 • 
• •	 •	 • 
• •	 •	 •
• •	 •	 • 
• •	 •	 • 
• •	 •	 • 
• •	 •	 •
* 
only under supervision of ophthalmologist
**
within limitations
Key to Symbols:
X = European Union * = European Economic Area
= EU Applicants
	
= Other
Table 1.2
Source: European Council of Optometry and Optics (1998)
•
• •
• •
• .1P
(optometrist)
•
•
•
•
• •
(dispensing optician)
•
• •
•
X Austria
X Belgium
* Croatia
;•.'{ Czech
' Republic
xDenmark
X Finland
X France
X Germany
XGreece
* Hungary
X Ireland
X Italy
x Luxembourg
X Netherlands
• 
• 
•
(optometrist)
•
(optometrist)
•
de facto 
• 
•
• • 
•
•
• •
•
•
* Norway
Poland
x Portugal
* Slovenia
X SPain 
X Sweden
Switzerland
United
Kingdom
loCitometrists)
•
(dispensing optician)
•
(optometrist)
Dispensing of optical appliances by optometrists and opticians
Dispensing may involve the supply, adaptation, fining and sale of optical appliance.
0 1 .,peitse CoiteCliVe	 Fit Coma( t Lenhes	 Fit Contact Lenses Alec	 fit Lont,it.1 Lenses 11. 1 ,/f11 nnnn)
SPOCIALleti
	
...num! Restriction 	Extra Training Only 	 Ophthalmologists Pi VSL r ut ui Oil,,
only under supervision of ophthalmologist
Key to Symbols:
X = European Union * = European Economic Area
= EU Applicants J = Other
Table 1.3
Source: European Council of Optometry and Optics (1998)
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Regulatory status of optometric and optical profession
Opticians make, fit and sell spectacles. Optometrists examine eyes, perform refraction and sometimes detect disease, injury or
abnormality of the eye. Optician-op tometnsts and optometrists are essentially the same profession
Legally Recognised
Optician-OptometristLegally Rei ogrused Legally Recimniced Optoniell n sl	 De l. .1(.1( Opturiwgisi
X Austria
XBelgium	 •
* Croatia	
•
Czech Republic	 •
X Denmark
X Finland
X France
XGermany
XGreece 
* Hungary
X Ireland
X Italy
X Luxembourg
X Netherlands
* Norway
* Poland	 •
X Portugal
* Slovenia	 •
X Spain
X Sweden
•
•
•
•
•
Switzerland	 •
, / United Kingdom	
•
	
•
* can only practise under supervision of ophthalmologist
Key to Symbols:
X = European Union * = European Economic Area
= EU Applicants J = Other
Table 1.4
Source: European Council of Optometry and Optics (1998)
Chapter 2
Health Care Resources in the European Union
2.1 Introduction
Health care is one of the basic human necessities and an integral
part of social organisation and welfare system for the population within any
state. When the National Health Service was established in the United Kingdom
over half a century ago, the concept of scarcity of resources was not even
considered applicable to health care planning and delivery especially in
British society. The ambitious planners were aiming for the creation of
something unique and the best model for the world. The health service,
easily accessible to the people in the UK was designed to fulfil socialistic
and moralistic ideals with an overall caring perspective.
However, in recent years there has been a growing debate on the question of
allocation and scarcity of health care resources and economics of providing
adequate health care in many countries including the United Kingdom and
other European Union member states. Health care related issues and problems
including the global scarcity of professional people are periodically reviewed
by the World Health Organisation, supported by epidemiological studies and
followed by appropriate recommendations (WHO, Fact Sheet no. 213, 2000).
Although scarcity of health care resources continues to be a subject of debate
and discussion among health care planners and economists in many countries,
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recipients of health care services and even some healthcare professionals may
be oblivious to such high level discussions. The fact that scarcity of natural
resources exists in the world has led some economists to compare it with health care
resources (Fuchs, 1980). However, it is debatable whether such comparisons are
valid. It is accepted by most people, including healthcare professionals, that
appropriate technological and scientific knowledge should be applied to explore
alternatives such as solar energy to continue power supply and that such projects
are expensive Health care resources can not be regarded in the same light as
natural resources despite that fact that consumers do expect the state to provide
continuing health care. Unlike natural resources, perhaps the only alternative to
health care is more health care.
Provision and allocation of health care resources requires a rational, critical
and logical analysis and a proper understanding by the state of the importance
and benefits of adequate funding in all areas of socia/ orgaiiisatiaa iEckidiag
health and welfare; and also social implications and economic consequences
of inadequate funding and insufficient provision for different professional
services for the people.
In the present times it is generally accepted that resources of any kind, including
those applicable to health care delivery, are scarce and allocation of these
resources is linked to complex state budgets, specialised and applied health
care economics, demographic factors, epidemiological studies and professional
manpower which requires fairly lengthy and costly education and training.
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Therefore, any evaluation for the purposes of allocation of funds requires
systematic analysis of available social and health related statistics, numerous
critical calculations and crucial decisions, also taking into account the
availability of the required number of professional people and technology
suitable for the delivery of effective health care.
There are two basic patterns of health care in the European Union. Some
countries provide National Health Services in which provision and financing
is primarily within the public sector. Under the second system services are
provided from private (usually non-profit) and public organisations financed
mainly from compulsory health insurance. Within these broad categories there is
considerable diversity in terms of financing, methods of organisation and the
pattern of delivery of health care. For example the Netherlands has a mixture
of public and private insurance, whereas in France most health insurance is
controlled by the state. In Germany a large number of funds are held by
occupation-related insurance schemes, whereas in Denmark funds are usually
controlled by county administrations (Commission of the European Communities,
Brussels, 1995).
2.2 Expenditure on Health Care in the European Union Countries
The population of the EU was approximately 374 million in 1997. With an
enlarged EU on 1 May 2004 it will be over 450 million. In 1996, 23.7% of the
EU population was under 20 years old, 20.8% of EU people were over 60 years
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old and 3.9% were over 80 years old. In 1994-96 EU countries spent approximately
between 6% and 10% of GDP on health care (10 to 15 % ofpublic expenditure). The
growth rate of the share of health care on GDP is considered equal to the growth rate
of per capita health expenditures minus the growth rate of per capita GDP. This should
be included as an explanatory variable (Barros, 1998).
GNP and GDP are useful tools for calculating national and domestic economic growth,
expenditure and budgets. The GNP is identical to GDP except that the former includes
income accruing to national residents from investments abroad. The GDP covers the
total value of finished goods and services produced by the national economy for a
specified time, usually one year. It does not include income from the domestic
economy to resident non-nationals. Unlike the GNP, GDP does not include the
accruing income to national residents from foreign investments. The GDP is based
upon the domestic economy, calculated before allowance is made either for
depreciation, consumption of capital or capital expenditure in production of
goods. Because of diversity in output of finished goods and services and variation
in methods of calculating costs, and the size of socio-economic inequalities in
determinants of national products, caution must be exercised in comparing
expenditure on healthcare in different European Union countries (Table 2.1).
Counting of both raw materials and finished goods (double counting) has to be
avoided for accurate economic evaluation of final products. Factors like the numbers
of unemployed, the ageing population and expenditure on social services like social
security benefits have to be taken into account before any meaningful comparisons
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can be made of the expenditure on health care (Table 2.1).
The present UK government's spending target of 8% of GDP is less than that
currently being spent on healthcare in the EU. Supposing the spending target in
the UK were the same as the EU average, a 5% real annual growth in the NHS
funding (after adjusting for inflation) would be insufficient to achieve it by the
year 2006 (Towse & Sussex, 2000). To achieve the level of spending like the
rest of the EU, the UK government would have to put 9.1% of its GDP
(not 8° o) into health care. This would require real increases in NHS spending
of 7.7°0 to 8.7°0 per annum for the period 2001-2006 (Towse & Sussex, 2000).
An average annual growth of 6.1% in real terms may not bring the UK up to the
European Union average of spending on health care (Klein and Dixon, 2000).
GDP or Gross Domestic Product may include the activities of economic operators
in the economic territory of a country, regardless of nationality, depending upon the
economic policies of the country. However, GNP or Gross National Product is the
final measure of total output, without any duplication, in any economic territory
during any specified period. GNP is predicated upon the nationality of the operators.
GNP is also regarded as a convenient indicator of economic activity of a country.
For most members of the European Union GDP and GNP are practically the same.
A difference of just 1 0 0 between GDP and GNP has been known to exist in four
European Union states with only two exceptions. In Ireland GNP was known to
be 13% below GDP and in Luxembourg GNP was 34% above the figure of GDP.
(Europe in Figures, 1992).
80
Health Care Expenditure in the EU
Approximate Population
in millions (1997)
Approximate Expenditure on Health
Share % of GDP
1994	 1995 1996
Austria 8.04 7.8 7.9 7.9
Belgium 10.13 8.1 8.0 7.9
Denmark 5.21 6.6 6.4 6.4
Finland 5.09 7.9 7.7 7.5
France 58.02 9.7 9.9 9.6
Germany 81.55 7.9 7.7 7.5
Greece 10.42 5.5 5.8 5.9
Ireland 3.57 7.6
Italy 57.24 8.4 7.7 7.6
Luxembourg 0.40 7.5 7.0
Netherlands 15.42 8.8 8.8 8.6
Portugal 9.91 7.8 8.2 8.2
Spain 39.17 7.3 7.6
Sweden 8.8
UK 59 6.9 6.9 6.9
Table 2.1
Source OECD 1996
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In 1993 in the EU countries, public spending accounted for three-quarters of total
spending on health care. Between 1980 and 1996, public speriding rose more slowly
than total spending in the EU member states and the average annual growth rate of
total health expenses exceeded GDP growth. In 1996 Germany and Luxembourg
spent almost 50% more per person on health care than EU average and in fact over
four times as much as Greece (Europe in Figures, 2000).
However, it has to be noted that any difference in health care expenditure growth
across different countries must take into account difference in costs. Higher or
lower costs in health care expenditure do not imply a higher or lower health
care expenditure growth rate. It is possible that countries with a higher health care
expenditure because of higher costs may have a lower health care expenditure
growth on per capita basis.
2.3 Health Care Professionals in the European Union
Tables 2.2 - 2.5 provide the number of Physicians, Dentists, Pharmacists and
Nurses per 100,000 inhabitants in the European Union states between 1985
and 1996. Between 1980 and 1996 the total number of physicians, dentists,
pharmacists and nurses had risen in all member states. In 1996 the number of
physicians per 100,000 people ranged from 174 in the UK to 569 in Italy (Table 2.2).
The UK has the lowest number of physicians according to these figures. However,
despite the fact that medical education is expensive, it has to be noted that some EU
countries like Italy and Spain with the highest number of medical graduates have
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unemployed doctors (Herzmann, 2003). Some Italian doctors never find work in
medicine (Thorne, 1996).
In the UK on 31st March 2001 the total membership of the Royal College of General
Practitioners was 18,917 (11,695 M; 7333 F) according to the Royal College of General
Practitioners reference book 2001-2002. The figures quoted by the publishers of
'Europe in Figures' may have included those registered medical practitioners in the UK
who are not members of the Royal College of General Practitioners.
Dentists range from 28 per 100,000 in Finland to 38 in Spain and around 104 in
Greece and Sweden (Table 2.3). Belgium, Finland and Spain have the largest number of
pharmacists per 100,000 people (Table 2.4). Nurses range from 2,130 per 100,000 in
Finland to 348 in Portugal (Table 2.5). The EU pharmaceutical spending represents
between 10°0 and 20°0 of total health care spending. France has the highest EU
consumption of medical and pharmaceutical products per person and UK the lowest
(Europe in Figures, 2000).
It is evident from above figures that there are major social and cultural differences in
the dimension, provision and pattern of healthcare within the EU. It is debatable
whether the concept of health and illness, the measurement of provision of health
care, the number and social distribution of healthcare professionals and the
explanation of the pattern of health care expenditure can ever be harmonised
within the EU.
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Physicians in the EU States per 100,000 inhabitants
1985	 1991	 1994	 1996
Austria	 257.4	 308.7	 339
Belgium	 292.4	 343.2	 364.5	 378.3
Denmark	 253.9	 290.6
Finland	 247.2	 269.8	 284.9
France	 271.7	 281.7
Germany	 255.9	 306.2	 328.5	 341.4
Greece	 293.4	 365.1	 388.9	 393.0
Ireland	 162.2	 170.3	 199.7	 210.8
Italy	 380.3	 504.5	 547.4	 569.7
Luxembourg	 181.0	 202.9	 228.2
Netherlands	 222.7
Portugal	 243.7	 286.9	 293.6	 301.4
Spain	 331.7	 394.4	 414.4	 421.9
Sweden	 289.9
UK	 151.2	 161.4	 164.5	 174.5
Table 2.2
Source : Europe in figures 2000
84
Dentists in the EU States per 100,000 inhabitants
	1985 	 1991	 1994	 1996
Austria	 40.7	 43.0	 45.0	 47.1
Belgium	 60.0	 71.4	 69.0	 69.9
Denmark	 92.7	 88.9	 88.1
Finland	 91.3	 92.3	 93.7
France	 64.0	 68.8
Germany	 62.6	 68.9	 72.8	 75.0
Greece	 88.1	 100.6	 104.4
Ireland	 33.0	 38.3	 41.9	 44.5
Italy	 59.9
Luxembourg	 45.9	 51.5	 49.6
Netherlands	 49.2
Portugal	 12.6	 17.1	 23.3	 28.0
Spain	 13.4	 28.9	 33.9	 37.9
Sweden	 103.9
UK
	 37.3	 38,3	 40.7	 41.7
Table 2.3
Source: Europe in figures 2000
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Pharmacists in the EU States per 100,000 inhabitants
1985	 1991	 1994	 1996
Austria	 41.5	 46,0	 50.0
Belgium	 107.6	 123.5	 132.3	 137.3
Denmark	 275,',	 27122,	 5,722,7	 50.4
Finland	 144.8	 138.5	 140.1	 141.7
France	 41.2	 45.3	 46.3
Germany	 46.3	 52.2	 53.9	 55.7
Greece	 60.4	 75.2	 78.3
Ireland	 58.3	 62.3	 65.4	 70.5
Italy
Luxembourg	 69.4	 82.2
Netherlands	 13.1	 15.2
Portugal	 41.6	 59.9	 63.9	 68.4
Spain	 79.7	 96.9	 103.1	 110.1
Sweden52.4	 ........
UK	 34.1	 36.5
Table 2.4
Source: Europe in figures 2000
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Nurses in the European Union States per 100,0'00 inhabitants
1985	 1991	 1994	 1996
Austria	 630.5
	 761.7
	 845.9	 7,11121
Belgium	 2511271;	 7171,7,	 1,7117,	 7751,5
Denmark	 581.7	 887.7
Finland	 1623.2	 1879.0
	 2071.1 2129.9
France
Greece
Ireland
Italy
Luxembourg	 596.4
Netherlands
Portugal	 239.7
	 298.0
	 323.5	 347.8
Spain
Sweden
UK
Table 2.5
Source Europe in figures 2000
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2.4 Eye Care Professionals in the European Union
Ophthalmology being a medical speciality, is fully identifiable both
educationally and structurally within the European Union member states,
providing a well established and internationally recognised professional service.
However, in the field of optometry it can be easily observed that within the
European Union there is considerable inequality of professional standards in the
services provided and a lack of harmonisation. The standard of professional
education and training, nomenclature of qualifications, titles, designations and
scope of practice in optometry within the European Union remains diverse.
However, as stated previously, there are signs that some progress is taking place
in the area of optometric education, for example, as mentioned previously,
the optometry degree from Utrecht, Netherlands were recently accepted by the
General Optical Council for registration in the United Kingdom (Grit, 2002).
Outside the EU but within Europe, the optometry degree course in Norway is being
modelled on the lines of British optometry degrees and the GOC have already been
invited as visitors. Optometrists holding Spanish university degrees can obtain
British registration after successfully completing a GOC approved supplementary
course in the UK (Martinez-Moral, 2002).
Optometrists in many EU countries are trained increasingly at universities and
institutes of an equivalent level and courses normally last three or four years.
This is the case in Finland, France, Germany, Ireland, Italy, the Netherlands, Portugal,
Spain and Sweden. Elsewhere, optometrists are usually trained at a technical school
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after high school, having gained either an intermediate high school certificate or a
baccalaureat i.e. a final high school certificate. Usually a course lasts two or three
years and includes a period of apprenticeship within an optical firm. Opticians are
also trained at a technical school after leaving secondary school.
Compared with the UK, German optometric education remains deficient in biomedical
aspects (Cagnolati, 2002). In Table 2.6 all those using the title Optometrist and
similar professionals in optometry/optics are listed, despite any variation in the
standard of education and scope of practice, variations in statutory regulations or
a lack of appropriate statutory regulations. The figures from Table 2.6 are presented in
Table 2.7 on the basis of eye care professionals in the EU states per 100,000 people.
In 1996 the number of ophthalmologists per 100,000 people ranged from approximately
14.39 (highest) in Greece to 1.27 (lowest) in the UK (Table 2.7). It should be noted
that in Greece, primary eye care is provided by ophthalmologists because optometric
practice contravenes their national laws. In the UK, unlike other EU countries except
Ireland, primary eye care is provided by optometrists. Because of variation in training
standard in optometry and scope of optometric practice, the description 'eye care
professional' does not carry the same meaning in the continental EU countries as it
does in the UK and Ireland. Therefore, any comparison of the numbers and distribution
of eye care professionals in the EU may not provide information concerning the
pattern of primary and secondary eye care.
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Number of Eye Care Professionals in the EU (1996)
(Approximate figures)
Includes all those using optometrist or similar tale despite
variation in training standard and scope of practice
as compared with the UK optometric profession
Country	 Ophthalmologists
	
Optometrists/Opticians
Austria	 560	 1200 Augenoptiker-meister
Belgium	 850	 3000 Diploma Holders
Denmark	 225	 1900
Finland	 380	 1170
France	 5400	 10000
Germany	 4000	 10500 Augenoptiker-meister
Greece	 1500	 30-40 Optometrists
1200 Opticians
Ireland	 31 Consultant
	
354 Optometrists
Ophthalmologists
	
160 Ophthalmic
	
138 Dispensing
	
Physicians
	
Opticians
Italy	 6000	 30000 Diploma Holders
11000 Working
Luxembourg	 31	 41
Netherlands	 420	 1350 Optometrists
2250 Opticians
Portugal	 650	 330
Spain	 3500	 6000
Sweden	 500	 1550
UK	 750	 7000 Optometrists
3650 Dispensing Opticians
Table 2.6
Source ECOO 1996
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Eye Care Professionals in the EU States per 100,000 inhabitants
Approximate figures 1996
Country	 Ophthalmologists	 Optometrists/Opticians
Austria	 6.96	 14.92 Augenoptiker-meister
Belgium	 8.39	 29.61 Diploma Holders
Denmark	 4.31	 36.40
Finland	 7.46	 22.98
France
	
9.30	 17.23
Germany	 4.90	 12.80 Augenoptiker-meister
Greece	 14.39	 0.33 Optometrists
11.51 Opticians
Ireland	 0.86 Consultant 	 9.91 Optometrists
Ophthalmologists
4.48 Ophthalmic	 3.86 Dispensing
Physicians	 Opticians
Italy	 10.48	 52.41 Diploma Holders
19.21 Working
Luxembourg	 7.75
	 10.25
Netherlands	 2.72
	 8.75 Optometrists
14.59 Opticians
Portugal	 6.55	 3.32
Spain	 8.93	 15.31
Sweden	 5.68	 17.60
UK	 1.27	 11.86 Optometrists
6.18 Dispensing Opticians
Table 2.7
Based upon ECOO figures (1996)
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2.5 A Panoramic view of Harmonisation of
Professions in the European Union
Union of several states with social, cultural and political diversity and
economic inequality is a relatively complex phenomena. The state is an
autonomous social institution regarded as a formal entity and it is organised
around several social functions which includes the provision of health and
education, enforcement of law and order and providing for general welfare
of people; thus the state consists of numerous and varied social institutions
including those classed as professions. States enact statutes sometimes peculiar
to their own social system, culture and traditions. States also tend to protect
their culture and guard their boundaries from intruders and any external threat.
With this background any suggestion of a full union of states with different cultures
and traditions may arouse suspicion amongst people. Some people may fear a possible
loss of their identity and erosion of their culture from a dominant or aggressive culture
within the Union or a fear of economic dominance from a dominant or aggressive
economy within the Union or a fear of any other form of domination.
Sir Winston Churchill used the phrase 'United States of Europe' several
times in the 1940's, during and after the second world war. For example in
October 1942 Sir Winston used this phrase while writing to his Foreign Secretary
and also publicly in Brussels in November 1945 and in Zurich in September 1946
(Wistrich, 1994; Agarwal, 1998 b).
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The term 'European Federation' was also used during the second world war
by several organisations e.g. Federal Union in Britain and the European
Union of Federalists on the European continent. After the war the French
foreign minister also used the term 'European Federation'. However, in 1951
six countries namely Belgium, France, West Germany, Italy, Luxembourg and
The Netherlands signed the Treaty of Paris which set up the European Coal and
Steel Community (ECSC).
Following the treaty of Rome in 1957 and the formation of a European Economic
Community, the term `European Union' came into usage after the Maastricht
agreement of 1991. The Treaty on European Union, also known as the Union Treaty
or the Maastricht Treaty was signed in 1991 and came into effect in November 1993.
In March 1997 the total population of the European Union comprising 15 member
states was approximately 372 million representing 8 per cent of the total world
population (Roney 1998). Although these states as full members of the EU are
given equal voting rights, there is a marked difference in the population figures.
These states represent distinct social and cultural systems and different regulations
concerning professions.
Taking into account the panorama of social and political issues and events and
especially dissimilarities in training and structure of professions like optometry, the
process of harmonisation of professions in the European Union remains a formidable
task. The professional culture in the European Union remains diverse and additionally
the level of development of the scientific and professional research and the standard
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of available literature in different languages of Europe remains varied.
2.6 Harmonisation of optometric profession
in the European Union
Harmonisation of all professions within the Union is one of the aims of the
European Commission, despite any structural or functional dissimilarities which may
exist in some professions. However, health care resources in the whole of the
European Union can be divided into two categories. The first category comprises
those health care professions such as medicine, dentistry and nursing which are
structurally and functionally similar throughout the EU and classed as harmonised.
In the second category professions such as optometry are structurally and functionally
dissimilar and not fully harmonised.
Taking into consideration the diversity of the optometric profession in the EU, the
announcement in 1998 by the Association of European Universities, Schools and
Colleges of Optometry (AEUSCO), supported by the European Council of Optometry
and Optics (EC00), that a European Diploma of Optometry will be offered was
probably not much of an event. A European Diploma of Optometry, designed to
provide a kind of hegemony over the optometric profession in the EU, was a step
towards harmonisation. The British Department of Health maintained a careful interest,
without direct input, in these developments (Bowis, 1995).
The first examinations, conducted in English, French and German, were held in
November 1998 in the UK, France and Germany. Out of 23 candidates, two
successfully completed all parts of the examination. The General Assembly of the
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European Council of Optometry and Optics, meeting in June 2001 at Helsinki
(Finland), decided to award the contract to manage the European Diploma of Optometry
to the German organisation, the Zentralverband der Augenoptiker (ZVA). The total
number of candidates taking all or some parts of the examinations conducted by the
ZVA in 2002-2003 was 30. Three candidates successfully completed all parts of the
examination (Zeilhoff, 2004).
In November 2002 at the ECOO meeting, held at Budapest (Hungary), it was
envisaged that the diploma will be available through several European optometry
universities, to 'top up' their degrees to the diploma standard. It was further envisaged
that each participating optometry school will be assessed by the ECOO and the
qualification they issue will be considered equivalent to European Diploma by the
year 2010. However, a diploma of this nature does not change the official status of
optometry in the EU. Optometry is not legally recognised in most EU countries.
The level of optometric training and enactment of statutory regulations in an EU
member country is a matter between the state, the medical profession,
ophthalmologists and those who wish to describe themselves as optometrists.
The process of professionalisation in optometry has been diverse for a considerable
period in all those countries which now constitute the European Union.
Harmonisation of professional optometry in the EU remains a slow and arduous
process. It is realised by the all concerned that a political treaty can not impose
instant harmonisation of different professional cultures. The treaty of Rome in 1957
did not result in any culmination of common optometric acts in the member states;
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whereas in 1958 in the United Kingdom, although not a member of the European
Economic Community at the time, a comprehensive act (Opticians Act of 1958)
pertaining to the practice of optometry was passed by the British Parliament resulting
in statutory registration of optometrists.
A lack of optometric education in Greece as against advanced education in the
UK are examples of variations in the level of optometric education in the EU.
The development of optometric education in the UK includes the creation of a
chair of Ocular Medicine in 1997 and appointment of an ophthalmologist to that
post in the Optometry department of the City University, London (Agarwal,
1997b). In 1995 a proposal was made to launch an ophthalmology and optometry
post-graduate degree course in the United Kingdom, combining the academic
resources of an ophthalmology department of a medical school and an optometry
department of a university (Anon, 1994). In October 2002 an optometrist was
appointed as a Professor of Ophthalmology at the University of Manchester. The
aforementioned developments in the British optometric profession remain without
any parallel in the other EU countries.
2.7	 Mutual Recognition of Professional Qualifications
in the European Union
The main legislation of the EU which affected the professions are the general
directives (89/48 EEC and 92/51 EEC ) for the mutual recognition of professional
qualifications. Optometrists are considered under the first directive (89/48 EEC)
and Dispensing Opticians under the second directive (92/51 EEC), However Sectoral
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Directives provided mandatory and automatic recognition of qualifications within
the EU states covering certain professions e.g. medicine, dentistry and veterinary
surgery. Sectoral Directives such as the 1977 directive covered freedom to provide
cross-border legal services and 20 years later, according to the 1997 directive, lawyers
qualified in one member state are fully entitled to practice in another member state.
The general directive of 1988 covered mutual recognition of professional qualifications.
This directive covered professions regulated by the state or by a chartered professional
association. The minimum education and training period required was accepted as three
year's post baccalaureate full time education leading to a university or equivalent
qualification. A commission study on recognition of professional qualifications and
diplomas was completed in 1994.
Provided the education and training leading to a professional qualification from a EU
member state was equivalent to that in another EU member state, then the qualification
will be deemed as equivalent and the holder of that qualification will not have to
re-qualify and will be allowed to become a member of that profession. However,
if the education and training was considerably different either in content or time then
the 'host' EU member state can require an aptitude test or a period of 'supervised
practice' of not more than three years without any need for re-qualifying.
Under the first and second general directives the General Optical Council has already
accepted the following qualifications in Optometry and Dispensing Optics from some
EU member states on an informal basis as being equivalent to the scope of practice
in the United Kingdom ( Table 2.8).
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European Union Directives on the Mutual Recognition of Qualifications
First and Second General Directives
Qualifications in Optometry and Dispensing Optics accepted by the
GOC as being equivalent to the scope of practice in the UK
EU Directive	 Profession	 Country & Qualifications
First General Directive	 Optometry	 Republic of Ireland
Optometry graduates or
equivalent
First General Directive	 Optometry	 Germany
Augenoptiker Meister together with
he Masters in Clinical Optometry
awarded by the Pennsylvania
College of Optometry USA
First General Directive	 Optometry	 Austria
Augenoptiker Meister together with
the Masters in Clinical Optometry
awarded by the Pennsylvania
College of Optometry USA
First General Directive	 Optometry	 Netherlands
Optometry graduates from the
Utrecht University (Post 1998)
Second General Directive Dispensing Optics France
Brevet de Teclmicien
Superieur Optician-Lunetier
Table 2.8	 ,
Information supplied by the General Optical Council (2002)
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2.7 (a) Mutual Recognition of Medical Qualifications
The basic principle of community law provided that the doctors have 'the
right of establishment as a self employed or employed person in any member state
of the European Union' subject to recognition of their qualifications. Simplified
authorisation and registration procedure merely to provide medical services in
another EU member state have also been provided. Recognition of medical
qualification is mandatory and automatic only if it was acquired in a EU member
state and listed in the directive.
Mandatory and automatic recognition of medical qualification for all EU member
states only applied if the qualification entitled a doctor to practise general medicine
or a medical speciality common to all EU member states and listed in the directive.
If qualification in a medical speciality was common in some EU member states
only and listed in the directive then recognition is mandatory and automatic
only in those EU member states. Other medical specialities which are either not
listed in the directive or are covered in respect of the 'host' EU member state,
recognition is granted on a case by case basis, only after the host EU member
state has made a comparison between the education and training received in the
EU member state of origin and that which is available in the host EU member
state. Applicants may in some cases be asked to undergo additional training.
In specific cases, especially older forms of training undertaken in some EU
member states prior to implementation of directives or qualifications with different
designations, recognition may be subject to certain requirements being fulfilled.
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There is no provision for general recognition of training received in countries
outside the EU member states. Such recognition, however, may be granted
by EU member states and it is binding only on the EU member state that grants
it and limited to the territory of that EU member state. The authorities of the
host EU member state have three months to process an application and to take
up the activity concerned. Any decision not to grant recognition must be a
reasoned one and it must also be possible to appeal against such decisions
in the national courts.
2.7 (b) Mutual Recognition of Dental Qualifications
The basic principle of community law provided that the dentists, like the
doctors, have 'the right of establishment as a self employed or employed person in
any member state of the European Union' subject to recognition of their qualifications.
Simplified authorisation and registration procedure merely to provide dental services
in another EU member state have also been provided. Recognition of dental qualification
is mandatory and automatic only if it was acquired in a EU member state and listed
in the directive. Mandatory and automatic recognition of dental qualification for
all EU member states only applied if the qualification entitled a dentist to practise
in a EU member state and is listed in the directive. For specialist qualification in
orthodontics and oral surgery, if listed in the directive, recognition is mandatory and
automatic only in those EU member states. Other dental specialities which are either
not listed in the directive or are covered in respect of the 'host' EU member state,
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recognition is granted on a case by case basis, only after the host EU member state has
made a comparison between the education and training received in the EU member
state of origin and that which is available in the host EU member state. Applicants may
in some cases be asked to undergo additional training. In specific cases, especially
older forms of training undertaken in some EU member states prior to implementation
of directives or qualifications with different designations, recognition may be subject to
certain requirements being fulfilled.
There is no provision for the recognition of dental training received in countries
outside the EU member states. Such recognition, however, may be granted by EU
member states. Such recognition is binding only on the EU member state that grants it
and limited to the territory of that EU member state. The authorities of the host EU
member state have three months to process an application and to take up the activity
concerned. Any decision not to grant recognition must be a reasoned one and it
must also be possible to appeal against such decisions in the national courts.
2.7 (c) Mutual Recognition of Qualifications in Paramedical Professions
First general directive on the liberal professions included optometry which
required three year's post baccalaureate full time education leading to a state
recognised qualification. The second directive included dispensing optics which
required two year's full time or equivalent education after high school. These
directives were different from sectorial directives which allowed medical, dental
and veterinary practitioners mutual recognition and freedom of movement within
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the EU. With the exception of General Care Nurses and Midwives, the
paramedical professions are included in the general system for the recognition of
professional qualifications in the EU member states. The profile of two professions
with the same name and designation or with different names and designations in
different EU member states may vary considerably.
The paramedical professions are subject to the rules and regulations in force in the
EU member state in which the profession in question is practised; the authorities in
that country lay down the conditions governing the right to take up and practice the
profession. In most cases the paramedical professions are closely regulated; practitioners
must be registered and enjoy a monopoly in providing treatment in their fields. In some
EU member states specific professional activities may be restricted to medically
qualified practitioners. For example only doctors are allowed to practise alternative
medicine, chiropractic and osteopathy in Austria, Belgium, France and Italy. However,
in some member states, persons not qualified as doctors holding other qualifications
are also allowed to practise alternative medicine or other specialities. For example:
Heilpralctiker (healers i.e. healer non-medical practitioners) in Germany; Chiropractors
in Denmark, Finland and the United Kingdom; Osteopaths in Finland and the
United Kingdom.
The paramedical professions listed in the general system for the recognition of
professional qualifications include optometrists, dispensing opticians and
orthoptists. Other paramedical professions included : care assistants, chiropodists,
chiropractors, dental hygienists, diagnostic radiographers, dieticians, hearing aid
makers, laboratory technicians, occupational therapists, osteopaths, physiotherapists,
masseur, psychologists, psychotherapists, speech therapists and specialist nurses.
2.7 (d) Mutual Recognition of Qualifications held by
Specialist Nurses , General care Nurses and Midwives
In some member states general care nurses also carry out specialist nursing
work. The recognition of qualification of specialist nurses, however, is covered by
the general system which also covers the recognition of paramedical professional
qualifications.
When a specialist nurse wishes to work in a member state where that specialist work
is undertaken by general care nurses the applicants are given two options. General
care nurses with specialist training who first acquired one of the general care
nursing qualifications listed in the directive are allowed mandatory recognition.
In cases of those nurses with specialist training who did not acquire general care
nursing qualification listed in the directive, the host EU member state must examine
such training and compare with their own training requirements. In those cases where
the difference between two professional qualifications is too great the general system
does not apply. The basic principle of community law provided that General Care
Nurses, like the doctors and dentists have 'the right of establishment as a self employed
or employed person in any member state of the European Union' subject to recognition
of their qualifications. Simplified authorisation and registration procedure merely to
provide general care nursing services in another EU member state have also been
provided. Recognition of General Care Nursing qualification is mandatory and
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automatic only if it was acquired in a EU member state and listed in the relevant
directive. If a general care Nursing qualification was recently..acquired and entitled
the holder to obtain registration in his/her home state then recognition in other EU
member states is mandatory and automatic.
However, recognition of older forms of training obtained prior to implementation of
directives or qualifications with different designations may be recognised subject to
the fulfilment of certain requirements. In the event of any legitimate doubts about the
authenticity of the nursing diploma held by the applicant, the host member state may
ask the relevant authorities, in the member state of origin of the applicant or the
member state from which he/she comes, to provide confirmation that the diploma is
authentic and the holder fulfils the minimum training requirement under the directive.
The authorities in the host member state are allowed three months to process an
application. Any decision not to grant recognition must be a reasoned decision.
Appeals can be made in the national courts against such decisions. There is no provision
for the recognition of nursing training received in states outside the European Union.
Recognition to such training may be granted by the EU member states but it is binding
only on the EU member state that grants it and does not extend beyond the territory
of the member state.
The basic principle of community law provided that Midwives, like the General Care
Nurses, have 'the right of establishment as a self employed or employed person in any
member state of the European Union' subject to recognition of their qualifications.
Qualifications acquired in a EU member state and listed in the relevant directive
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are eligible for mandatory and automatic recognition in all the EU member states.
2.8 Proposed New Directive from the European
Union on the Mutual Recognition of Professional
Qualifications
The European Parliament, the Council and the Commission at the time of the
adoption of the proposed new directive number 2001/19/EC in May 2001
agreed that 'it is important to have consolidated versions, easily accessible to everyone,
of the legal texts applicable in the field of mutual recognition of qualifications'.
The commission stated its intention to continue this work in two parts, initially to
integrate the Sectoral Directive into a consolidated framework and then examine the
'possibility of consolidating the Directives relating to the general system in order to
continue simplifying the legislation and further facilitate the free provision of
services with regard to the conclusion of Lisbon summit'.
The commission also created a high level task force on Skills and Mobility which
produced a report in December 2001. The report stated that the' EU and Member
States should attach priority to increasing the speed and ease of professional
recognition (for regulated professions) including conditions supporting more
automatic recognition and introduce a more transparent and flexible regime for
the recognition of qualifications in the regulated professions by 2005'. The
commission further stated that a 'clear, secure and quick system for the
recognition of qualifications in the field of the regulated professions is required
to ensure free movement'.
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This is important to help to ensure that employment vacancies are filled by qualified
applicants and to ensure that there is regular supply of qualified service suppliers to
meet market demand. The free movement of qualified professionals makes
a particular contribution to the knowledge based society. Conditions of free
movement have also proven to have particular importance in cases of specific
shortages of qualified personnel at specific times in different member states for
such professions as Teachers, Veterinary Surgeons, Doctors and Nurses'.
The European Parliament, the Council and the Commission are clearly aiming
to consolidate the health care resources in the new directive by proposing a free,
speedy and easier movement of various professionals within the European Union,.
However, article 5 in the new Directive number 2001/19/EC which was adopted in
May 2001, proposes that for the purposes of this Directive, where the service provider
moves to the territory of the host member state, the pursuit of a professional activity for
a period of not more than sixteen weeks per year in a member state by a professional
establishment in another member state shall be presumed to constitute a provision
of services
Taking into account the dissimilarities in the training and scope of practice in
optometry within the EU, this proposal clearly constitutes a threat to public health
and is not likely to be accepted by the British optometric profession and the General
Optical Council. Also, to monitor proposals of this nature, an Alliance of UK Health
Regulators on Europe (AURE*) already exists in the UK.
The regulatory bodies in the UK have legal powers to establish, maintain and monitor
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the standard of health and social care professionals and safeguard the health and
well-being of patients and service users to ensure that members of the public
have access to and are treated by adequately and suitably qualified and competent
professionals.
It should be taken into account by all concerned in Brussels that Optometrists in the UK
as primary health care practitioners have been determining ocular health of their
patients for over half a century. In 1952, Lord Crook as chairman of the
interdepartmental committee on the statutory registration of opticians reported that
'several witnesses representing medical and ophthalmological organisations have
informed us that there is no difference between the detection and the diagnosis of
ocular abnormality, the two processes being inseparable'.
It has to be noted that the UK optometrists now diagnose and monitor ocular pathology
and only refer patients when necessary. UK optometrists also participate in shared and
delegated care of ocular conditions like glaucoma. and diabetic retinopathy which
may cause visual impairment or blindness. In the field of ocular therapeutics,
supplementary prescribing is part of British optometry and independent prescribing
status is already on the agenda of the Department of Health.
The European Parliament, before allowing free and easy movement of optometrists in
the EU, will have to take measures to harmonise education, professional structure,
scope of practice and legal status of optometry in the EU. Professional titles,
designations and nomenclature of optometric qualifications in the EU would also
require harmonisation. Those legislators responsible for the laws governing health care
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professions in the EU will have to look into the operational aspects of optometry
as an autonomous health care profession for the enhancement of vision and
prevention of visual impairment and blindness.
* The AURE (Alliance of UK Health Regulators on Europe) gathers representatives
of UK regulatory bodies of the health professions covered by the commission proposal
representing the General Medical Council, General Dental Council, General Optical
Council, General Osteopathic Council, General Chiropractic Council, # Health
Professions Council, Nursing and Midwifery Council, Royal Pharmaceutical Society
of Great Britain, General Social Care Council and Pharmaceutical Society of Northern
Ireland.
# The Health Professions Council in the United Kingdom regulates 12 professions
and these are art therapists, chiropodists/podiatrists, clinical scientists, dieticians,
medical laboratory scientific officers (MLS0s), Occupational therapists, orthoptists,
prosthetists and orthotists, paramedics, physiotherapists, radiographers and speech
and language therapists.
Summary
Issues like harmonisation, mutual recognition of professional qualifications, speedy
movement of professionals within the EU and health care expenditure are discussed
in this chapter. Social and cultural differences in the dimension, provision and
pattern of health care within the EU are highlighted. It is discussed whether the
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concept of health and illness, the measurement of provision of health care, the
number and social distribution of health care professionals and the explanation
of the pattern of health care expenditure can ever be fully harmonised within
the European Union.
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Chapter 3
Economics of Eye Health Care Delivery
3.1 Introduction
Health economics based calculations, a relatively new concept in the
field of health care, may provide different values for identical services and
may cover several dimensions, often complex, affecting many aspects of
health care delivery and different specialities including eye health care. On
the basis of a disciplinary matrix of health economics any evaluation and
measurement of various costs and benefits involved from the outcome of
specific services provided to people, including different procedures and
techniques, may include:- cost-benefit analysis (CBA), cost-minimisation
analysis (CMA), cost-utility analysis (CUA), cost-effectiveness analysis
(CEA), opportunity costs, quality adjusted life years (QALY ), handicap
adjusted life years (HAL Y), disability adjusted life years (DALY ), health
related quality of life (HRQL) and healthy years equivalent (HY E).
Calculations may also include the costs of resources required and overall
economics of providing adequate and appropriate healthcare to all patients.
Costs may also include economics of training medical and other health
care professionals.
However, it should be stated here that in the context of measurement of the
cost of time in the provision of appropriate health care to patients, it is
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debatable whether, in a healthcare environment, physical time should be
considered synonymous with actual professional time (Agarwal, 2000 b).
Any enforcement of time constraint in the provision of healthcare may not
provide a satisfactory outcome because of unpredictability of actual time
required in the clinical decision making process. It has to be noted that the
economics of time management in the delivery of health care is a separate
issue as compared with time and motion study; the latter is normally linked to
the economics of industrial output and productivity which is defined as the
ratio of output to input and generally relevant in a non-health care setting.
In recent years there has been a phenomenal rise in interest in health care
related economics, especially on the question of scarcity and allocation of
health care resources by the health system policy makers, the health
economists, politicians and also some other people probably not fully
conversant or acquainted with the complexities of clinical decision making
process and patient management. Some of these analysts utilise well
established methods of evaluating costs by using those procedures, techniques
and principles of economics which in fact have their origins in a non-health
related work environment. Interestingly in 1844 a French engineer named
Jules Dupuit (1804-66) proposed cost-effectiveness analysis in a non-health
care setting (http://www. Britannica.com , 2003).and in the United States
flood-control benefits had to exceed the cost under the 1936 US flood control
act (http://www. britannica.com, 2003).
It would, therefore, not be surprising if there was a professional or policy
decision disagreement or a lack of understanding between health economists
and clinicians on matters affecting clinical decisions and patient welfare
regardless of age and status of prognosis All those professionals involved
in health care and clinical work are fully aware of the fact that there are
circumstances when even clinical guidelines can not be followed strictly and
complex professional skills and methods are often required for exploration
and investigation of cases in diagnosing and solving clinical problems.
Since differential diagnosis and clinical decision making is an intricate process,
it would not be surprising if health economists, lay workers in the healthcare
field, lay media researchers, business analysts and others find clinical variations
confounding. In any event the idea of scarcity of resources in healthcare and
at the same time expectations of high quality service and care from health care
professionals seems contradictory.
Debate continues on the question of interposition and intervention by health
economists in health care and any consequential advantages or disadvantages
for the recipients of professional and clinical services.
Kernick (2000), giving his medical viewpoint, has commented that 'the EBM/HE
(evidence based medicine / health economics) industrial complex now employs a
vast array of researchers armed with Government grants and contracts to find
solutions to largely intractable problems. Resources that might otherwise be used
in direct healthcare'. Kernick continues 'using its ultimate instrument, economic
analysis alongside the randomised controlled trial, the burgeoning industry seeks
to discover the essential truth without us so that our intervention can be directed
by explicit guidelines derived from rigorous enquiry'. ' Things were not much
better in the world of economics. Although still managing to suppress the fact
that no one was actually taking any notice of economic evaluations, Homo-
Economicus was not behaving as theory directed'.
'Then came the masterstroke. If patients could be duped into believing that
the incessant outpouring of the modern medical machine - with all its
trappings - is really needed, but that there is not enough to go round
	 then
the technical framework of effectiveness and cost effectiveness would be
welcomed as a true salvation and the paradigm would remain secure'.
In another medical viewpoint Loewy (1980) commented that 'of late an
increasing number of papers in this (New England Journal of Medicine) and
other journals have been concerned with "cost effectiveness" of diagnostic
and therapeutic procedures'. Inherent in these articles is the view that 'choices
will be predicated not only on the basis of strictly clinical considerations but
also on the basis of economic considerations as they may affect the patient,
the hospital and society'. Loewy further stated 'It is my contention that such
considerations are not germane to ethical medical practice, that they occupy
space in journals that would be better occupied by substantive matter, and
that they serve to orient physicians towards consideration of economics which
is not their legitimate problem. It is dangerous to introduce extraneous factors
into medical decisions, since consideration of such factors may eventually lead
to age, social usefulness and other matters relevant to medical practice.
The example of medicine in Nazi Germany is too close to need further
elucidation'. Loewy continues 'It is incumbent on the physician (especially
in a critical situation) to practice not cost-effectiveness but medicine that is
as safe as possible for that patient under the particular circumstances.
Optimisation of survival and not optimisation of cost-effectiveness is the only
ethical imperative. To select diagnosis on the basis of cost-effectiveness is
a deliberate statistical gamble; to use diagnostic tests in an unthinking
medical fashion is poor medicine, not because of cost but because
unthinking medicine is dangerous for the patient. Ethical physicians do
not base their practices on the patient's ability to pay or choose
diagnostic and therapeutic procedures on the basis of their cost. It may be
argued that the welfare of society is threatened by escalating medical costs;
indeed the argument at first appears to introduce a dilemma. Y et a large
proportion of our ills are due to smoking, heavy drinking and overeating
and the consequences of these indulgences consume a large portion of
medical- care dollars. It is unfair to deprive those who have not
been overindulgent of the best medical care while allowing the
overindulgence of others to consume the available money. Furthermore,
our society clearly has money to spend on luxuries and baubles. A
physician who changes his or her way of practising medicine because of cost
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rather than purely medical considerations has indeed embarked on the
"slippery slope" of compromised ethics and waffled priorities'.
In our context it is necessary to review the basics of currently used cost
identification, cost determination, cost evaluation and appropriate
analytical methods in health care economics since these are equally applied
by the health economists and health analysts to eye health care delivery. The
main stated objective of health economics is to provide adequate health care
to all citizens by choosing and prioritising appropriate procedures and
interventions.
3.2 Identification, Measurement & Valuation of Costs in Health Care
Health care costs have to be identified, measured and valued and these
can be direct, indirect and intangible. Direct costs are divided into fixed and
variable. Indirect costs are normally estimated by using human capital
method and willingness to pay (WTP) method. Intangible costs are not always
quantifiable dependant upon the method used.; if a human capital method is
used then time and productivity outcomes may be measured and when
willingness to pay (WTP) method is used then implicitly intangible costs may
be included in the monetary values. Sometimes it may be necessary to use
cost utility analysis (CUA) method for measuring intangible costs.
Identification of costs requires an evaluation of the identified resources
consumed which may be gross or detailed and then monetary values are
assigned to such resources. Measurement and valuation of costs will be
discussed later in this work. Costs may be health care system based, patient
based or external and not apparent Health care system costs comprise
administrative and operational and these include capital expenditure,
property maintenance and running overheads, administration and office staff
salaries, equipment, health care supplies, drugs and medicines; professional
costs include salaries and fees paid to physicians, medical specialists and
other health care professionals, laboratory and diagnostic testing and support
staff time. Smith and Brown (2000) observed that 'often direct costs come in
the form of charges and the true medical costs may be obscured, or difficult to
measure, since they do not empirically measure the forgone opportunity cost of
using these resources for other purposes'. In some cases costs could also
include hospitalisation, long term care and rehabilitation.
Patient based costs are those directly incurred by patients and their families
and relatives and indirect costs are disability, loss of income, loss of
employment and lost opportunity. Costs not easily measured or can not be
measured are those attributed to grief, psychological causes, suffering and
also pain. However, cost measurements will not be accurate if two
establishments with similar overheads were providing service to people not
equal in numbers. If one establishment e.g. an eye department in a hospital
was very busy and the other was not then in such cases estimates have to be
used. Luce and Elixhauser (1990) have stated that 'the primary objective of
the economic evaluation of medical care technologies is to incorporate a
consideration of resource consumption into decisions about their use. By an
explicit examination of economic information, it is possible to assess the
health benefits derived from the use of a technology relative to its costs. The
costs and benefits of technologies can then be compared, making it possible to
rationalise decision-making in an environment of limited resources'.
According to these authors two types of economic information are relevant in
our context. Information about economic costs included in providing the
necessary technology and information with reference to the evaluation of
economic consequences of using a technology.
3.2 (a) Study Perspective and Time Frame of Cost Analyses
The perspective from which the costs are to be measured is an
important factor when conducting cost analyses. The perspective could be
local, regional, national, international, routine governmental or state
commissioned, managed care organisation (MCO) and health maintenance
organisation (HMO) based, health insurance provider based or from the
perspective of providers of healthcare services such as physicians,
ophthalmologists and optometrists. In most cases the perspective of cost
evaluation and analyses is governmental and societal for appropriate
allocation of healthcare and related resources in order to maximise the
healthcare benefits. It is equally important to specify the time frame over
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which a healthcare intervention or programme is to be implemented since it
can affect the costs and ultimately the benefits.
3.2 (b) Sensitivity Analyses
During cost evaluation or cost effective analysis, precise information or
data may not be available for some variables or it may contain elements of
uncertainty which may be accidental. Uncertainty may be present in all
economic evaluations. Under such conditions estimates can be used on the
basis of available information and such estimates are then subjected to a
rigorous process called sensitivity analyses. However, under some
circumstances especially when the use of resources is uncertain, costs can
not be estimated with certainty. According to Smith and Brown (2000)
sensitivity analyses are particularly useful in determining the robustness of the
overall cost effectiveness analysis. Briggs, Sculpher and Buxton (1994) have
stated that sensitivity analysis is not a single method; four types can be
identified to analyse uncertainty in economic evaluations. These are simple
sensitivity analysis, threshold analysis, analysis of extremes and probabilistic
sensitivity analysis. Sensitivity analyses can help point out critical values
above or below which the cost effectiveness of a programme can not be
shown. This is known as threshold analysis. When two therapies are compared,
high and low costs can be generated for both and examined under analysis of
extremes. In an ophthalmic context using this method for example
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extracapsular cataract extraction could be compared with phacoemulsification.
Probabilistic sensitivity analysis allows the analyst to 'assign ranges and
distributions to uncertain variables within evaluations that are being modelled
using decision analytical techniques' (Briggs et al, 1994).
3.2 (c) Cost Benefit Analysis (CBA)
It is reasonable to state that almost all health care cost evaluation
methods and techniques are ultimately linked to Cost Benefit Analysis and
welfare economics. CBA compares the value of consumed resources (the
cost) with the value of outcome or results (the benefit). CBA is only
possible when the benefits are also expressed in the same unit of measure as
the costs which is usually a monetary unit. Normally CBA measures all the
inputs and outputs of service, treatment and care in common currency units. In
other words both numerator and denominator are measured in the same
monetary unit. It then becomes possible to compare the cost of
treatments and the entire health planning for the same or different health
problems. The cost element covers the obvious financial costs of services
and also other costs to the patient, patient's family and society in general. The
other costs may include loss of earnings, benefits provided by the state,
disruption of family life and loss of function through side effects of treatment
and other manifestations of disease, illness and health related problems. The
cost element may also include the cost of professional education and training
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professionals providing different services.
Benefits include restoration of functions to the patient such as relief of pain,
improvement in vision and enhancement of functions dependent upon vision,
mobility and any consequential ability of the patient and family to contribute
further for family benefit and society in general. However, the issue of
benefit measurements becomes complicated when factors such as the age of
the patient and quality adjusted life years (QALY) are also included. It
is, nevertheless, realised that some benefits may not be easily measurable in
monetary terms. For example it has been suggested that benefits could also
include 'reassurance value' (Drummond et al, 1999) arising from knowledge
of a clinical procedure or a test. Opponents of this suggestion have argued that
a person could exhibit anxiety if they did not feel reassured in the process of
receiving health care. CBA could be described as benefit minus cost or
as a ratio of cost to benefit. The net benefit could be a measure of the
absolute benefit to society of any specific health care programme which
obviously includes ophthalmic care The assignment of money or monetary
valuation of health outcomes includes investment in a person's human capital,
valuation related to revealed preferences and finally contingent valuation or
studies examining stated preferences (Drummond et al, 1999).
The utilisation of health care programmes and services can be regarded as an
investment in a person's human capital. Valuation under revealed preference
examines the relationship between particular health risk associated with a
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hazardous occupation and the rate of pay which employees are required to
accept. Miner's Nystagmus (involuntary, regular, repetitive eye movement
with variable frequency and direction) resulting from years of coal mining is a
good example of specific health risk from a hazardous occupation. Other
examples are asbestosis (a lung disease, a form of pneumoconiosis caused by
fibres of asbestos inhaled by those who are exposed to the mineral) and
repetitive strain injury (RSI, pain with associated loss of function for
example in a limb resulting from its repeated movement or sustained static
loading). Contingent valuation (stated preferences) examines hypothetical
situations and willingness to pay (WTP) or willingness to accept (WTA) by
those patients expecting to receive treatment. Uncertainty because of market
value fluctuations and individual variations in WTP or WTA valuation are
important factors in this type of valuation. The value of the normal healthy
time generated can be quantified in terms of a person's renewed, increased or
improved production in employment. However, many analysts and decision
makers consider this kind of valuation unethical and find it rather difficult to
measure human life or quality of life in monetary units (Weinstein and
Fineberg, 1980), quoted by Drummond et al (1999). After receiving
professional training in medicine, dentistry, optometry, nursing or any other
health related discipline, professionals detest facing 'hard nosed, cold-
blooded economist placing money values on human life and human suffering'
(Mooney, 1992). Despite any opposition to valuation of health outcomes it is
very often not realised by the critics that such valuations are carried out
implicitly in daily life when decisions are made by individuals, societies and
even governments that 'trade-off health objectives against other benefits
(Drummond et al 1999).
Cost Benefit Analysis should not be confused either with cost comparison or
cost saving studies. (Drummond et al. 1999) citing the works of Zamke et al.
(1997) have stated that sixty percent of studies claiming to be CBA were in
fact cost comparisons without any attempt to value benefits in monetary terms.
In a study of Pertussis Vaccination cost saving evaluation and cost
comparison was erroneously labelled as CBA (Koplan et al, 1979). The aim
of CBA is to assess whether or not the benefits exceed the costs. An
affirmative answer would simply indicate that in terms of social benefits
the programme was worthy. CBA results should be useful in decision making
for the allocation of health care funds efficiently and thus maximising efficiency
in the delivery of health care. However, allocation problems may arise when
CBA is confused with cost comparison or cost saving.
3.2 (d) Cost Effectiveness Analysis (CEA)
CEA estimates the value of resources consumed (the costs) per unit
of outcome (the effectiveness). For the purpose of CEA costs are expressed in
monetary units whereas the outcome is expressed as a clinical measure which
can be described as cost per successfully treated patient; for example, cost
per eye for a cataract patient with a successful outcome following surgical
treatment. The cost effectiveness ratio obtained is in fact a measure of the
cost per unit of health effect. Smith and Brown (2000) have stated that 'in
their simplest form, health effects might be regarded as the number of life
years saved, or more particularly in an ophthalmological context, the number
of sight years saved from vision loss and blindness'. If health effects
obtained by two treatment options are equal then cost considerations need to
be assessed between both groups and the least costly options are likely to be
regarded as the most efficient in terms of the allocation of resources. Cost-
effectiveness can be described as the financial cost for an outcome or result
of a service or procedure including any impact such a service may have on
the community. Any evaluation of cost-effectiveness would cover the total
cost of that service.
However, with the same or similar objectives there can be different or
modified versions or different modes of providing such services; the
differences may be procedural, structural and/or in the method of delivery.
The health care economists and planners would naturally choose the most
economical model provided the quality assurance element remains unaffected.
In any event cost-effectiveness should not be considered a synonym for
cheapness and it implies that alternatives were fully considered. Cost
effectiveness relies on the basic economic concept of opportunity cost. Since
resources are either limited or scarce, choices must be made. The lost
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opportunity is described as opportunity cost. However, cost-minimisation is
another form of evaluation for the purposes of comparing the cost of
alternative treatments with identical outcomes.
3.2 (e) Cost Utility Analysis (CUA)
CUA can be described as a subset of CEA which uses quality adjusted
effectiveness measures. CUA is an evaluation of common measure of the
satisfaction derived from consumption of all services. Utility value can be
appended to the expected outcome of a service or treatment and this can be
described as QALYS, an acronym for Quality Adjusted Life Years. It consists
of an average expectation of life after treatment and multiplied by an index of
quality of life. Such an index is an evaluated average of a set of scores
representing an aspect of life-quality namely pain and lack of mobility or
visual impairment during the expected remaining years of typical patients.
On this basis the score would be considerably less for a comatose patient for
five years as against almost normally functional patient for a period of three
years. An average total cost of treatment and care divided by QALYs
provides cost per QALY. On this basis it then also becomes possible
(a) to compare treatments for the same disease in terms of cost per QALY and
(b) to compare cost per QALY for treatment of diverse conditions e.g. artificial
hip replacement versus cataract surgery. Expectation of quality of life remains
the key factor in QALYS.
3.2 (0 Cost Minimisation Analysis (CMA)
CMA estimates the value of resources consumed (the costs) for alternative
treatments with similar outcomes. Following two similar treatments with similar
efficacy, one may result in fewer adverse events or less adverse effects and
consequently fewer health care resources are consumed; it would then indicate
that this treatment achieves identical results at a lower cost, e.g. treatment of
glaucoma with Beta-blockers as against other drugs.
3.2 (g) Cost of Illness Analysis
Cost of illness analysis attempts to measure all the treatment costs of
any specific disease and also other associated costs over a given period of
time, such as for example the annual cost of any cardiovascular disease or
an ocular disease like glaucoma in terms of lost productivity and the costs
incurred in screening, investigation, diagnosis, medical treatment and
management. This kind of cost analysis could be used by those involved in
decision making process for the allocation of funds for the management of
various diseases and illnesses, periodical appraisal of the provision of specific
clinical services and development of clinical services support system.
3.2 (h) Opportunity Cost
There may be a considerable difference in the availability and level of
services provided between a wide range of publicly and privately supported
and funded health care plans, since resources are often limited and may
operate under some form of budgetary restriction or economic constraint.
Choices must be made between different resource allocations and alternatives
have to be chosen constantly. The lost opportunity is then described as
opportunity cost. According to Luce and Elixhauser (1990) 'The opportunity
cost of an activity is the value of the alternative endeavours that might have
been undertaken with the same available resources'.
In our context, when two or more ophthalmic clinics are compared, the
opportunity cost of each is explicit or precisely expressed. If within the
allocated resources 20 patients are treated in clinic A, as against 10 patients
in clinic B, the opportunity cost of shifting the resources from A to B is the
cost of treating 10 patients. When we refer to the cost-effectiveness of a
single ophthalmic clinic, opportunity cost is either implicit or inferred. For
example, it is highly unlikely that we could find better alternative uses for
£200 worth of ophthalmic care that actually saved one patient's eyesight. On
the other hand £2 million spent on eye care would have a high opportunity
cost element because with £2 million worth of resources we should be
able to do more than simply save one patient's eyesight. Alternative plans,
procedures and methods for the implementation of eye care have to be
explored and adopted to save the eyesight of people at a much lower cost
without compromising the standard and quality of care. The resources worth
£2 million could be apportioned or distributed to other uses in such a way that
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it may save the sight of 20,000 people. It is obvious that the use of health
care resources without alternatives would be less cost effective.
Opportunity cost is a basic economic concept with the objective of assigning
monetary values to all alternative costs. Smith and Brown (2000) have stated
that 'by producing more of one good there must be a reduction in the
production of (or lost opportunity) of one or more other goods'. On the
question of opportunity cost valuation, Garber et al (1996) have stated
that 'the real cost to society of a resource consumed or freed up as part
of a health intervention (or as a result of it) is the value of that resource in
its next best use to society. Because resources are more scarce than the needs
for which they can be used, doing more of a given health service employing
more doctors or nurses, utilising more space and equipment for hospital beds,
using more chemical or biological products means forgoing something else
of value. In an ideal analysis from the societal perspective therefore,
resources should be valued at an amount equal to their best alternative
use -their opportunity cost.' Generally, in an open and fully competitive
market, the price of any product or service could simply be regarded as
equalling the opportunity cost valuation.
However, it should be stated that in the medical and healthcare fields
because of historical reasons there has been no competition and this mode
of care has persisted in our times. This has resulted in the existence of a real
divergence of market prices and true cost attributable to several distorting
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factors (Luce and Elixhauser, 1990). For example, less lucrative products and
services may be subsidised from the earnings on more profitable ones and
cross shifting may occur to some patients and their third party payers from
those who are not able to meet their medical or healthcare bills. Additionally,
part of the opportunity cost to the patient is the cost of the time required for
undergoing investigation and treatment procedures and in this respect it has
been proposed that 'the best approximation of the opportunity cost of time for
working age adults is the wage, they are, or could be making in the paid work'
(Smith and Brown, 2000).
These authors, however, have pointed out that this method ignores the
inequality of wages between the sexes and various age groups. However,
within the healthcare systems, both state owned and privately owned, the
purchasers or the recipients of services including agencies and individuals
may readily accept the charges set by the providers of healthcare services
namely physicians, ophthalmologists, optometrists and others without
comparing the prices. Luce et al (1996) have suggested that such prices may
not be far from the true reflection of opportunity cost. They have stated that
'the real cost to society of a given resource is its opportunity cost, the value of
resource in its next best alternative use. For most purposes, market prices
provide a reasonable estimate of opportunity cost. For example the wages of a
registered nurse or the charge for an office visit generally provide an adequate
measure of the value of the resource consumed'.
3.2 (i) Marginal Analysis
Taking into consideration that the healthcare resources are often
limited and operate under budgetary restrictions, maximisation of benefits
remains a crucial factor in resource allocation decisions. It should be noted
that an important aspect of healthcare economics is additional or marginal
effects of additional or marginal increase in resource expenditure. Marginal
cost is, in essence, additional to total expenditure affecting costs and also
benefits. Any cost, additional to total cost, resulting from an increased or
additional output of one unit is considered marginal cost. It can also be
described as marginal variable cost. Usually, the first unit of a resource is
much more costly than the last unit from the same resource. For example,
the full cost of a single cataract removal procedure e.g. phacoemulsification or
extracapsular cataract extraction would be very expensive, whereas the
marginal cost of performing 1000th cataract operation within a specific period
e.g. one year would be relatively small. However, average cost as distinct
from marginal cost is based upon different calculations. For example, the
cost of providing a single cataract removal operation is different from the
average cost of cataract operations for the whole year. From cost calculation
point of view this distinction becomes crucial because sometimes it is
necessary to evaluate a cataract operation on the basis of marginal cost and
other times on the basis of average cost. It is to be expected that a cataract
patient or providers of health cover e.g. an insurer would be interested
in average cost, whereas a hospital or a clinic would be more interested in
calculating marginal cost of a cataract operation. The stated charges or price
of a service normally reflects its average cost, not its marginal cost (Luce
and Elixhauser, 1990).
In general the average cost decreases as the output increases. However, when the
output reaches its full capacity, inefficiencies may arise due to factors like
congestion in the system leading to an increase in average cost. Ultimately, the
recipients of professional services bear the cost of inefficiency in the system
and remain oblivious at the same time. However, diversification of professional
and clinical responsibilities with the provision of additional education and
training to certain healthcare professionals like the optometrists may provide
a cost-effective solution.
3.2 (j) Health Related Quality of Life (HRQL)
The term HRQL was used by Guyatt, Feeny and Patrick (1993)
because it was realised that 'widely valued aspects of life exist that are
generally not considered as health, including income, freedom and quality of
the environment'. It was realised by these researchers that although low or
unstable income, the lack of freedom or a low quality environment may
adversely affect health, these problems often remain distant from a health or
medical concern; when a patient is ill, diseased or visually impaired, almost
all aspects of life can become health related. Health Status, functional status
and quality of life are three concepts often used interchangeably to refer to
the same domain of 'health' (Guyatt et al 1993). HRQL can be measured in
two ways (a) generic instruments provide a summary of HRQL and include
health profiles and instruments that generate health utilities and (b) specific
instruments that focus on problems associated with single diseases, patient
groups or areas of function. Questionnaires can be used to used to measure
cross-sectional differences in the quality of life between patients at a point in
time (discriminative instruments) or longitudinal changes in the quality of
life within patients (evaluative instruments). Clinicians and health related
policy makers, having recognised the importance of measuring HRQL, are
expected to identify trivial, small, moderate and large differences from HRQL
measurements. Investigations in HRQL have led to instruments suitable for
detecting minimally important effects in clinical trials for measuring the
health of populations and for providing information for policy decisions
(Guyatt et al 1993).
'A new framework developed by the WHO divides HRQL into overlapping
domains that begin at the level of the body's physiological or psychological
function and extend to an individual's participation in real life situations'
(Manuel and Shultz, 2003).
3.2 (k) Healthy Years Equivalent (RYE)
RYE measures the lifetime health profile of an individual. According
131
to Gafni (1994) HYE is 'based upon the theoretical foundations of utility
theory, stems directly from the individual's utility function, thus fully
reflecting his or her preferences. It combines outcomes of both quality of life
(morbidity) and survival (mortality) and thus can serve as common unit of
measure for all programmes, allowing comparisons across programmes'.
A comparison was made between healthy years equivalent (HYE) and quality
adjusted life years (QALY) by Mehrez and Gafni (1989) and the authors found
that although QALY's are easier to measure, the measurement of HYE 'if
properly conducted, results in a valid and reliable outcome by using tools of
utility measurement'. These researchers used HYE definition by Torrance
(1976) based upon health (function) continuum. Torrance stated that 'health is
seen as a continuum running from death at the one extreme to perfect health at
the other extreme, with the continuum representing the instantaneous total
health of the individual'. Instantaneous health was defined by Torrance as 'the
level offunctioning of an individual at a particular point of time'.
Lifetime health profile of an individual can be described as a vector Q =
where qi is the ith element of the vector and qi is also the health state of
the individual at the ith period covering the whole life. Perfect health is
denoted by zr and g as death. In an ophthalmic context healthy years
equivalent could be replaced with normal eyesight years equivalent (NEYE) .
The lifetime ocular profile of an individual could be described as a vector
E — {ei} where ei is the ith element of the vector. Let ei be the visual state of
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the individual at the ith period covering the whole life; denoting as
representing visual acuity 6/6 (20/20) with a normal field of vision with or
without correction and e representing blindness. It is proposed that in an
ophthalmic context normal eyesight years equivalent (NEYE) could be
measured by employing similar methods used for measuring healthy years
equivalent (HYE) and a lifetime ocular \ visual profile of an individual
could be described for the purposes of economic evaluation. Economic
analyses are primarily concerned with resource allocation and valuation of a
specific health-related or wellness attribute. The most commonly used
measure for the valuation of outcome in such analyses is QALY which
combines qualitative and quantitative aspects of life in one dimension
(Gafiii, 1997).
3.2 (1) Willingness-to-Pay (WTP)
WTP or willingness to pay method in cost-benefit analyses or CBA
can be obtained either by direct or indirect measurements. Under the first
method direct questioning is carried out to determine the amount the person
is willing to pay and it is expressed in common currency units. Under the
second method the amount is inferred from the available information.
According to Gafni (1991) 'the method of willingness to pay is one approach
to the valuation of health benefits, which, if properly employed, is consistent
with the principles of welfare economics and cost-benefit analysis'. The
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author has stated that willingness-to-accept' (WTA) should also be used
for the purposes of evaluating costs and benefits. A technique of economic
measurement known as the contingent valuation method (CV14 is used to
consider a hypothetical scenario by asking people WTP questions for the
benefit of everybody and to determine the amount recipients of services may
be willing to pay. This technique could be used to determine the amount
people would be willing to pay to eradicate preventable visual impairment and
blindness in a specified region. CVM could also be used by asking willingness
to accept (WTA) questions (Diener et al, 1998).
3.2 (m) Problems Encountered in Cost Determination
Despite the fact that best attempt is made in cost evaluations,
problems may still be encountered during the course of an economic analysis.
Additional factors may have to be examined before determining the cost of a
new product. For example, research and development (R&D) costs of new
drugs should also be taken into account for cost measurements and resource
allocations.
In our context, the price of a new drug for treating glaucoma, for example,
should incorporate the costs incurred in research and clinical trials over a long
period. However, during the trial period a drug may be more expensive
because of clinical protocol and the price may have been overestimated.
According to Luce and Elixhauser (1990) a commonly accepted method is to
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use actual or expected costs because valuation of research and development
costs is difficult and their allocation may not be accomplished
satisfactorily. It may also be difficult to forecast the future efficiency and even
efficacy of a new drug and after a period real or projected clinical evidence
will affect the valuation. Changes in technology, research methods and
treatment may also influence cost determinations and future planning for
services. However, it is also possible that a new product may become more
cost effective after a few years. Other valuation problems include omission,
failure to include depreciation and double counting of costs. Omission of
overheads will certainly provide incorrect costs and so will the failure to
include depreciation of relevant equipment. Analysts may inadvertently
include disability benefits during the course of analysing cost of illness;
double counting will also provide inaccurate valuations.
Calculation of the loss of potential income causes problems because of
disparity in earnings in different social groups. Those with lower expected
income will have lower economic value for their lives as against those in the
higher expected income bracket. Similarly those with a poor prognosis may be
willing to pay (WTP) for necessary care as against those without such
prognosis and relatively in a better state of health.
Smith and Brown (2000) have stated that 'mortality costs' arise due to early
death or changes in life expectancy 'as a result of the presence or absence
of a given healthcare intervention or programme' and 'morbidity costs'
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are attributed to 'lost productivity due to time spent in recuperating or
convalescing'. The cost of time spent by the members of family and others
very rarely forms a part of cost analysis. Health economists continue to argue
over the terms indirect cost and productivity cost and whether or not these
should remain interchangeable.
There is a lack of agreement on the question of an acceptable definition
of the term productivity cost. However, a definition provided by Brouwer et al
(1997) and quoted by Rothermich and Pathak (1999) may be appropriate.
Brouwer et al (1997) defined productivity costs as the 'costs associated with
production loss and replacement costs due to illness, disability and death of
productive persons, both paid and unpaid'. Debate continues as to which
productivity costs can be easily measured. Debate also continues on the
question of indirect costs and whether direct and indirect costs should be
combined during the course of cost analyses.
3.2 (n) Dynamic Modelling
Simulation techniques were used in computing over three decades ago
which involved building a model of a system and testing the model instead of
testing the system (George, 1965, 1972, 1973). The technique of heuristic
programming was also applied which included short cuts, hypotheses and
modelling in computing; additionally the techniques of multiprogramming
and ad hoc programming were used. The ultimate aim was to make decisions
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efficient and quick and steadily improve the standard of outcome. An
alternative to simulation was equation solving which was not suitable for
solving economic or biological problems (Hollingdale and Tootill, 1970).
Arbib in 1964 pointed out the distinction between artificial intelligence and
simulation which was between making a computer solve a problem anyhow or
making it solve the problem like a human would. The general purpose digital
computer could also be programmed to become 'isomorphic with any dynamic
system whatever' (Ashby, 1964).
Dynamic modelling is a computer based operation with adaptive tools which
provide for simulations to generate activity data for a given period. The
generated activity data will include resource availability and also resource
usage. Dynamic modelling examines the complex interaction between
protocols and processes and also the causes and effects on the target
population (Kirby and Peel, 1998).
Although greater confidence in results can be achieved by using larger
sample sizes, it is not always possible to collect data relating to large
populations because of high costs involved in such operations. Dynamic
modelling is used to simulate results from representative smaller population
samples. New protocols and practices, new ways of working and assessing
and any impact of change on resources, waiting lists, contracts and budgets
can be closely examined and tested using smaller samples. The outcome from
computer based simulation can provide useful information to all those
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responsible for scrutiny, allocation and management of scarce resources.
Dynamic modelling can also provide feedback and verification of earlier
works to a suitable panel such as the Delphi panel in the design of new
models. The Delphi panel enables a wellness management model to be
enhanced by incorporating real world practices; the use of Delphi panel
techniques is a cost effective and reliable way of collecting information as a
proxy for the real data. Delphi panels can provide valuable data by providing
access to certain other data which may not exist anywhere else or by
providing real world examples of clinical practices which by their nature can
be extremely variable (Kirby and Peel, 1998).
All those involved in clinical, health care or related work are fully aware
that as a matter of fact there are circumstances when clinical guidelines can
not be followed strictly and complex professional skills and methods are
required to investigate and solve a clinical problem. Clinical decision making
is an intricate process and it would certainly not be surprising if business
analysts, health economists and non-clinical workers in health care field find
clinical variations confounding (Agarwal, 2000 a).
Dynamic modelling - Delphi panels could be very useful in such
circumstances. It should also be noted that dynamic programming could be
used for the purposes of testing data for sequential, consequential or inferential
decisions in management and also risk management in eye healthcare.
3.3 Summary
In this chapter, costs in eye healthcare delivery with efficient use of
resources and without compromising the quality of care are discussed. All
healthcare cost evaluations are ultimately linked to cost-benefit analysis and
welfare economics.
The cost-benefit analysis is a systematic, quantitative method of assessing
healthcare costs and benefits. The purpose of a cost-benefit analysis is to support
an efficient resource allocation plan for healthcare through an informed decision
making process. The cost-benefit analysis should demonstrate that having
considered two or more alternatives, the chosen alternative is the most cost-
efficient and cost-effective without compromising the standard of service and
quality of healthcare and within the budgetary constraints.
It could be argued that cost-effectiveness analysis is a simplified cost-benefit
analysis. Cost-utility can be described as a subset of cost-effectiveness analysis
which uses quality adjusted effectiveness measures. Marginal analysis covers
marginal cost which is additional to total expenditure affecting both costs and
benefits. Cost-minimisation with a view to efficient use of resources may be
useful provided it is not regarded as a tool for cheapness and does not
compromise quality or standard of healthcare.
When two interventions or therapies are compared, high and low costs could be
generated for both and examined under analysis of extremes. Generally in any
given system the average cost decreases as the output increases. When the output
reaches its full capacity inefficiencies may arise due to factors like overloading or
congestion in the system leading to an increase in average cost. It should be
possible to forecast such an event with dynamic modelling.
The concept of opportunity cost, the cost of opportunity foregone, is a basic
element of economics now used in healthcare economics. It should be noted that
healthcare economics originated in a non-health related environment and it is still
evolving.
Chapter 4
Pattern of Eye Healthcare Delivery in the Enropean Union
4.1 Introduction
Whereas the state is expected to provide suitable infrastructure and
resources for all healthcare needs of all its citizens and an international
healthcare agency like the World Health Organisation (WHO) is expected to
authorise contingency and epidemiological studies to cover different aspects of
public healthcare, it is ultimately the responsibility of a suitably trained
practitioner or clinician from whichever field to provide the necessary
professional care, sometimes onerous, on a one to one basis.
In the eye healthcare field, in addition to providing services for the
enhancement of visual performance, the most obvious task for an
optometrist is prevention or avoidance of blindness and visual impairment by
providing appropriate primary and diagnostic eye care to the people.
In established market economies (EME) and industrialised countries,
cataract, glaucoma, diabetic retinopathy and age related macular degeneration
are generally considered the main causes of visual impairment and blindness.
It should be noted that the established market economies (EME) of North
America and Western Europe include the current EU member states,
Australia, New Zealand and Japan. For the purposes of WHO studies and
statistics, an acronym FSE is also used to describe the former socialist
market economies of the Russian federation and Eastern Europe. On the basis
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of economic development six other groups cover rest of the world
(See Appendix 1). On a global basis, the major causes of visual
impairment and blindness also include trachoma, malnutrition and congenital
cataract causing childhood blindness. However, a large proportion of ocular
conditions are treatable with appropriate interventions and according to WHO
estimates revised in February 2000 (WHO, FS 213, 2000) about 80% of global
blindness or visual impairment is avoidable hence the pattern of eye health
care delivery anywhere in the world assumes a very special significance.
The first World Health Assembly in 1948 adopted a resolution on the care of
the blind, it was only in 1972 that the World Health Organisation authorised
epidemiological studies relating to blindness. According to 1972 estimates, at
that time blind people numbered between10-15 million globally (Weale,
1998). In 1975 the World Health Assembly approved studies for the
prevention of blindness and in 1978 the World Health Organisation
programme for the Prevention of Blindness (PBL) was formally established.
The WHO also encouraged the International Agency for the Prevention of
Blindness (IAPB) to work with non-governmental organisations (NG0s).
By 1980 the WHO PBL programme began working on the development of a
primary eye care model as part of primary healthcare (Thylefors, 1998). It
should be noted that despite the fact that the World Health Organisation has
recommended an international definition of blindness, countries may still have
their own variations because of legal, economic, social and probably
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cultural reasons. For example, there are two definitions of blindness presently
in use in the UK. The Royal National Institute for the Blind (RNLB) uses
VA< or =6/60 (VA < or =20/200; VA < or =0.1) and not the WHO visual
acuity <3/60 (<20/400; <0.05) for classification as blind. Interestingly in
the USA and Canada VA <or = 20/200 (VA<or=6/60; VA<or=0.1) is used for
the purposes of legal definition of blindness.
In the UK the WHO definition is used on the official form BD8 for the
purposes of certification and registration as blind or partially sighted.
According to RNIB in 1985-86 out of every 100 blind people in the UK, 64
were not registered and 87 out of 100 partially sighted people were also not
registered (Evans et al, 1996). The National Council for the Blind in the
Republic of Ireland (NCBI) uses visual acuity 6/60 or less (20/200; 0.1 or
less) for certification and registration as blind and not the WHO definition.
In Finland, a modification of WHO definition is used for inclusion in the
Finnish Register of Visual Impairment maintained by the Finnish Federation
of the Visually Handicapped. The Danish Society of the Blind also uses a
modified version of WHO definition of blindness. In Denmark, blindness
is divided into three categories, social (VA 6/60 or less), practical (VA
1/60 or less) and total. However, even a small variation in the definition of
blindness, especially the visual acuity, will provide variable statistical
information on the causes of blindness and visual impairment and also the
figures concerning the numbers of registered blind and partially sighted
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people within the EU. Therefore, any statistical comparison within the EU
for the purposes of management of avoidable blindness or visual impairment
may prove to be inconsistent since statistical conclusions generally show
sensitivity towards varied figures. Definition of blindness also varies within
the EME. It would certainly be helpful if the EU member states could
agree to have a common EU definition of blindness and visual impairment.
However, the WHO definition of blindness (ICD 10) has already been
incorporated into the International Statistical Classification of Diseases and
Related Health Problems, generally referred to as the ICD.
4.2 (a) The Provision of Eye Healthcare Delivery in the EU
Although in most EU countries both primary and secondary eye care is
provided by ophthalmologists, in the UK and the Republic of Ireland primary
and diagnostic eye care is shared between family physicians, optometrists and
ophthalmologists. Despite the fact that optometry degrees from Utrecht,
Netherlands are now accepted by the GOC for registration in the UK and
optometry degree holders from Spain can obtain British registration after
successfully completing GOC approved additional training in optometry in the
UK, the scope of optometric practice and the pattern of eye healthcare
delivery in these states and elsewhere in the EU remains diverse and unlike
the pattern found in the UK and the Republic of Ireland.
In some areas of eye healthcare in the UK, optometrists and GPs are
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required to provide almost identical ophthalmic referral service, for example
hospital referral for cataract patients (Johnston, 2003); .both practitioners are
expected to diagnose the condition and also discuss risks and benefits with
patients before referring them for an ophthalmological review.
Family physicians in most EU countries provide a mixture of basic eye care
and screening for ocular conditions requiring referral for ophthalmological
services. To a large extent many aspects of eye care services provided by the
British and Irish optometrists are similar to those provided by family
physicians in most of the other EU states. In the UK and the Republic of
Ireland GPs regularly seek diagnostic opinion from optometrists before
referring a patient for an ophthalmological review and assessment.
A majority of British GPs regard British optometry as an invaluable resource
of clinical expertise. A survey of the opinions of 800 British GPs regarding the
services provided by the British optometrists was carried out by Agarwal at the
City University in 1990 (Agarwal, 1996 a). In the survey, out of 396 replies,
several GPs identified different clinical reasons for regular referrals to
optometrists which included ophthalmoscopic assessment, glaucoma,
diabetic retinopathy, diagnostic retinopathy, optic disc assessment and
headaches without obvious neurological causes. In the survey almost 95%
of respondent British GPs were satisfied with the services provided by
optometrists, highly valuing clinical assessments made by optometrists and
regarded optometry as a primary health care profession. One respondent GP
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stated that optometrists were excellent at diagnosis and more eye pathology
was detected by an average optometrist than an average GP. British GPs also
indicated that they would welcome an extension of professional services
provided by optometrists through additional training and certification.
It is a matter of fact that currently the role of optometrists in the delivery of
eye care in most of the EU remains diverse and unlike the model found in
the UK. British optometrists as primary healthcare practitioners already
participate in shared care schemes monitoring the ocular complications of
systemic conditions like diabetes and vascular hypertension. It is a significant
change in the eye healthcare field and for British optometry that almost three
decades later shared care is transforming into delegated care.
Under a new scheme known The Glasgow Integrated Eye Service (GIES),
optometrists in the Glasgow area are now working even more closely with the
GPs and ophthalmologists with full support of the local Health Board. Patients
in Glasgow area have to wait for over a year to get a Hospital Eye Service
appointment with an ophthalmologist. Under this pilot project GPs will
formally refer selected patients to participating optometrists with a guarantee
that patients will be seen within 48 hours. Optometrists will then be expected
to follow an agreed protocol and following their own clinical assessment will
decide whether or not a patient has to be referred for an ophthalmological
review. Under the GIES scheme, refraction will not be a required element of
patient assessment (OQ no. 45, 2003). This scheme will no doubt reduce
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hospital waiting lists for those patients in the need of secondary ophthalmic
care since most of primary eye care will be delegated to, optometrists. Each
participating optometrist will be expected to provide services under GIES for
700 to 1000 patients every year.
It is anticipated that similar schemes to provide delegated eye care will operate
all over the United Kingdom in due course. However, another new
development in the eye healthcare field has taken place in the historic county
of Gloucestershire. In January 2000 at a workshop attended by all consultant
ophthalmologists and over 90% of registered optometrists in the county, direct
hospital referral by optometrists for cataract patients was launched involving
optometrists, ophthalmologists and also general practitioners from
Gloucestershire (Price, 2003). Under this scheme, following direct hospital
referral of patients by optometrists, GPs will also provide additional clinical
information directly to hospital concerned. The success of this scheme was
evident from the fact that the Health Authority in the area agreed to introduce
a referral fee for participating optometrists. Ongoing audit is used to confirm
the quality and quantity of referrals. Optometrists also play an important role
in educating patients. About one month after surgery, patients without clinical
complications are seen in an 'optometrist-led fast track follow up clinic'
(Price, 2003). In a separate study, from the case notes of patients who had
cataract surgery during 1997-98 in Peterborough, it was recommended that
patients without complications can be discharged 'to the care of their
optometrists on the first day following cataract surgery' (Muthucumarana
and Rimmer, 2000).
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It has to be noted that for many years optometrists in the UK have performed
ocular biometry i.e. axial length measurements, anterior chamber depth
determination, lens thickness calculations and other measurements required
to determine intraocular lens (TOL) power and selection of suitable IOL
lenses. It is indeed significant that over the last 20 years British
optometrists have actively participated in pre-surgical and post-operative
cataract management and IOL selection process.
However, in an European Union context a review of four selected eye
conditions namely cataract, glaucoma, diabetic retinopathy and age-related
macular degeneration, being the major causes of blindness and visual
impairment, may provide us with a basis for future planning in the
management of these conditions, prevention or avoidance of blindness and
delivery of appropriate eye healthcare with quality assurance in all EU
member states.
4.2 (b) Management of Cataract in the Delivery of Eye Healthcare
Despite enormous global and regional variations in the incidence and
prevalence of visual impairment and blindness due to cataract, it remains a
major cause of blindness in almost every country in the world (Appendix 5 and
6). There are several ways of classifying cataract. Crick and Khaw (2003) have
classified it on the basis of stage of development (e.g. intumescent, mature,
hypermature), anatomical position of the opacity (e.g. cortical, nuclear,
subcapsular) and aetiology (e.g. diabetic, traumatic). Crick and Khaw (2003)
have stated that 'in clinical practice all three classifications are used when
describing a cataract e.g. marked corticosteroid-induced posterior subcapsular
opacities'. Broadway et al (1999) have classified cataract by age (congenital or
age-related), stage (early to hypermature), morphology (capsular, sub-capsular,
cortical or nuclear) and aetiology. According to Dolin (1998), cataracts are
generally categorised into congenital, trauma-related, secondary and age-
related; aetiology and histology based classifications are also used. Chitkara
(1999) observed that 'numerous individual causes of cataracts exist and often
multiple factors act together, with plenty of scope for overlap between the
groups. Some causes predispose to a specific morphologic variety of cataract,
while other causes predispose to the common senile variety. Also a given
cause may produce many different morphologic forms of cataract'. According
to Chitkara (1999), classification of causes of cataract includes age-related,
physical factors, radiation, systemic disorders, dermatologic disorders,
endocrine disorders, central nervous system disorders, secondary and toxic
causes.
Dolin (1998) has listed three types of risk factors associated with cataract.
Definite risk factors include age, diabetes, gender (female), smoking, steroids
and sunlight; possible risk factors include alcohol, oestrogen, hypertension,
limited education, low body mass, low height, low weight, low social class,
myopia, renal failure, rural residence, severe diarrhoea or dehydration,
and possible protective factors may include use of aspirin and antioxidant
vitamins.
Glaucoma has long been regarded as a risk factor for cataract. Further studies
are required to determine whether it is glaucoma or the treatment of glaucoma
that may be considered as a risk factor (Dolin, 1998). However, it was
concluded in a study by Kuppens et al (1995) that 'untreated primary open
angle glaucoma or untreated ocular hypertension do not seem to increase
significantly the risk of developing cataract'. According to Crick and Khaw
(2003) ocular risk factors may include acute angle closure glaucoma, myopia,
prolonged uveitis, retinitis pigmentosa, long standing retinal detachment and
heterochromic cyclitis.
Cataract is primarily a disease associated with the ageing process although
it has been observed that some families or ethnic groups may be more
susceptible to this condition (West et al, 1998). Genetically determined isolated
cataract accounts for approximately 10% of congenital cataracts (Hurst, 1992).
In the Beaver Dam Eye Study (Heiba et al, 1995) segregation analysis was used
to show that there may be recessive genes that predispose the population to both
nuclear and cortical cataract (Hall and Rosenthal, 1999).
Age related cataract may not be preventable but blindness is usually
avoidable. It was estimated in 1996 that in the UK 'between a fifth and a
third of people aged 65 or 74 will develop some lens opacity over a five
year period' (Effective Health Care, 1996). Approximately 5% people in the
age group 55-64 and 40% over the age of 75 develop cataracts (Klein et al,
1992 b). It was observed that 63% develop cortical type cataract, the most
common in the UK (Brown and Hill, 1987). In a study by Minassian et al
(2000) the backlog of people with vision impairing (<6/12) cataract in the 65
and older population in England was estimated to be 2.6 million. The WHO
estimated that in 1990 out of 38 million blind people in the world, cataract
(ICD 366) accounted for almost 16 million (41.8%) blind and a further 110
million visually impaired (Thylefors et al 1995; WHO/1990/PBL/94.40).
By the year 2000 the numbers had increased to 40-45 million and
approximately 20-22.5 million (50%) blind due to cataract (WHO, FS 213,
2000). These estimates are based upon the WHO definition of blindness i.e.
best corrected VA <3/60 (<20/400; 0.05) or finger counting at 3m in the
better eye or a visual field loss in each eye to less than 10 degrees from
fixation. If, for the purposes of this estimate, we were to adopt the RNIB
definition of blindness i.e. best corrected VA 6/60 or less (20/200; 0.10
or less) then the global percentage of blindness in general and due to specific
causes like cataract would be considerably higher. The WHO cataract
blindness estimate (1990) for the established market economies (EME) was
3.5% and for the former socialist economies (FSE) it was 8.3%, out of 38
million blind globally. The EME/FSE cataract blindness figures for later years
are not available. As stated previously the established market economies are
essentially an economic cluster of states which also includes all the current
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EU member states. The WHO estimates have shown that blindness figures
vary considerably between specific economies and territories, sometimes
even 5-10 fold. However, within a territory or a country, estimated figures of
blindness may be very different for a specific city or even an area within a
city. In 1994 it was estimated by the International Eye Foundation that in
Bulgaria in the Sofia district (urban and rural) 42% of blindness was due
to cataract (IEF, 1994). This estimate was slightly higher than the WHO
global figure for 1990 which was 41.8% (WHO/1990/PBL/94.40).
In England and Wales during 1990-91 cataract-induced blindness and partial
sight (WHO definition) in all age groups was 3.3% and 7.0% respectively
(Evans, 1995; Evans et al 1996). In an Irish study cataract accounted for 11%
of blindness (VA < or = 6/60 or 20/200 or 0.1) and one third of these patients
had an associated cause and one tenth had a cognitive deficit (Munier et al
1998). However, unlike the official British figures published by Her Majesty's
Stationary Office, the following blindness figures for other EU countries were
obtained mostly from non-governmental agencies e.g. blind associations and
from published material in various medical journals covering some local
areas and populations. There was no response regarding blindness figures from
government departments and health ministries, ophthalmological,
optometric, and optical societies and associations of most EU countries. The
requested information was either not available or did not exist.
The Finnish Register of Visual Impairment (1993 annual statistics) did not
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specify cataract separately. In a separate Finnish study only 1.3% were
recorded as blind due to cataract on the basis of the WHO definition (Hirvela
and Laatikainen, 1995). It was stated in another study from Finland that
progression of visual loss in patients waiting for cataract surgery varied
significantly and for many the extended delay caused remarkable disability for
the remainder of their lives (Leinonen and Laatikainen, 1999).
In an Italian study based on the National Household Health Survey (NIIHS)
cataract accounted for 23 % of blindness in the southern region. (Nicolosi et
al, 1994). It was observed that the causes of avoidable blindness were more
frequently reported in southern than in northern Italy.
In the territory surrounding Turin, in north west Italy, the case notes of 4549
residents who were certified blind between 1967 and 1991 were examined
with regard to cause of visual loss, age at onset, and the year of onset of
VA <or =1/20, by Porta et al (1995). It was found from the case notes that
26.7% had already been certified blind due to cataract. The purpose of this
search by the authors was to collect information on the causes of certified
blindness before implementing permanent screening for diabetic retinopathy.
However, these figures are useful in providing information concerning
blindness due to cataract in northern Italy.
In a French study conducted at the Orleans regional hospital serving a
semi-rural area in France cataract accounted for 13.3% of blindness in
patients aged 60 years or older (Cohen et al 2000). It was reported in a study
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from The Netherlands that 'adequate implementation of surgery to treat
cataract could reduce visual impairment by one third' (Klaver et al, 1998).
On the basis of 1992 figures from Organizacion Nacional de Ciegos (ONCE)
cataract induced blindness in Spain was recorded as 3.4%. Incidence of
blindness due to cataract in Wurttemberg-Hohenzollern, Germany between
1994-98 was recorded as 3.32% (Trautner et al, 2003). In a Swedish study
poor visual acuity after cataract surgery was found in 22% patients, mostly as
a result of concurrent age-related maculopathy, diabetes or glaucoma
(Monestam and Wachtmeister, 1999).
Ageing is unavoidable and remains a significant factor in the prevalence
of visual impairment and blindness in any given population. For any future
planning for eye healthcare delivery it should be noted that the elderly
population is increasing throughout the world. It is estimated that by the year
2020 in the established market economies and industrialised world in
general, the elderly population will increase by 186% and in the rest of the
world by 356%. The WHO estimates that by the year 2020, globally there
will be 54 million blind people aged 60 or over.
In 1993 the blindness percentage for people aged 60 or over in the
established market economies (EME) and the former socialist market
economies (FSE) was 11.2°0 of the total blindness in the world
(WHO/1990/PBL/94.40). The main obstacles to cataract surgery in eastern
European countries were state budgetary limitations, insufficient supply of
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consumables, under utilisation of operating theatres and poor diagnosis of
surgical needs of patients (Kocur et al, 2002).
The WHO has envisaged a very likely increase in the number of people
requiring cataract operations by the year 2020 and has actually adopted 2020
as its target year in the campaign for the prevention or avoidance of visual
impairment / blindness (WHO, FS 214, 2000). The ultimate aim remains the
elimination of avoidable blindness throughout the world.
In the United Kingdom an estimated 200,000 cataract operations are
performed annually (Johnston, 2003). In England and Wales, a total of 132,866
cataract operations were performed in 1995-96 on people falling in the age
range 65 and older (Minassian et al, 2000). In England the rate of cataract
surgery financed by the NHS has been increasing since 1993, although there is
considerable variation in the number of surgical interventions for cataracts
between districts (Effective Health Care, 1996). A study conducted in 1994 in
the northern region of England showed that there was considerable variation
in the threshold for cataract surgical intervention. The level of visual acuity
impairment due to cataract at which ophthalmologists decided to operate
significantly varied between districts (Effective Health Care, 1996).
According to WHO the number of cataract operations per million population
per annum (Cataract Surgical Rate or CSR) is a useful measure of the delivery
of eye care since CSR varies in different economies, countries and even
within a country (WHO, FS 214, 2000). The CSR in the UK is probably
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between 4000 and 4500 i.e. about 100 operations per working week per
million population (Wormald and Foster, 2004).
It is estimated that the number of people with cataract blindness will increase
and more resources will be required for cataract surgery to avoid blindness.
However, it has also been suggested that delaying the onset of cataract by 10
years could reduce the annual number of cataract operations by 45% (Hall
and Rosenthal, 1999). This requires identifying avoidable risk factors for
cataract. It is already known that there are certain attributes or factors, described
as risk factors, which contribute in increasing a person's chances of developing
a cataract. As stated previously some risk factors are considered almost definite
and these include normal and premature ageing, sunlight (LTV-B radiation),
malnutrition and smoking (Dolin, 1998); and also alcohol abuse (Agarwal,
1997 a). Some of these risk factors like malnutrition, smoking and alcohol abuse
could be avoidable. However, a majority of risk factors remain unavoidable
e.g. renal complications, hypertension, low height, low weight, low body
mass, socio-economic factors and environmental factors e.g. rural residence.
Evidently, the risks involved in the onset of cataract are multi-factorial (West and
Valmadrid, 1995).
Congenital cataract was found to be one of the three major causes of
childhood blindness (12/99) in Scotland in the Royal Blind School in
Edinburgh and it was the most common cause of partial sight or blindness in
a nationally representative cohort of 15,000 ten year old children in Britain
(Lloyd et al, 1992). It is estimated that congenital cataract occurs in one in
10,000 births, excluding those with multiple abnormalities (Moore, 1994).
The Royal College of Ophthalmologists (RCO) and the Royal College of
Paediatrics and Child Health (RCPCH) have recommended that all babies
should be screened for this condition. Congenital cataract needs to be
identified within 6 to 8 weeks following birth for urgent ophthalmic
intervention to avoid blindness (Barnard and Edgar,1996). Such cataracts
may occur in isolation or as part of a congenital or inherited disease or
syndrome causing blindness (Swann & Zahner, 1995).
Childhood blindness accounts for 3.3% of global blindness due to all causes
including congenital cataract according to WHO estimates (WHO, FS 213,
2000). Infants born at weights 2500g or below have a three to four fold
increased odds of developing infantile cataract (SanGiovanni et al, 2002).
Clear guidelines for screening are needed to establish the incidence and
prevalence of childhood blindness due to congenital, infantile and juvenile
form of cataracts. It should be noted that Childhood is defined by the United
Nations International Children's Emergency Fund (UNICEF) as a period of
life from birth until 16 years of age.
According to a recent pilot study investigating 'one stop' cataract surgery
facility, British optometrists can accurately predict the need for cataract
surgery without the need for general practitioner involvement (Gaskell et al,
2001). It was concluded from this pilot study that 'one stop' cataract surgery
157
is feasible because of several benefits to the patients such as abolition of the
need to visit the general practitioner for consultation and referral and the
hospital pre-surgical assessment. There was a high level of patient
satisfaction reported in a separate 'one stop' cataract service study (1997-99)
at the Bristol Eye Hospital (Hughes et al, 2001). Patients were satisfied with
the service because only one hospital visit was required as against three.
In a separate study carried out at the School of Community Health Sciences
at the Medical School in Nottingham, views of older people on key issues
concerning cataract surgery were sought (Ross et al, 2003). The main issues
were hospital waiting lists, complication rates from surgery and the use of
junior surgeons. Most respondents thought that surgeon grade was not
important whereas risk of damage to sight and/or waiting time were
important. Potential cataract patients preferred a greater risk of complication
combined with a short waiting rather than a low complication rate and a
longer waiting list (Ross et al, 2003).
Additional resources are continually required for identification and
management of risk factors in eye healthcare and also interventions at different
levels of eye care. It is indeed debatable whether applying extra resources
for maximising efficiency within the existing system always leads to real
efficiency. For the avoidance of blindness and visual impairment,
alternative methods of management of eye care have to be explored. It is
understood that appropriately trained human resources are the core component
in the prevention, treatment and rehabilitation of avoidable blindness.
Optometrists in the UK already receive superior professional education
compared with many other countries in the EU and many countries in the
world. In established market economies the cost of providing all forms of
health care is high and continues to escalate. Therefore, it may be more cost
effective and equally efficient if secondary eye care including specific
surgical intervention is also provided by British and Irish optometrists with
additional training and certification. It is realised that in the rest of the EU,
raising educational and professional standards in optometry remains a priority
before any harmonisation can take place.
In the United Kingdom the main issue regarding cataract surgery is not the
quality of treatment but the waiting time for surgical intervention.
4.2 (c) Management of Glaucomas in the Delivery of Eye Healthcare
Identification of risk factors in glaucoma requires a carefully planned
screening strategy because it is a collection of diseases which can cause
irreversible loss of visual function and blindness. Glaucoma, of all types and
forms is a major cause of blindness, second commonest in the world after
cataracts. It is a major public health problem throughout the world affecting
65 million people and an estimated 7 million become blind due to glaucoma
(O'Donoghue, 2001). Glaucoma is classified as open angle or angle closure
type, and may also be described as primary or secondary. Developmental
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glaucoma is also described as congenital glaucoma (Johnson, 1998).
It is reported that approximately 80% of glaucoma sufferers are primary
open angle glaucoma (POAG) type (Tuck and Crick, 1997a). Epidemiological
surveys in many countries have also indicated that 50% or more POAG
patients remain undetected (Tuck and Crick, 1997b). POAG is a common
ocular condition with a raised intraocular pressure causing damage to optic
nerve fibres and resulting in irreversible damage to the field of vision. This
insidious condition with an open anterior chamber angle is chronic, bilateral
and asymptomatic i.e. people are usually not aware of irreversible damage to
their field of vision. The Glaucomas mainly affect the middle aged and
elderly, and account for 8-15% of blindness registration in the western
countries (Tuck and Crick, 1998 b).
The risk factors for POAG include family history, elevated intraocular
pressure, ageing, ethnicity, myopia, diabetes, systemic hypertension and
evidence of vascular spasm such as migraine (Fraser and Wormald,
1999; Galloway and Amoaku, 1999; Lee, 1998; Johnson, 1998). There is an
ongoing debate whether or not POAG is associated with diabetes (Johnson,
1998). People of African, Afro-American and Afro-Caribbean descent
are reportedly more susceptible to POAG (Fraser and Wormald, 1999).
Associated risk factors may include socio-economic, gender, smoking and
alcohol abuse (Fraser and Wormald, 1999). Ocular risk factors are routinely
assessed during an eye examination which would include ophthalmoscopy,
tonometry, perimetry, gonioscopy if necessary, determination of visual
anomalies and an assessment of refractive errors. However, sometimes
these tests may not provide conclusive evidence of glaucoma. It should be
noted that TOP measurement is a poor diagnostic tool. At best it identifies the
presence of a risk factor for glaucoma. The TOP level may be sufficiently
elevated to justify repeated measurements and prophylactic hypotensive
treatment, but an elevated TOP does not confirm a diagnosis of glaucoma.
Also not all patients with glaucoma have an intraocular pressure above the
normal range (Hitchings, 1996). Visual fields are often normal until a patient
loses half of their nerve fibre layer and reliance on cupping of optic disc is
often misleading (Sherman, 2000).
For investigation purposes, clinicians regard family history as an established
indicator of primary open angle glaucoma. From the available twin and family
studies the proportion of hereditary POAG can be in the range of 70-80%
(Johnson, 1998). Other studies indicate that 10-50% POAG patients report a
family history of this disease (Tielsch et a1,1994). Since siblings share the
greatest proportion of genes, that relationship is regarded as a predictor for
inheriting POAG. It has been known that both dominant and recessive
Mendelian inheritance patterns exist for POAG (Hill, 1995).
On the question of gender as a risk factor in glaucoma, the Baltimore (Tielsch
et al, 1991), Beaver Dam (Klein et al, 1992c) and Roscommon (Coffey et al,
1993) studies did not find a significant difference in men and women. The
Rotterdam (Dielmans et al, 1994) and Barbados (Leske et a1,1994) studies
found men at greater risk, but the Dalby study (Bengtsson, 1981a) and the
Australian Blue Mountain Eye Study (Mitchell et al, 1996) found higher risk
for women. In 1980 in the west of Scotland, it was observed that blindness
was caused due to glaucoma in 11.2% women as against 19.9% men
(Ghaffour et al, 1983). However, these studies do not provide conclusive
evidence that gender is a risk factor. It should be noted that variations in
conclusions in these studies may be due to different study designs and
research methods.
Whereas myopia is implicated with POAG, a high degree of hypermetropia
may be related to closed angle type glaucoma both chronic and acute, usually
determined by direct or indirect gonioscopy. People of Mongoloid origin may
be more susceptible to closed angle type glaucoma (Johnson, 1998).
In England and Wales, between April 1990 and March 1991, on the basis of
certifications (BD8 forms) it was found that 11.7% of blindness was caused
due to glaucoma in all age groups (Evans, 1995; Evans et al, 1996).
However, 12.9°0 were certified as blind in the age group 65 years and
over. As stated previously, the BD8 figures are based upon WHO and
not RNIB definition of blindness.
According to the WHO figures (WHO/1990/PBL/94.40), glaucoma accounted
for 7.5% of total world blindness in the established market economies (EME)
and 6.8% in formerly socialist economies (FSE).
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Despite repeated requests for information on the incidence and prevalence of
blindness due to glaucoma and other causes from the relevant agencies,
organisations and government departments in the EU, even basic information
was not available from most EU member states. However, the following
information from a variety of random and non-governmental sources from
some EU countries gives a general indication that blindness due to glaucoma
in the EU ranges between 5-25%. Because of variations in blindness definition
in the EU, it is not possible to make meaningful comparisons. The following
statement from the European Blind Union (2003), based in Paris, is self
explanatory: 'the numbers of blind and partially sighted people in European
countries are based on estimates provided by the national members of the EBU
and are an approximation of a highly complex reality. Lack of official statistics
and varied legal definitions of blindness and partial sight make it particularly
difficult to work out accurate numbers'.
On the basis of applications for membership during 1993 to the Danish Society
of the Blind (VA < or = 6/60; VA < or= 0,1) 5% of blindness was caused due
to glaucoma (Rosenberg and Klie, 1996). However, in 1993 edition of the
Finnish register of Visual Impairment, 10% of visual impairment was
recorded due to glaucoma.
In Germany, blindness certificates from the region of Oberbayem were studied
to obtain data for the incidence, prevalence and causes of blindness in Bavaria
and it was found that 17% of blindness was caused due to glaucoma
(Krumpaszky and Klauss, 1992). In the city of Hessia in Germany, blindness
caused due to glaucoma was found to be 12.6% (visual acuity <or = 0.05 or
,
equivalent visual handicap) according to 1996 figures based on blindness
compensation payments (Graf et al, 1999). In this study VA < or = 0.05
(or equivalent visual handicap) was defined as 'substantial visual handicap'.
In a separate population based study from Wurttemberg-Hohenzolem
(Germany) on the incidence of legal blindness (VA<1/50) based on
information from social services found glaucoma as the cause of blindness in
1.6/100,000 people (Krumpaszky et al, 1999).
In Italy 7° o of blindness was recorded due to glaucoma according to the
National Household Health Survey (Niclosi et a1,1994). In the area
surrounding Turin, in north west Italy, the case notes of 4549 residents who
were certified blind between 1967 and 1991 were examined with regard to
the cause of visual loss, age of onset, and the year of onset of VA <or=1/20,
by Porta et al (1995). It was found from the case notes that 8.9% had already
been certified blind due to glaucoma.
The 1994 estimate for France, provided by Federation des Aveugles et
Handicapes de France, suggests that 5% of blindness was recorded due to
glaucoma (FAHV, 1996).
Bengtsson (1981b) reported that in Sweden the prevalence rate of glaucoma
associated with visual field loss increased with ageing and reached a rate
of 4-5°0 in people over the age of 75.
The highest glaucoma blindness figures (25%) from an EU member state were
recorded in Roscommon County in Ireland (Coffey et al, 1993). In this study
a total of 2186 people over the age of 50 were examined, which represented a
99.5% response rate. However in another study concerning the causes of
blindness in the adult population of the Republic of Ireland the figure recorded
was 16% (Munier et al, 1998). The difference in Roscommon figures was
attributed to 'actual differences between geographically separate areas' (Tuck
and Crick, 1998a).
Glaucoma diagnosis requires extra vigilance in the identification of risk
factors, repeated tests and long term surveillance of ocular health of all
those patients suspected of having glaucoma. Complex clinical skills are
required for treating glaucoma. It has already been estimated that the elderly
population in every country will increase and so will the blindness figures
due to glaucoma. It is certainly not practical to expect a total of 750 British
ophthalmologists to provide a mixture of primary and secondary eye care
to almost 60 million people in the UK.
Furthermore, GPs in the UK are not geared or equipped to provide a deliberate
and disease-specific screening, early detection or assessment of ocular
conditions like 'diabetic retinopathy or open angle glaucoma' (Smeeth,
1998). These conditions may remain undiagnosed especially when patients
have not reported any symptoms. Smeeth (1998) has rightly pointed out that
'unreported or undiagnosed visual impairment is common among older people
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and is associated with considerable morbidity. Testing for visual acuity is
easy and quick but may not accurately reflect the level of functional disability
caused by the visual problem in everyday living'.
In a recent paper by Tuck and Crick (2003) it was projected that the number
of POAG cases in England and Wales is 'estimated to increase by a third over
the 20 years to 2021 and then continue upwards at a similar pace to 2031'.
These authors have commented that 'to cope with additional pressures, a
thorough reappraisal of the present system for detection, referral, diagnosis,
treatment and monitoring of the disease is likely to be required'.
The concept of shared eye care in the UK is now almost three decades old
(Burns-Cox, 1995). Harrison et al (1988), writing in the British Medical
Journal, stated that the 'use of a community based service to screen for
glaucoma could save unnecessary consultant outpatient appointments'. In
1995, Burns-Cox stated that 'optometrists are those chiefly responsible for
detecting ocular hypertension and glaucoma. Sixty thousand out of the 6.3
million NHS eye tests carried out each year are for this diagnosis'.
Development of high quality shared eye care supports providers of both
primary and secondary care. 'Shared care between optometrists and
those medically qualified is highly relevant to suspected glaucoma' (Bums-
Cox, 1995).
In the Bristol Shared Care Glaucoma Study it was concluded that 'trained
community optometrists are able to make reliable measurements of the factors
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important to the assessment of glaucoma patients and glaucoma suspects'
(Spry et al, 1999). In a follow up study two years later it was concluded that
'there were no marked or statistically significant differences in outcome
between patients followed up in the hospital eye service or by community
optometrists' (Gray et al, 2000).
In another study (Theodossiades and Murdoch, 1999), it was concluded that
the positive predictive value of optometric referrals was highest when the three
screening tests (intra-ocular pressures, optic disc assessment and perimetry)
were performed.
It was stated in a study by Banes et al (2000) that an 'optometrist was
capable of undertaking routine glaucoma assessment and of making good
clinical decisions'. In this study 54 patients were recruited and clinically
assessed by an optometrist. Subsequently a research fellow i.e. an
ophthalmologist, assessed the same patients independently. The results of
the study showed that 'there was a high level of agreement between the
optometrist and the 'gold standard' of experienced ophthalmologist, in all
aspects of patient evaluation and management'. The study suggested that
'by using everyday clinical skills, in combination with a structured training
programme, optometrists in the future could make a valuable contribution
to patient care in glaucoma clinics'.
In a Manchester based glaucoma referral refinement study by Henson et al
(2003), patients with suspected glaucoma were referred by their optometrists
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to a group of specially trained community optometrists with a view to hospital
referral, under an agreed protocol, instead of being referred to their general
medical practitioner. The number of suspect glaucoma cases referred to the
Manchester Royal Eye Hospital was reduced by 40%, thus saving hospital
resources.
Clinical management of glaucoma is indeed a distinct sub-speciality.
Choplin and Lundy (1998), ophthalmoogists and editors of 'Atlas of
Glaucoma', have stated that 'to try to describe multiple disease, conditions,
and scenarios in a widely disparate group of patients with a single term
glaucoma is subject to frustration. Glaucomologists do not deal with a
single disease'.
The Department of Health has already embarked on its plans for optometrists
to prescribe therapeutics for treating patients with eye disease (Anon, 2003).
The competency framework for supplementary and independent prescribing
optometrists, was prepared by the National Prescribing Centre under contract
from the General Optical Council (Anon, 2004). With the present level of
training, British optometrists, with further specialisation in glaucoma
management especially diagnosis and treatment, would be ideally suited to
provide a cost-effective and efficient service. In the rest of the European
Union, optometrists with appropriate training and support from their
governments and the medical profession, will have to assume a much
bigger role in the surveillance and management of glaucoma.
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4.2 (d) Management of Diabetic Retinopathy in the Delivery of Eye
Healthcare
Retinopathy is a predictable complication of diabetes and a major
cause of blindness in the world. Factors associated with increased risk of
diabetes include ageing, obesity, ethnicity, alcohol abuse, smoking and a
lower socio-economic status. Diabetes which starts in childhood or
adolescence is usually more severe than that beginning in middle or old age.
Duration of diabetes is a good predictor of diabetic retinopathy and several
other ocular complications like cataract, glaucoma, vitreous haemorrhage
and retinal detachment.
Susceptibility to diabetes may also depend upon genetic factors but the
pattern is not likely to follow a Mendelian characteristic either for insulin
dependent or non-insulin dependent diabetes (Klein and Klein, 1998).
Interestingly in a study of maternally inherited diabetes and deafness (MEDD)
it was found that 86% of patients who received an ophthalmological
examination had macular pattern dystrophy (Guillausseau et al, 2001). In
MIDD patients, bilateral macular pattern dystrophy (MPD) was characterised
by linear pigmentation surrounding the macula and optic disc (Massin et
al, 1999).
Ethnicity is considered as an increased risk factor in the incidence of diabetes
because people of certain ethno-racial groups like those of south Asian origin
or descent have shown a higher prevalence of diabetes mellitus (Manuel
and Schultz, 2003). However, such conclusions are generally sensitive to
considerations like study designs, protocols for examination and documentation.
These factors and changing demography may explain variability in results
pertaining to ethnic groups. Manuel and Schultz (2003) have commented that
'there is no gold standard for assigning an individual to an ethnic group or for
determining someone's ethnicity as part of a population based survey'. Generally
an ethno-racial status is determined on the basis of common origin and culture.
However, it is debatable whether culture remains a valid criteria for such studies
in view of migration of people all over the world, often leading to a compromise
in their culture and life style. A study of Japanese Americans found 'lower rates
of retinopathy than in Japanese who reside in Japan' (Klein and Klein,
1998).
It has been suggested that elevated systolic blood pressure may be a moderate
risk factor for diabetic retinopathy (Benson, 1999). It has also been suggested
that high blood pressure independent of coexisting nephropathy is not a
strong risk factor for diabetic retinopathy (Benson, 1999). In diabetic women
who start a pregnancy without retinopathy, there is a 10% risk of developing
non-proliferative diabetic retinopathy (Benson, 1999). Those with non-
proliferative diabetic retinopathy at the onset of their pregnancy associated
with systemic hypertension tend to show characteristics of proliferative
diabetic retinopathy i.e. progression with haemorrhages, cotton wool spots
and macular oedema. High risk groups include women with a history of
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gestational diabetes mellitus (GDM) or who have delivered a baby that weighs
more than 9 pounds or 4 kg (Levene, 2003). It has been reported that there is
an up to 50% risk of future diabetes in women with GDM (Gadsby, 2002).
Children of women with a history of GDM may also be at risk of developing
diabetes (Domhorst and Rossi, 1998).
Diabetic retinopathy usually starts developing in those people who have had
diabetes for 5-10 years or more and retinal lesions such as microaneurysms,
dot and blot and flame shaped haemorrhages usually appear after this period.
After 10 years, about 55% of those patients not having insulin treatment i.e.
non-insulin dependent diabetes mellitus (NIDDM or type two) are likely to
show retinal lesions as against 70% of insulin dependent diabetes mellitus
patients i.e. IDDM or type one (Klein and Klein, 1998). It should be noted
that in 1999 the WHO renamed IDDM and NIDDM as type 1 and type 2
diabetes. The majority of diabetic patients are type two which is more
common than type one. It was estimated that in 2001 there -welt 151 wioì
people with diabetes worldwide and over 90% of these had type 2 diabetes
(Levene, 2003).
After a period of five years or more, mild retinal lesions slowly start
developing usually in the form of soft exudates and cotton wool spots. At the
next stage pre-proliferative retinopathy may appear leading to proliferative
retinopathy and maculopathy. Proliferative diabetic retinopathy (PDR) often
develops in poorly controlled diabetics (Galloway and Arnoaku, 1999).
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It should be noted that the old classification of diabetic retinopathy was
enlarged by the ETDRS (1991) or Early Treatment Diabetic Retinopathy
Study. The ETDRS (1991) classification covers 13 levels from no retinopathy
to PDR characterised by neo-vascularisation and vitreous haemorrhage. The
ETDRS (1991) and other ongoing studies like the Diabetes Control and
Complications Trial Research Group (DCCT, 1995), the United Kingdom
Prospective Diabetes Study Group or UKPDS (Kohner et al, 2001) and the
Diabetic Retinopathy Study (DRS, 1976, 1978) have provided guidelines for
the management of diabetic retinopathy. Generally after 20-30 years, the
incidence of diabetic retinopathy rises to 95% and 30-50% of these patients
develop PDR (Benson, 1999). in almost every diabetic patient, duration of
diabetes is clearly a predictor of diabetic retinopathy. Retinal lesions account
for almost 80% of blindness in diabetics and the remaining 20% may develop
cataracts (Crick and Khaw, 2003).
Diabetes remains a major cause of visual impairment and blindness in all
regions of the world including the established market economies and
industrialised countries. Diabetes prevalence figures are mostly estimated.
In 1999 the WHO recommended a new definition for diagnosing diabetes as a
result of epidemiological studies which have shown that there is a closer
relationship between a fasting glucose value of 7mmo1/1 and the two hour
value of 11.1mmoUl. In the new definition the cut off point for diagnosing
diabetes using a fasting plasma glucose has been lowered from 7.8mmo1/1
to 7.0mmo111 (WHO, 1999a).
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Amos et al (1997) projected the prevalence of diabetes worldwide for the
years 2000 and 2010. as 151 million and 220 million people respectively.
Although it was estimated that in 2001 there were 151 million people with
diabetes worldwide (Levene, 2003), the WHO estimated 171 million diabetic
sufferers worldwide during the same year (THF, 2001). Three years later in an
estimate from the International Diabetes Federation (IDF) this figure had risen
by 23 million people. In August 2003, the DDF stated in a press release that
'some 194 million people worldwide or 5.1% of the adult population, have
diabetes and this is expected to escalate to 333 million, or 6.3%, by 2025'
(IDF, 2003). In the press release it was also stated that 'some 314 million
people worldwide, or 8.2% of the adult population, are estimated to have
impaired glucose tolerance (IGT), a state which often precedes diabetes'.
Amos et al (1997) projected the prevalence of diabetes for Europe for the
years 2000 and 2010 as 26 million and 33 million people respectively.
The WHO estimates for the prevalence of diabetes (1980-1997) in selected
European countries.(WHO, 1999b) are incomplete (missing data) and only
cover 8 EU countries. It is, therefore, not possible to make any meaningful
comparisons.
In March 1997, the European Association for the study of Diabetes (EASD)
stated in a press release that there were over 10 million people with diabetes in
Europe (EASD,1997). In April 2004, in a joint press release, the International
Diabetes Federation and the Diabetes Federation of Ireland stated that
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'approximately 60 million people live with diabetes in the enlarged Europe,
over 50% of whom are unaware of their condition' (DFI, 2004). In 1997 the
population of the EU (15 member states) was approximately 374 million and
it was estimated that over 10 million people were living with diabetes. With an
enlarged EU (25 member states) the population in May 2004 was
approximately 450 million. In seven years since 1997, with 75 million more
people in an enlarged EU, the estimated number of people with diabetes
shows a massive increase. It would be simplistic to conclude that the states
entering the EU in 2004 mostly consisted of people with diabetes. However,
these estimates suggest that diabetes may be expanding as an epidemic in the
EU. As stated previously, such conclusions are generally sensitive to
considerations like study designs, protocols for examination and
documentation. Also the size of socio-economic inequalities in determinants
of diabetes in the EU is not known. Passa (2002) has stated that 'Diabetes
trends in Europe are alarming; health care professionals involved in diabetes
care must be made aware of these detrimental trends, and healthcare delivery
to patients with diabetes must be improved'.
It was reported that the European Union, in their draft 6 th framework in 2001,
decided to drop diabetes as a specific target disease along with cancer,
cardiovascular disease and neurological diseases. The President of the EASD
(European Association for the Study of Diabetes) described the EU resolution
as a 'potentially disastrous decision for Europe' (Nerup, 2001).
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In a study, the prevalence of diabetes known to GPs (family physicians)
between 1999-2000 in eight European countries was investigated by a group
of researchers (Fleming et al, 2004). It was found that all age prevalence was
lowest in Slovenia and highest in Belgium. It should be noted that since 1989,
the Belgian Diabetes Registry is studying all types of diabetes presenting
before age 40 in Belgium and provides a paradigm of how diabetes registries
may also contribute to the advancement of knowledge on disease
heterogeneity, aetiology, prediction and prevention (Gorus et al, 2004).
Diabetes registries have demonstrated that the lifetime risk of diabetes
amounts to at least 10% in the western world (Gorus et al, 2004). It is
proposed by de Beaufort et al (2003) that 'monitoring risk factors for diabetes
and its complications will offer the possibility to evaluate the development in
time, as well as the influence of possible interventions'.
In a study on the age-and sex-specific prevalence of diabetes and impaired
glucose regulation (IGR), in 13 cohorts from 8 European countries, according
to the revised WHO criteria for diabetes, it was found that most European
populations have a moderate to low prevalence of diabetes and impaired
glucose regulation. However, it was concluded that diabetes and IGR will be
underestimated in Europe, particularly in women and in elderly men, if
diagnoses are based on fasting glucose determination alone (DECODE, 2003).
It is estimated that in the established market economies and industrialised
countries diabetes in the elderly people may prove to be 'the most important
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epidemic in the 21't century' and approximately 20% of the population aged
75+ will develop this disease (Sclater, 2003). It is projected that the number
of people with diagnosed diabetes may increase by 165% by the year 2050; the
largest increase is projected for the 75+ age group: 275% in women and
437% in men (Sclater, 2003).
Several newly industrialised countries and emerging economies are now
witnessing a rapid increase in diabetes and related complications like
retinopathy in their populations. This may partly be due to the fact that
people in newly industrialised countries have adopted a western life style and
diet. However, there is a huge geographical variation in the prevalence of type
two diabetes in different ethnic groups in different economies, ranging from
500 0 in Pima American Indians in Arizona, to less than 2% in African Bantu
tribesmen in Tanzania (Gregory, 2003).
The WHO estimates of major causes of blindness, as per demographic
regions (see appendix 5 and 6), due to 'other disorders' have included most
causes of blindness excepting glaucoma and cataract and these have
accounted for 89% of blindness in the EME countries and 84.9% in the FSE
countries (WHO/1990/PBL/94.40). The WHO has stated that whereas cataract
is the most important cause of blindness in all developing regions, 'other
disorders' (e.g. diabetes, macular degeneration, etc.) largely dominate in the
'Established Market Economies' and in the 'Former Socialist Economies of
Europe' (WHO/1990/PBL/94.40).
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The WHO has further stated that there were 'several shortcomings in the
models developed for disease estimates due to paucity of population-based
data on the prevention of blindness particularly for 'Established Market
Economies', 'Former Socialist Economies of Europe' and 'Latin America
and the Caribbean' (WHO/1990/PBL/94.40).
The following information from a variety of sources in some EU and FSE
countries gives a general indication that blindness due to diabetic retinopathy
in these regions probably ranges between 9-16%. It was not possible to
determine the protocol for examinations, method of documentation and study
designs for this information, therefore any comparison of figures remains
invalid. It should also be noted that official blindness figures for diabetic
retinopathy from most EU and FSE countries are not available. Lack of
official statistics combined with a lack of uniformity for definition of partial
sight and blindness in the EU makes it difficult to compare various causes
of blindness.
In the 1993 edition of the Finnish register of Visual Impairment, 9% of
visual impairment recorded was due to diabetic retinopathy and in the age
group 18-39 years old 12.6% of visual impairment was due to proliferative
diabetic retinopathy (PDR). The figures for the older age group 40-64 were
recorded as 11.3% for PDR and 3% for non-proliferative type diabetic
retinopathy. It would appear that within the established market economies
Finland has a high incidence of diabetes mellitus (approximately 30-49%
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higher than Japan) and it increases in Finnish children by 5.6% in the age
group up to four years (North, 1998).
In a study from Karolinska Institute conducted during 1992-95 in Stockholm
County in Sweden, diabetic blindness in the age group 18-84 years was recorded
in 2.2 % cases in 1995 (Wandell et al, 1998). In another study from Sweden
conducted by Henricsson et al (1996), 2133 diabetics were screened and
examined during 1990-95 on the basis of VA <or=0.1 for blindness or
VA <or=0.2-0.4 for visual impairment. According to these researchers
multivariate analysis showed a statistically significant association between
blindness/visual impairment, and old age, long duration of diabetes, and poor
glycaemic control' and 'retinopathy was the major cause of blindness and visual
impairment in patients with diabetes' (Henricsson et al 1996).
According to the Copenhagen City Eye study from Denmark conducted
during 1986-88 it was found that 9.52% diabetics suffered from unilateral
blindness (age group 60-80 years) on the basis of the Danish definition of
blindness (VA 0.1 or worse) known as the National Criteria of Blindness
(Buch et al, 2001). In a previous study from Denmark published in 1996 it
was found that diabetic retinopathy caused 8.4% blindness (VA<or=6/60) on
the basis of 1585 membership applications to the Danish Society of the Blind
(Rosenberg and Klie, 1996). The authors noted that a change of definition to
VA<6/60 would have reduced the number of formally blind by 32% and the
WHO definition (VA <3/60) would have further reduced the percentage of
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formally blind. On the basis of the WHO definition only 35% (562 subjects
out of 1585 membership applications) would have been considered blind
(Rosenberg and Klie, 1996).
In the city of Hessia in Germany, blindness caused due to diabetic
retinopathy was reported as 15% according to 1996 figures (VA < or = 0.05 or
equivalent visual handicap) based on blindness compensation payments (Graf
et al, 1999). In the upper Bavaria 13% of blindness was reported due to
diabetic retinopathy (Krumpaszky and Klauss, 1992).
A separate population - based study from Wurttembrg-Hohenzollern in
Germany on the incidence of legal blindness (VA <1/50) based on materials
from the social services found diabetic retinopathy to be the cause of blindness
in 2.01/100,000 people (Krumpaszky et al, 1999). In another separate study
the files of all newly registered blindness-allowance recipients in
Wurttemberg-Hohenzollern in 1994-98 were reviewed and it was found that
2.13/100.000 suffered from blindness (VA <1/50) due to diabetic retinopathy
(Trautner et al, 2003). However, it was concluded from this study that
secondary prevention measures should be intensified.
In the Italian blindness figures published in 1994 diabetes was not mentioned;
it was simply recorded that the most frequent causes of blindness (33%)
among the registry of the blind and the welfare lists of the Ministry of the
Interior were retinal diseases (Nicolosi et al 1994). However, between 1967-
1991 in the province of Turin in north west Italy 13.1% cases were recorded
as having bilateral blindness due to diabetic retinopathy (Porta et al, 1995).
In a study from Greece conducted at a teaching centre of the university eye
clinic at Patras from 1989-1999, although blindness figures were not given,
it was found that 71.7% diabetics had non-proliferative retinopathy and 10.4%
had proliferative diabetic retinopathy (Pharmakalcis et al, 2002).
Data on visual impairment and blindness in patients attending ophthalmology
clinics at the Orleans regional hospital centre serving a semi-rural area in
France were studied and it was found that 16.6% of severe visual impairment
in patients over 60 was caused due to diabetic retinopathy (Cohen et al, 2000).
In another estimate from France 16% of blindness was recorded due to
diabetic retinopathy (FAT-TV, 1996).
In a recent study from Spain on the prevalence of diabetic retinopathy in the
province of Valladolid, screening for diabetic retinopathy in the rural areas
was found to be deficient (Lopez et al, 2002). Diabetic retinopathy was found
in 48.6% of 1DDM and 14.7% of N1DDM patients; blindness figures were
not given. However, according to Organizacion Nacional De Ciegos (National
organisation for the blind) in 1992 diabetic retinopathy was the cause of
blindness in 18.9% from a total of 3714 registered blind (ONCE, 1994).
In a Portuguese study it was stated that in advanced retinopathy laser
photocoagulation is effective in decreasing deterioration by 50%
(Cunha-Vaz, 1998).
Figures for diabetes induced blindness from two FSE countries ranged
between 6-15%. In Poland at the Cracow branch of the Polish Association of
the Blind, diabetes accounted for 6.2% cases (Pantoflinski et al, 2001). In 1993
it was estimated that in Bulgaria in the Sofia district (urban and rural)
15% of blindness was caused by diabetic retinopathy (IEF, 1994). It was
concluded from an international study on eye healthcare services in eastern
Europe that more specialist doctors were required, screening for diabetic eye
complications needed improvement and technical equipment was required
(Kocur et al 2002).
In England and Wales, between April 1990 and March 1991, on the basis of
certifications (BD8 forms) and registration it was found that 3.4% of
blindness was caused due to diabetic retinopathy in all age groups (Evans et
al, 1996). However, 11.9% were certified as blind in the age group 16-64
years. As stated previously, the BD8 figures are based upon WHO and not
RNIB definition of blindness.
It was stated earlier that by the year 2020 in the established market economies
the elderly population will increase by 186%. Visual impairment and blindness
due to diabetic retinopathy is also likely to increase proportionately.
A consultant physician (Winocour, 2003) recently commented that 'there has
been a marked increase in the incidence of diabetes which is threatening to
reach epidemic proportions'. Winocour further commented that 'efforts to
create unrealistic targets also create more unsettling pressures in health care
systems. In the UK the hospital waiting list debacle has led to fabrication of
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data'. In the next 10-15 years the incidence of diabetic retinopathy and
blindness as a consequence is also likely to reach epidemic proportions, if it
has not reached that level already.
In the UK there are approximately 1.5 million people with known diabetes and
another one million in whom diabetes is not diagnosed as yet (Levene,2003).
The incidence of type 2 diabetes is rising dramatically due to the large increase
in obese people in recent times and increased longevity (Wallace, 2002). It is
projected that due to population ageing, in 2036 there will be approximately
20% more cases of type 2 diabetes than in 2000 (Bagust et al, 2002). It is
predicted by these researchers that in the next 30 years type 2 diabetes will
present a serious clinical and financial challenge to the UK NHS.
The emergence of type 2 diabetes in children has also been causing concern
in industrialised and industrialising countries (Fagot-Campagna, 2000). Two
decades ago type 2 diabetes was described in children of specific groups e.g.
the Pima American Indians (Matthews and Wallace, 2002). Type 2 Diabetes is
increasing rapidly worldwide at a younger age (Silink, 2002). Keiss et al
(2003) have stated that 'there is high hidden prevalence and a lack of exact
data on the epidemiology of the disease in Europe'. According to these
researchers 'in Germany only 70 patients below the age of 15 years were
identified in the systematic, nationwide DPV (Diabetessoftware fur
prospektive Verlaufsdolcumentation) diabetes survey, but our calculations
suggest that more than 5000 young people in Germany at present would meet
the diagnostic criteria of type 2 diabetes'. However, in an Austrian study it was
concluded that type 2 diabetes is 'rare but exists in children under 15 years in
Austria' (Rami et al, 2003).
In a recently published paper (Ehtisham and Barrett, 2004), from Birmingham
Children's Hospital, it is stated that until recently only type 1 diabetes was
assumed to be the diagnosis of almost all children. The first cases of type 2
diabetes reported in the UK children was in the year 2000 (Ehtisham et al,
2000). Affected children were overweight or obese, often female, pubertal,
predominantly of ethnic minority (South Asian) origin and had a family
history of type 2 diabetes. According to Levene (2003) the prevalence of type
2 diabetes is 'particularly high in populations that have changed from a
traditional to a modern life style, such as migrant Afro-Caribbeans and Indo-
Asians in the UK'. The underlying cause of type 2 diabetes is likely to be
related to the epidemic of childhood obesity (Ehtisham and Barrett, 2004;
Renders et al, 2003; Silink, 2002). Many children do not feel they have an
illness as they are asymptomatic at diagnosis. Out of 28 children, one
developed cataract seven years after diagnosis. (Gold, 2002). The increasing
incidence of childhood obesity in the UK and 'the inevitable rise in type 2
diabetes from an early age is likely to have a major long term impact on the
healthcare system in the UK' (Drake et al, 2002).
In 1984, in a randomised controlled trial of routine hospital clinic care versus
routine general practice care for type 2 diabetes, it was found that routine care
in general medical practice was 'less satisfactory than care by the hospital
diabetic clinic' (Hayes and Harries, 1984).
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In a recent study 'the problems and barriers perceived by GPs whilst
providing diabetes care in primary care in England and Wales' were identified
following a 'descriptive postal survey using a self-administered questionnaire'
(Agarwal et al, 2002). The authors highlighted in the study that the 'greatest
barriers' to GP practices providing 'desirable care' were ' lack of time/under-
fUnding and keeping up to dale in the area of diabetes, followed by lack of
space, inadequate chiropody, dietetics, ophthalmology and access to
secondary care'.
GPs in the UK are neither geared nor equipped to provide an eye disease-
specific screening, early detection or assessment of ocular conditions like
diabetic retinopathy (Smeeth, 1998). Additionally, GPs may not gain
sufficient experience to diagnose retinopathy with confidence (Mason &
Drummond, 1995; Mason, Drummond and Woodward, 1996). It is generally
recognised that while British optometrists receive around 300 hours of
instructions in ocular examination as part of tfieir trainfits acid certiadiba,
medical schools may provide approximately 10 hours of training in retinal
observation for the future GPs (Mason and Drummond, 1995).
Taking into account the above mentioned pattern of clinical training, a recent
comment made by a GP that 'Opticians are as good as doctors at finding
retinopathy' (Warren, 2002) would appear somewhat outdated and rather
condescending. Interestingly, it was noted by two ophthalmologists in 1985
that optometrists then had the skill to detect diabetic retinopathy at a treatable
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stage (Burns-Cox and Hart, 1985). In a study in 1988 it was found that
optometrists were 'more likely than general practitioners to diagnose
retinopathy requiring photocoagulation' (Harrison et al, 1988). It is estimated
that 20% of patients would have developed retinopathy by the time diabetes
is diagnosed by their GPs (Davison, 2003). It is generally agreed within
medicine that GPs lack confidence in their training in ophthalmology
(Smeeth, 1998).
In 1976, the preliminary report of the diabetic retinopathy study research
group stated that photocoagulation treatment prevented severe visual loss in
eyes with proliferative retinopathy (DRS,1976). By 1978 two shared care
schemes were set up in England (in Poole, Dorset and in Frenchay, Bristol)
for the purposes of timely screening for diabetic retinopathy and retinal
photocoagulation treatment to prevent blindness (Bums-Cox, 1995).
Participants in the schemes included optometrists, general medical
practitioners (family physicians), diabetic physicians and ophthalmologists.
Since then British optometrists have been participating in shared care
schemes, both community based and Hospital Eye Service based, developed
under an agreed protocol and supported by the Royal College of
Ophthalmologists, Royal College of General Practitioners and the College of
Optometrists. Shared care schemes optimise provision of primary and
secondary eye care resources and meet local requirements for the benefit of
patients. Under the scheme patients visit optometrists for particular
procedures. Organisers of shared care schemes may devise a plan, if
necessary, with a locally agreed protocol.
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Three researchers from Moodields Eye Hospital evaluated new optometric
referrals in a busy out-patient clinic. The results of clinical appraisal showed a
high level of diagnostic accuracy which suggested that the role of hospital
optometrists may be successfully extended 'to include some aspects of patient
evaluation not typically undertaken' (Oster et al, 1999).
It was concluded in a study by Hammond et al (1996) that optometrists with
suitable training would be an effective body to screen for diabetic retinopathy.
In another study it was concluded that 'suitably trained and accredited
community optometrists performed well when screening for diabetic
retinopathy' (Prasad et al 2001). A recent study at the University of Leeds
confirmed that 'the prevention of diabetic complications will not only benefit
patients, but potentially reduce overall healthcare expenditure' (Williams
et al, 2002).
Consultant ophthalmologists, the implicit gold standard for identifying serious
retinopathy, can not realistically provide eye screening to all those individuals
diagnosed with diabetes. In 1994 there were an estimated 433 whole-time
consultant ophthalmologists in England, approximately one for every 1100
diabetics (Mason 8,:. Drummond, 1995; Mason, Drummond and Woodward,
1996). In 1996 there were approximately a total of 750 ophthalmologists in
the UK for a population of almost 60 million people i.e. 1.27 per 100,000
inhabitants.
An early diagnosis of diabetes combined with regular screenin g for ocular
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manifestations, especially the interior of the eye for vitreous, retinal and
macular lesions, is essential in the management of diabetes related
complications. Timely evaluation of diabetic retinopathy is crucial for
appropriate ophthalmic intervention like retinal photocoagulation for the
avoidance of visual impairment and total blindness.
Effective measures must be taken by the state to combat serious public health
implications of the real and projected increase in the incidence of diabetes and
related complications in the UK. Clearly British optometrists could be given
greater responsibilities and appropriate resources for assessment, surveillance
and diagnosis of diabetic retinopathy which should include screening with
retinal photography and if necessary fluorescein angiography. British
optometrists could also be actively involved in the treatment processes such
as laser photocoaeulation to avoid the risk of severe vision loss due to
proliferative diabetic retinopathy and macular oedema. The effectiveness of laser
photocoagulation is best before any loss of vision occurs and falls sharply if
applied later (Burns-Cox et al, 1985; Hux et al, 2003).
The main objective of the St. Vincent declaration of October 1989 was
reduction of diabetes-induced blindness in Europe by one third within five
years (Anon, 1990). The declaration was made under the auspices of the
World Health Organisation (Europe) and the International Diabetes Federation
(Europe). Thus far the aims of the St. Vincent declaration of 1989 have not
been achieved (Hone et al, 2002).
In order to avoid an increase in visual impairment and blindness in the EU, all
member states will have to carry out a complete reappraisal of the system of
delivery of eye healthcare for the population.
Maximisation of efficiency within the existing healthcare system has failed to
produce desirable results. Development of appropriate human resources e.g.
properly trained and licensed optometrists throughout the EU for effective
screening of diabetes-induced visual impairment and timely treatment needs
to be given priority.
4.2 (e) Management of Age-Related Macular Degeneration in the
Delivery of Eye Healthcare
Age-related macular degeneration (AMID) leads to irreversible loss of
central vision causing difficulties in normal activities of life like driving,
reading and increased risk of falls and injuries for the sufferer. AMID usually
causes serious physical, social and emotional problems, significantly
impairing quality of life. Despite the fact that AMID has fairly extensive ocular
morbidity because it is widely prevalent in the established market economies,
the precise aetiology or pathogenesis of this condition is not fully understood
(Ambati et al, 2003; Edwards eta!, 1999). Furthermore, the size of socio-
economic inequalities in determinants of ocular morbidity for conditions like
AMID in different EU countries is not known. The main risk factors for AMID
include ageing, gender (female), ethnicity (mostly caucasians), smoking,
dietary deficiencies, systemic hypertension and strong family history. A
188
significant genetic influence in AM]) was confirmed from two separate twin
studies (Gottfredsdottir et al 1999; Hammond et al, 2002).
The early stages of AM]) are characterised by soft drusen and lesions of retinal
pigment epithelium (RPE). In the later stages AMID is distinguished by the
presence of well defined areas of retinal pigment epithelium loss
(geographical atrophy), choroidal neovascularisation (CNV), pigment
epithelial detachment and disciform scarring i.e. fibrous scarring of the macula
(Gottleib, 2002). AMD is either dry or wet; the latter is characterised with
neovascularisation causing central vision loss and usually requires urgent
ophthalmological intervention. It was found that after 3 years, 63% of
untreated CNV patients showed mean visual acuity in the region of <6/60
(<20/200) and in some cases even worse than 6/240 or <20/800
(Gottleib, 2002).
Investigation of AMID consists of retinal and choroidal angiography using
dyes like fluorescein and indocyanine green and a specially designed fundus
camera with filters for an accurate diagnosis. The modem techniques of
digital angiography and tomography allow a better view of choroidal
neovascularisation. Prior to a full retinal investigation Arnsler grid is used to
detect visual distortions and abnormalities. Patients are encouraged to use
Amsler grid for self monitoring. Another method, described as the Macular
Computerised Psychophysical Test (MCPT), using hyperacuity also allows
evaluation of central macular visual field (Loewenstein et al, 2003).
Interventions like thermal laser photocoagulation, photodynamic therapy
with Verteporfin or transpupillary thermo therapy may delay serious visual
impairment in eyes with choroidal neovascularisation. The effectiveness of
photodynamic therapy is currently being assessed by the National Institute of
Clinical Excellence (NICE) and the widespread availability of this somewhat
expensive treatment has become a political issue.
Other interventions include radiography, submacular surgery, macular
translocation, proton beam / scleral plaque, external beam radiation and food
supplements / nutrients like lutein (Chopdar, 2003). Treatment may be
appropriate in some cases and may halt or slow down the progression of the
disease. Oxidative damage to retina may be a risk factor and dietary or
supplemental antioxidants may play a protective role. The Age-Related Eye
Disease Study (AREDS) reported a beneficial effect of high-dose
supplements, taken for approximately six years, in delaying the progression of
intermediate AMD to advanced AMID (McBee et al, 2003). AREDS and
subsequent research on dietary intake or supplement use have not indicated a
protective role of antioxidant or supplement use in the incidence or prevalence
of early AMID and number of cases were insufficient to investigate effects on
late AMID. Persons with intermediate AMID and without contraindications may
consider using antioxidant and zinc supplements (McBee et al, 2003). The
lutein supplementation antioxidant trial (LAST) was conducted to determine
whether nutritional supplementation with lutein or lutein together with a broad
spectrum of antioxidants, vitamins and minerals improves visual functions
and symptoms in atrophic age-related macular degeneration (Richer et al,
2004). It was concluded that although visual function is improved, further
studies are needed to assess long term effects of this treatment. The findings
of the LAST 'support a possible therapeutic role of lutein in AMD' (Bartlett
and Eperjesi, 2003). However, Blodi (2004) stated that 'nutritional
supplements are not without risks and their effects must be diligently and
accurately monitored'. The value of lutein and zeaxanthin remains uncertain,
although one or both of these carotenoids may be better than carotene (Jampol,
2003). However, no technique or treatment has yet offered cure of this
condition (Gottleib, 2002).
AMD still remains a leading cause of visual impairment and blindness mostly
in the EME and industrialised world. The WHO has already acknowledged
that the 'lack of relevant epidemiological data makes it impossible to present
separate specific statistics for a number of well known causes of blindness
like age-related macular degeneration' (WH011990/PBL/94.40). The WHO
has further acknowledged that age-related macular degeneration will be
increasingly prevalent with the greying of the world population' and that age-
related macular degeneration (AMD) is a major cause of blindness in older
people in the established market economies. In England and Wales during
1990-91 on the basis of ophthalmological certifications (BD8 forms), 48.5%
of blindness in all age groups was recorded due to age-related macular
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degeneration (Evans, 1995; Evans et al, 1996). During the same period in the
age group 65 years and above, 54.5% were certified as blind due to AMD. In
another study it was found that choroidal neovascularisation (CNV)
accounted for 3.5% white British patients as against only 0.1% patients of
black African descent in a similar age group (Gregor et al, 1978).
In the Republic of Ireland AMID accounted for 16% of blindness on the basis
of registrations with the National Council for the blind (Munier et al, 1998).
The criteria used for registration was best corrected VA 6/60 (0.1) or less in
the better eye or a visual field restricted to 20 degrees or less. Owen et al
(2003) have reported that the pooled data from several studies showed that the
prevalence of visual loss due to age-related macular degeneration increased
exponentially from the age of 75-85 years, with 3.5% exhibiting visual
impairment beyond the age of 75 years. It was estimated that currently in the
UK there are 214,000 people with visual impairment caused by AMID eligible
for registration as partially sighted or blind and this number is expected to
increase to 239,000 by the year 2011 (Owen et al, 2003).
In the EU countries more than 50% of blindness is caused due to AMID in the
60+ age group. These figures vary because of the difference in blindness
criteria and definitions used within the EU. However, it was concluded from
the Rotterdam study that AMD was the major cause of the prevalence of
blindness in persons 75 years or older (Klaver et al, 1998).
In the Finnish Register of Visual Impairment (1993 statistics) blindness due to
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AMID in the 65+ age group was recorded as 51.7%. In Finland in the county
of Oulu in a separate epidemiological cross-sectional population study of
inhabitants (70 years or older) 4.6% of blindness was recorded due to
age-related maculopathy (Hirvela and Laatikainen, 1995).
In Germany, in the Upper Bavaria, in a review of blindness certificates to
ascertain the causes of blindness, it was found that 28% of blindness (all age
groups) was caused due to MAD which was considered a leading cause of
visual impairment and blindness (Krumpaszky and Klauss, 1992). In 1996 on
the basis of a study carried out in Hessia in Germany, the most frequent cause
of blindness (41°0) was AMID (Graf et al, 1998). In a separate study, also in
Germany, the causes of legal blindness (VA <1150) were analysed in
Wurttemberg-Hohenzollern based on data from social services in 1994 and the
major cause of blindness (3.92/1000,000) was AMID (Krumpaszky et al, 1999).
Also in Germany the files of all newly registered blindness allowance
recipients in Wurttemberg-Hohenzollern between 1994-1998 were reviewed
and it was found that 5.29% suffered from blindness (VA < or = 1/50) due to
AMID (Trautner, 2003). The most single cause of blindness recorded was
macular degeneration in that study. It should be noted that data on blindness
allowance recipients or blind registers only provide information on the
incidence of certification and not the incidence or prevalence of AMID.
In an interesting study from Denmark AMD was investigated in the age group
60-80 years on the basis of VA 6/9 or less. A visual impairment in the region
of 6/9-6/12 was described as the tip of an iceberg (71.7%) and as the
predominant base; partial impairment 6/18-6/36 as an interjacent area (15%)
and the major impairment or blindness (6/60 or less) in the remaining 13.3%
(Vinding, 1990). In a separate study also from Denmark, on the basis of
membership applications in 1993 to the Danish Society of the Blind it was
found that the majority of applicants (92%) were 60 years or over and AMID
was recorded as the major cause of blindness (VA <or =6/60) in 78%
applicants (Rosenberg and Klie, 1996).
In Denmark, in the Copenhagen City Eye Study the prevalence rates of
bilateral and unilateral blindness using WHO criteria (VA <3/60 or <0.05)
were recorded as 0.53% and 3.38% respectively. On the basis of National
Criteria (NC) of blindness (VA <or-6/60; VA <or=20/200; VA <or=0.1) the
figures rose to 1.06% (unilateral) and 4.4% (bilateral). However, using NC as
the basis, AMID was the main cause of blindness accounting for 60% of all
blind people in the age group 60+ years (Buch et al, 2001).
An observational study was carried out in two French centres on patients aged
60 years or older with an exudative form of A.MD and a distance VA
<or-20/40 in the best eye. It was concluded that early detection and treatment
of patients with AMID was necessary, supporting the argument that costs are
higher in patients with the lowest visual acuity (Bonastre et al, 2003). In
another French study at an ophthalmology clinic in Orleans, in the age group
60 or over, AMID was the leading cause of severe visual impairment
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(VA 6/60 or less in the better eye) in 48% patients (Cohen et al, 2000). The
Beaver Dam Eye Study concluded that age-related maculopathy is common in
older people and poses a substantial public health problem (Klein et al, 1992 a).
The Age-Related Eye Disease Study Research Group has recommended that
persons older than 55 should have their eyes examined with pupils dilated to
determine the risk of developing advanced AMD (AREDS, 2001).
According to a recently published survey by the AMID Alliance International
conducted in North America and Europe, there is a low public awareness of
AMID which may influence early detection of this disease and may result in
people not receiving prompt medical attention (Rosenthal and Thompson,
2003). Tt was found that 70% of respondents were not familiar with AMID and
only 2% were aware that AMID is the leading cause of blindness. In a recent
British study by Owen et al (2003) it was concluded that the prevalence of
AMID is 'likely to increase with time'.
Large scale health related problems require resources and are often regarded
as social problems. Age-related macular degeneration is a health-related
problem of social magnitude mostly in the established market economies.
As stated previously, the elderly population is growing throu ghout the world.
Measures like self monitoring by using the Amsler grid are indeed useful but
will not solve the real problem of increasing visual impairment or blindness
due to AMID. All societies have to accept the fact that health-related problems
require proper economic backin g and most importantly adequate professional
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resources. The question is not simply that of organising regular retinal
screenings to identify a disease like age-related macular degeneration.
Adequate manpower (or womanpower) is also required to treat this condition.
Ultimately British optometrists will have to be given more responsibilities.
Eventually optometrists in the rest of the EU will have to follow suit with
proper professional training, certification and support.
4.3 Summary
Within the established market economies and former socialist
economies, the European continent incorporates a large diversity of social and
political traditions and also professional cultures in spite of geographical
proximity of states. In the European Union, education and professional training
also evolved differently from one country to the other.
The definition of blindness varies between different EU member countries.
Accurate blindness figures from most EU countries are not available (see
Appendix 4). With reference to blindness figures there was no response from
various organisations and government departments of most EU countries.
Presumably the requested information was either not available or did not
exist. Blindness registration information from an EU country may provide
insufficient data on the incidence of certification based upon blindness
definition used for the purposes of registration for blindness allowance.
This type of information, if available, does not provide data on
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the prevalence of ocular diseases causing visual impairment and
blindness.
This chapter covers the management of four eye diseases in the European
Union: cataract, glaucoma, diabetic retinopathy and age-related macular
degeneration, being the major causes of visual impairment and blindness.
However, there is no uniformity in the management of ocular pathology by
optometrists in the EU. Although referral to medical practitioners by
optometrists is allowed in most EU countries, monitoring of ocular
pathology by optometrists is only allowed in the United Kingdom. Under the
GOC revised rules on referrals that came into force on 1 January 2000,
optometrists are allowed to manage the eye conditions of their patients, and
only refer when clinically necessary. Shared care, delegated care, decision on
referrals, direct referral to hospital eye departments and supplementary
prescribing are all part of British optometric practice. Independent prescribing
status for British optometrists is already on the agenda of the Department of
Health and the General Optical Council. Presently, the role of optometry in
the management of ocular pathology in the United Kingdom and the rest of
the European Union are separate issues.
Chapter 5
Optometry and Eye Healthcare in the EU: a British
Perspective, a Perspective for the Future
and Conclusions
5.1 Optometry and Eye Healthcare in the EU: A British Perspective
Professionalisation is a continuous and logical process necessary for the
development of all professions, both structurally and functionally, leading to a
recognised professional status and autonomy on the basis of training, specialised
knowledge and delivery of quality service. In the context of evolution and sociology
of healthcare professions like optometry, the past experience clearly indicates that
the process of professionalisation is slow, non-linear, tortuous, requiring decades and
even centuries of cumulative effort.
There are several key issues concerning the status, structure and performance
of optometry as a profession in the European Union which need addressing.
The crucial factors in these issues include a lack of uniformity in the level and
standard of academic and professional education, the level of professional
work in accordance with the existing laws in the EU member states and the
relationship of optometry with medicine and ophthalmology.
In most of the EU optometry as a profession is either non-existent or exists as a
dispensing optics based technical skill or as an auxiliary occupation to
medicine and ophthalmology. For example in France there are virtually no
optometrists; 6500 opticians and 1500 orthoptists in France carry out
delegated tasks, ancillary to ophthalmology, in the area of low vision aids,
binocular vision, visual fields and electrophysiology (Sahel, 1998). In the UK
optometry is an autonomous eye healthcare profession complimentary to
medicine and ophthalmology with a well established and fully recognised
social and inter-professional status.
In the United Kingdom, Ophthalmology is regarded as a 'consultant led
practice of ophthalmic surgery' (Kirkness, 2002). Approximately 7000 British
optometrists provide an increasing amount of primary eye healthcare working
very closely with General Practitioners (Family Physicians) and
ophthalmologists. In the EU countries primary eye care is provided by
ophthalmologists. Furthermore, it is debatable whether the primary eye care
mode of practice of an average ophthalmologist in the EU should be equated
with that of largely secondary eye care provided by an average British
ophthalmologist. In countries like Germany sometimes there are three
ophthalmologists in practice in a small town with a population of no more
than 10,000 (Kirkness, 2002). Patients are usually referred by these
ophthalmologists for surgery to the nearest university clinic or a cataract
centre. In contrast in the UK similar professional services are normally
provided by optometrists.
In the Netherlands, data from a national survey was used to explore the
position of ophthalmologists, general medical practitioners (family
physicians), optometrists, orthoptists, and opticians as 'the gatekeepers in
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vision care'. Opinions from patients in the Netherlands indicated a preference
for professional services from a medically qualified gatekeeper like a GP
(family physician) or an ophthalmologist rather than a non-medical person
such as an optometrist (Stevens et al, 2002).
In contrast, the UK optometrists are expected to play a bigger role than that
of the gatekeeper. For example the UK optometrists are expected to evaluate
patients for cataract surgery (Gaskell, 2001; Hughes, 2001) and diabetic
retinopathy treatment (Hammond et al, 1996; Prasad et al, 2001). Under the
National Health (Primary Care) Act of 1997 British optometrists are allowed
to monitor ocular pathology and refer patients directly to hospitals by using
their professional judgement under the revised regulations of the General
Optical Council which came into force on 1 January 2000. In glaucoma
management community optometrists in the UK provide a comparable service
to that provided by hospital eye service (Riad et al, 2003).
The extension of prescribing rights to new professional groups was the subject
of a UK government-commissioned review, which cited British optometrists as
potential candidates (Mason and Mason, 2002). A survey by these authors
indicated that optometrist participation in the UK could increase patient access
to ocular therapeutic care by between 29% and 50%. The Department of
Health in the UK has already embarked on its plans for optometrists to
prescribe therapeutics for treating patients with eye disease (Anon, 2003).
The competency framework for supplementary and independent prescribing
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optometrists, was prepared by the National Prescribing Centre under contract
from the General Optical Council (Anon, 2004).
Within the last two years, Ireland and The Netherlands have allowed the use
of diagnostic, not therapeutic, drugs by optometrists. In February 2003 the
Irish Parliament discussed whether optometrists in Ireland could, in future,
be allowed to use therapeutic drugs. With the exception of the UK, none of the
other European Union countries allow optometrists to use therapeutic drugs.
It seems unlikely that in the foreseeable future, training in ocular therapeutics
for optometrists will be allowed in the rest of the EU countries, possibly
because of medical and ophthalmological attitude towards optometry, a kind
of professional 'tribalism' or 'territorialism' in the EU or the medical
profession may be exercising disproportionate influence on the policy makers
in the EU. However, there is no justification in not allowing optometry to
develop on the lines of the British model throughout the EU.
It should be noted that after receiving expensive medical education some EU
countries like Italy and Spain have unemployed doctors (Herzmann, 2003).
In Greece, full optometric practice contravenes the national laws. It seems
inconceivable that in a socially and technologically advancing world, full
practice of optometry which in the UK and Ireland (and countries like the US,
Canada and Australia) is a well established and effective method of screening
for ocular conditions to avoid visual impairment and blindness in the
population, actually contravenes national laws of some EU countries.
In contrast, not too long ago, an eminent British ophthalmologist proposed the
formation of community ophthalmic teams which will include optometrists.
Writing in the British Journal of Ophthalmology he stated that British
Optometrists 'by far the largest group, have much to contribute, primarily in
the management of refractive disorders. However, their place in preventive
ophthalmology is growing and the usefulness and quality of their work would
certainly further increase if they were part of a community ophthalmic team.
This would, with a realistic adjustment of their training, help to fulfil their
medical ambitions' (Blach, 2001).
It appears that in many EU countries some archetypal concepts and deeply
rooted notions of artisans and craftsmen including spectacle makers or sellers
have survived from the craft guilds of medieval Europe. These notions may
still exist in the thinking and attitude of some legislators responsible for the
laws governing health care professions like optometry in the EU, seriously
hampering the process of professionalisation and especially the caring aspect.
In developed and advanced societies there is an awareness of a universal
healthcare culture also covering most areas of health-related social problems.
The borders of ethnocentrism have already been crossed and as a matter of fact
we now share a common healthcare culture in the world. It appears that in
some countries there is a lack of willingness on the part of lawmakers and
others to share and implement those healthcare philosophies which are
universal in nature, well tried and tested and necessary for the welfare of
people. In the eye healthcare field the obvious task for the policy makers is the
eradication of avoidable visual impairment and blindness and not to succumb
to pressures from any source by not accepting universal healthcare
philosophies. It should be realised by all concerned that multiple forces are
transforming the pattern of health-related problems. The increasing number
of elderly people, the emergence of new diseases causing more health-related
problems and changing demography due to expanded movement of people,
require more healthcare resources. It has to be noted that ethical and quality
healthcare is a constituent element of human rights and also an integral part of
the social expectations of the recipients of professional services.
EU member states must reach a consensus about the core functions which have
to be performed by the old established and the newer healthcare professions.
Before the next stage of an enlarged European Union, strategic eye healthcare
definitions, with a specific role for optometry, are required for all EU
countries. Although in socio-economic or political terms the aim to harmonise
all healthcare professions within the EU is laudable, in practical terms the
proposal is fraught with serious problems especially for professions like
optometry. Harmonisation implies uniformity with equality and neither of
these exist in optometry in the EU. Taking into consideration the diversity of
optometry within the EU, the Association of European Universities Schools
and Colleges of Optometry (AEUSCO) supported by the European Council of
Optometry and Optics (ECOO) launched a European Diploma in Optometry
203
about 5 years ago. Out of twenty three candidates, two successfully
completed all parts of the examination. In 2002-2003, the total number of
candidates taking all or part of the examination was thirty. Only three
candidates successfully completed all parts of the examination. A diploma of
this nature may be useful in terms of entry into British optometry but it does
not solve the problem of inequality in optometric training or lack of statutory
regulations within the EU. It does not change the present official status of
optometry in most EU countries.
Optometry degrees from Utrecht in the Netherlands are now accepted by the
General Optical Council for registration as an optometrist in the UK.
Obtaining a degree from outside the UK for registration in the UK is a
separate issue and it does not create equality in terms of scope and mode of
practice under the medical or optometry acts or laws of the Netherlands which
are different when compared with those of the United Kingdom.
Significantly, ophthalmologists in the UK also felt that with the possible
exception of Ireland, none of the other EU nations provided a well structured
training in ophthalmology similar to that in Britain with the associated
controls of both the local deanery and the Royal College of Ophthalmologists'
quinquennial inspection (KirIcriess, 2002). It was felt that none of the other EU
countries have a 'rigorous examination system and none as demanding as that
in the UK or Ireland'. Becoming a specialist in ophthalmology takes four years
in Italy but more than seven years in the United Kingdom (Herzmann, 2003).
In order to standardise ophthalmology, a Diploma of the European Board of
Ophthalmology (EBO) was instituted about 5-6 years ago (Eustace, 1997).
So far this diploma has not achieved much popularity. With this background it
is not a surprise that British ophthalmologists and optometrists are gravely
concerned about the following proposed legislation in the EU.
The European Commission has proposed a single directive for all
professions including those from the healthcare sector, together with the
setting up of an expert group primarily responsible for healthcare professions.
Under the new rules it will be easier for healthcare professionals, including
doctors, midwives, nurses and others to work in any EU country (Watson,
2002; Mead, 2003). However, under the new proposals healthcare
professionals from one member state would be allowed to practise for up to
four months without re gistration with the regulating authority in another
member state.
It is argued by the critics of this proposal that this would prevent regulators
from taking action against a person if a problem arose and they would not be
able to prevent the professional from repeating the problem with another
patient either in their own or another member state (Watson, 2002). Supporters
of the new EU proposal maintain that in the event of a complaint against
healthcare professionals like doctors, dentists, optometrists, pharmacists,
nurses and others, the trading standards office and the department of health
could easily forward all the information to the foreign re gulatory body (Obi,
2003). This is a separate issue. One of the points against the proposal is
inequality in the standards of practice within the EU in certain health-related
professions. It should be noted that variations and inequalities in healthcare
standards in the EU also carry medico-legal implications (Lynch, 2003). It is
generally acknowledged that the healthcare systems of the existing members of
the EU are diverse and that some EU laws may have profound consequences
for the organisation of the national healthcare systems and may cause a major
impact on health service provisions, despite the best attempt of national
governments to retain control. (Duncan, 2002; Mossialos and McKee, 2002).
On the question of the influence of the European Court of Justice (ECJ) on
healthcare policies, debate continues whether 'the ECJ should be allowed to
assume a vanguard role in health policy making by default' (Randall, 2001). It
is claimed that the ECJ is moving faster than the member states in establishing
free movement of healthcare professionals (Tremblay, 2003). However,
mutual recognition of post-graduate medical qualifications within the EU
remains unresolved. Despite the fact that GP training is well organised in the
UK, membership of the Royal College of General Practitioners (NURCGP) is
not transferable to all European Union member states. This has already
resulted in Germany being taken to the European Court of Laws, but the matter
remains unresolved (Herzmann, 2003).
There are approximately 70,000 (seventy thousand) unemployed doctors in
Italy, and Spain has an excess of doctors resulting in little patient contact in
training (Herzmann, 2003). Many Italian doctors have more than one job and
some never find work in medicine (Thorne, 1996). In Italy, the ratio of
physicians is 583 per 100,000 people and nearly 39,000 -doctors can not find
jobs in various medical fields i.e. more thanl 1% of the Italian medical
profession (Calcopietro, 2002). In Spain the ratio of physicians is over 400
per 100,000 people and in Greece the ratio is over 300 physicians per
100,000 inhabitants (Forgacs,2002).
Under the new directive of the European Commission these doctors will be
entitled to practice in Britain for 16 weeks at a time without registration.
The Alliance of UK Health Regulators on Europe (AURE) which includes the
regulatory bodies of medicine, dentistry, optometry, midwives and others have
argued that no single body could 'incorporate the professional expertise of and
range of knowledge necessary to oversee and manage issues relating to
practice across all the health professions' (Watson, 2002). The first political
battle against the proposal was lost in June 2003 at the European parliament
in Brussels (Watson, 2003).
However, under the auspices of AURE, the British medical organisations, the
Royal College of Ophthalmologists, optometric organisations and others will
continue their fight against new European Union legislation which they believe
poses a danger to patients in Britain. In a letter sent to selected Members of
the European Parliament (MEPs) the BMA has warned that the proposed
liberalisation of services is not appropriate for health professions. The BMA
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noted that 'a doctor treating patients in a country should always be accountable
to that country's regulatory authority' (Watson, 2002).
Indeed this logical opinion applies equally to all healthcare professions.
British standards in eye healthcare must be maintained and from a British
perspective optometry in the EU must be reformed effectively and improve to
British standards before any freedom of movement is implemented under any
EU legislation.
5.2	 Perspective for the future
It would appear that presently most issues under discussion
affecting British eye healthcare are primarily concerned with cost and benefit
analysis for the purposes of allocation of resources. This originates from an
ongoing tussle between principles, priorities and pragmatism, almost
bywords in the vocabulary of all those responsible for healthcare. The main
objective of health policy makers is the successful conclusion of programmes
from a medical and economic point of view. Health insurers would primarily
be concerned with economics related to medical matters. Growth of medical
care guaranteed by insurance is not related to public or social reform.
Epidemics, when viewed from a health-related public welfare perspective,
acquire a different meaning. Political and economic significance of disease
may be different from social significance. With this kind of diverse
background, the strategic difference originating from differing viewpoints
may result in a clash of interests similar to that found between groups defining
pragmatism to suit their own working model.
In its most familiar, popular and broadest sense, pragmatism refers to actions
and to those concepts which are useful, workable and lead to practical
consequences. However, it may appear that in the context of the economics of
healthcare, principles and pragmatism are two dissimilar philosophies which
can be contradictory and in some instances may affect the choice of certain
priorities.
Pragmatism as a concept is open to different interpretations, and decisions
based upon the philosophy of pragmatism remain open to criticism. It is
generally believed that the pragmatists may reject abstract philosophies and
fundamental truth if these do not provide practical results and if ideas do not
carry monetary values. Achieving goals and objectives and approving those
policies which are successful economically are re garded as pragmatic and in
this respect cynics might argue that even plurality of shifting truths may be
acceptable to those people who think of themselves as genuine pragmatists.
In a healthcare setting
 duty of care may be different from deontological ethics
which opposes pragmatism in its purest form and states that an action is right
if it conforms to duty, and duty it must be without any exception and
regardless of consequences. However, it has to be taken into account that
there is a special relationship that exists between principles, priorities and
pragmatism. in the context of healthcare professions, the relationship
between healthcare, ethics and pragmatism may be in a sense described as
analogous to that found between syntax, semantics and pragmatics in the field
of linguistics. This analogy is drawn here only for the purpose of comparing
the relationship of these concepts. It should be noted that pragmatics, as
distinct from pragmatism, is that branch of study in semiotics which deals
with the positive relationship of the user with words, signs and symbols in
social life (Agarwal, 1998 c). Supporters of pragmatism in healthcare would
argue that a positive relationship exists between pragmatism and recipients of
healthcare. The debate continues.
In 1995, the Royal College of Physicians (RCP) called for a national council to
help determine priorities in the health service. In the RCP report 'Setting
Priorities in the NHS: A Framework for Decision Making' the president
stressed the point that choices had to be made within the NHS since not
everything that was possible was affordable (Smith, 1995). The RCP report
further argued that equity for the whole population was more important than
freedom of individual choices but there was a need for 'more open systems by
which priorities can be made and much greater involvement by the public'
(Smith, 1995). In a separate comment it was stated that a principal objective
of the NHS is to maximise health of the people (Culyer, 1997). It was later
argued by a different group that soliciting public opinion was a waste of
money (Torgerson & Gosden, 2000) followed by another comment that the
tax payers should always be asked (Cookson and Dolan, 2000).
On the question of healthcare, governments in the Netherlands and Sweden
also examined the national criteria for priorities with different conclusions.
The Swedish commission rejected the benefit principle and the idea of
deploying resources to help many people with mild disorders instead of a few
with severe injuries or giving priority to those patients who are most profitable
to society. In conclusion the Swedish commission emphasised human dignity,
need and social solidarity and stated that all people have the same rights
irrespective of their personal characteristics, the resources should be devoted
to those in greatest need and the most vulnerable groups should be given
special consideration (Klein, 1995).
However, the Dunning report of the Dutch commission recommended that all
claims must pass a four point test such as necessity, effectiveness, efficiency
and individual responsibility. Around the same time a commission from New
Zealand, although outside the EU but within the EME, recommended a four
point criteria for priority which were provision of benefit, value for money,
fair use of resources and consistency with community needs.
With the exception of Sweden the others have attempted to include priority
with principles and pragmatism at the same time in their recommendations.
An element of scarcity of resources or rationing of healthcare services clearly
shows in some of these recommendations.
It is debatable whether any kind of prioritisation or maximisation of efficiency
in the existing system always produces the desired economic results and
benefits. Imposition of 'target setting and production line values' affects
professional judgement of doctors or the needs of individual patients' and
'excessi‘e, intrusive audit and the imposition of diktats by the state leads to
stifling of inno\ ation' was the comment of the outgoing BMA chairman Ian
Bogle (Beecham, 2003). He further commented that 'paranoid centralism....
will turn professionals into bean counters answerable not to their patients but
to politicians, auditors, commissioners and managers'. Here pragmatism has
been misinterpreted and ethics and principles disregarded in the name of
efficiency.
The recently proposed reformation of NHS trusts into foundation trusts (Health
and Social Care Act, 2003) allowing extra freedom for the management of
healthcare affairs (Dixon, 2003) is unlikely to have any significant impact on
the pattern of eye healthcare delivery in the UK.
A survey was conducted to determine the vision-related quality of life (VR-
Q014 in an elderly UK population and a substantial national prevalence of
VR-Q0L impairment was found, linking ocular disease with social deprivation
(Frost et al, 2001).
The president of the Royal College of Ophthalmologists already conceded in
1999 that in the United Kingdom and elsewhere, it is proving difficult to
maximise all 3 components of the eternal triangle based on access for
patients, affordability and quality; and 'the scope, success and expense of
modern health care has increased demand to a level that may be difficult to
sustain' (Jay, 1999),
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Generally in any given system the average cost decreases as the output
increases. When the output reaches its full capacity, inefficiencies may arise
due to factors like overloading or congestion in the system leading to an
increase in average cost. The recipients of professional services bear the cost
of inefficiency in the system. Ultimately overloading leads to system failure.
In a healthcare environment poor performance or critical incidents due to
system failure can lead to permanent disability. An analogy may be found in
the eye healthcare field in the UK.
It is recognised that in the UK many ophthalmologists provide their support
to optometrists in the provision of eye healthcare. However, with the growing
elderly population, changing demography and insufficient funds the UK will
remain short of human resources in the management of sight threatening
conditions and avoidance of increase in visual impairment and blindness
unless very specific measures are taken. It is not realistic to expect
approximately 750 British ophthalmologists to provide shared primary and
all secondary eye care to 60 million people in the United Kingdom.
On the question of easing the burden on the hospital eye services in the UK,
a consultant (McLeod, 2003) from Manchester Royal Eye hospital recently
stated that a higher standard of ophthalmic primary care will not necessarily
reduce the burden on the hospital eye service' and 'suitably motivated
optometrists' should be trained 'to provide a more advanced level of
ophthalmic primary care' because 'there is whole lot of undiscovered eye
pathology out there'. The role of primary eye care optometrist within a
community setting is crucial in avoiding visual impairment and blindness.
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5.3 Conclusions
The present professional status and future development of optometry in
the United Kingdom and in the European Union are separate issues. Whereas
optometry in Britain is working very closely with medicine and steadily
moving forward as a profession complimentary to ophthalmology; with the
exception of Ireland, optometry in the rest of the European Union
countries is restricted by national laws, decrees and acts like L'Acte
Medicate or Actus Medic us to those professional activities which are
normally carried out by registered dispensing opticians in the United
Kingdom. From a British perspective there are no equivalent working
optometrists in the EU because the professional status and level of work of
those using the title 'optometrist' is different from that found in the UK.
Optometrists in the UK are allowed to monitor ocular pathology, manage eye
conditions of their patients and only refer when clinically necessary. Direct
referral to Hospital Eye Service, encouraged by the General Optical Council,
is part of British optometric practice. The Department of Health has already
approved supplementary and independent prescribing status for British
optometrists. The College of Optometrists provides a voluntary Continuing
Education and Training (CET) scheme as part of Continuing Professional
Development (CPD). The CET scheme, which will become compulsory, is
designed to enable British optometrists to maintain and improve upon the
standards of knowledge and competence after qualifying.
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The issues concerning the future development of optometry in the UK and
the rest of the EU are different and have to be addressed separately. Whereas
optometry in the EU has to develop to a standard similar to that which
presently exists in the UK, optometry in the UK has to move forward to
provide professional services consistent with eye care needs and availability
of eye healthcare services. As stated previously, it is certainly not realistic to
expect 750 British ophthalmologists to provide shared primary and all
secondary eye care to nearly 60 million people. Effective measures must be
taken by the state to combat serious public health implications of visual
impairment and blindness. Optometrists in the UK are practising in an
environment of expanding roles. British optometrists, with appropriate training
and certification, could be given greater responsibilities which could, for
example, include procedures like fluorescein angiography and laser
photocoagulation.
As stated previously, the present pattern of eye healthcare delivery and a
perspective for the future in the UK and Ireland and the rest of the European
Union are separate issues. Law makers in the EU have to be made aware of the
fact that a political treaty of union of states does not produce instant
harmonisation or reciprocity in professional standards. Professional cultures in
the EU are diverse. EU member states must reach a consensus about the core
functions which have to be performed by the old established and the newer
healthcare professions. Before the next stage of an enlarged European Union,
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strategic eye healthcare definitions, with a specific role for optometry, are
required for all EU countries. Although in socio-economic or political terms
the aim to harmonise all healthcare professions within the EU is laudable, in
practical terms the proposal is fraught with serious problems especially for a
profession like optometry. Harmonisation implies uniformity with equality and
presently neither of these exist in optometry in the EU.
In conclusion, the responsibility for the specific task of ophthalmic
intervention could be given to British optometrists with appropriate additional
training and this would provide a pragmatic solution to a human resources
problem in eye healthcare in the UK. Hopefully, such a model will be
adopted by the future optometrists throughout the European Union provided
they get full support from their governments and also from medicine and
ophthalmology in their countries.
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APPENDIX I
World Bank Economic Regions
Grouping of countries on the basis of
World Bank Development Report
The world is divided into following eight groups on economic basis i.e.
the types of economy and the stages of economic development.
The WHO arranges and presents the published data according to the
World Bank grouping of countries.
(1) EME : The established market economies of North America, and Western
Europe which include Japan, Australia and New Zealand
(2) FSE : The former socialist market economies of the Russian Federation and
Eastern Europe.
(3) IND	 India is considered a separate economic region.
(4) CHI : China is also considered a separate economic region.
(5) OAI : Other Asian countries and Islands: includes all the other countries of
south, south-east and east Asia and the islands of the pacific.
(6) SSA : Sub-Saharan Africa : all of Africa with the exception of western
Sahara, Morocco, Algeria, Tunisia, Libya and Egypt, which are
assigned to the Middle Eastern crescent.
(7) LAC : Latin America and the Caribbean includes Mexico, all of Central and
South America and the Caribbean Islands.
(8) 1VTEC : The Middle Eastern crescent, similar to the WHO Eastern
Mediterranean Region, in that it encompasses Afghanistan and
Pakistan as well as Saudi Arabia, the Gulf States and North Africa.
Additionally it includes Israel, Turkey and the new Asian republics
formed from the southern states of the former Soviet Union.
Note: The political group G8 consists of selected countries from EME
& FSE and it is not in the WHO scheme of presentations.
References: (1) Johnson and Foster (1998), The Epidemiology of Eye Disease,
edited by Johnson, Minassian and Weale, Chapman and Hall, 7-30.
(2) WHO (1990), Global data on blindness, an update, World Health
Organisation, Geneva, WHO/PBL/94.40.
(3) The World Bank development Reports (1990-1993).
APPENDIX II
LogMar
Conversion Table
For Notations Recording Visual Acuity
Snellen 6m	 Snellen 20ft Decimal
1.0 6/60 20/200 0.10
0.9 6/48 20/160 0.125
0.8 6/38 20/125 0.16
0.7 6/30 20/100 0.20
0.6 6/24 20/80 0.25
0.5 6/19 20/63 0.32
0.4 6/15 20/50 0.40
0.3 6/12 20/40 0.50
0.2 6/9.5 20/32 0.63
0.1 6/7.5 20/25 0.80
0.0 6 6 20/20 1.00
-0.1 6/4.8 20/16 1.25
-0.2 6/3.8 20/12.5 1.60
-0.3 6/3 20/10 2.00
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APPENDIX DI
The World Health Organisation Classification of
Blindness and Visual Impairment
Category of	 Visual Acuity With Best Correction
visual	 Maximum less than	 Minimum equal to or
impairment	 better than
6/18	 6/60
20/70	 20/200
0,3	 0.1
6/60	 3/60 (finger counting at 3m)
20/200	 20/400
0.1	 0/05
3/60 (finger counting at 3m) 	 1/60 (finger counting at 1m)
	
20.400	 20/1200
	
0.05	 0.02
1/60 (finger counting at 1m)	 Light Perception
20/1200
0.02
5	 NO LIGHT	 PERCEPTION
Note:	 Categories 1 - 2 (Low Vision) 	 Categories 3 -5 (Blindness)
Adapted from the WHO Recommended
Definition of Blindness and Visual Impairment
(1992)
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Appendix IV
Ocular Morbidity in the European Union
and European Blind Union Statistics
It appears that detailed data and statistics concerning ocular morbidity in the
European Union member states is not available. Also the size of socio-economic
inequalities in determinants of ocular morbidity in different European Union
countries is not known. It is, therefore, not possible to compare ocular morbidity
in the European Union.
Furthermore, blind registers only provide data on the incidence of certification
based upon blindness definition used for the purposes of registration and
blindness allowance. This type of information, if available, may not provide data
on the incidence and prevalence of ocular diseases causing visual impairment and
blindness.
The following statement (2003) from the European Blind Union (EBU) based in
Paris is self-explanatory.
'The number of blind and partially sighted in European countries are based upon
estimates provided by the national members of European Blind Union (EBU) and
are an approximation of a highly complex reality. Lack of official statistics and
varied legal definitions of blindness and partial sight make it particularly difficult
to work out accurate numbers. In Particular the number of visually impaired
elderly people is on the increase. Many of them do not consider it useful to start
rehabilitation courses and as a consequence fall out of official registers. At
European Union level the figures generally used by those involved in
campaigning to promote the interests of visually impaired people is 7.4 million
out of a general population of about 385 million'.
However, it should be noted that morbidity is defined as the state of being
diseased and morbidity rate depends upon the incidence and prevalence of a
disease in any given population. A measure of disease frequency may express
morbidity rate and such studies can include the frequency of ocular diseases
causing visual impairment and blindness The prevalence rate is defined as the
proportion of a population having a disease at one point in time. The prevalence
rate is usually expressed as 1 in a million or 1 in 100, 000 or smaller for common
diseases. The incidence rate is the proportion of a defined population developing
a disease within the stated period. The incidence rate can be expressed as 1 in a
thousand at risk.
The attached statistics and information compiled by the European Blind Union
covering all the 15 EU member states only provides incomplete data on
blindness and visual impairment.
List of Current EU Countries:
Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy,
Luxembourg, Netherlands, Portugal, Spain, Sweden and United Kingdom.
The EU after 1 May 2004:
The EU will be enlarged on 1 May 2004 and the following countries from
Europe will become part of it: Cyprus, the Czech Republic, Estonia, Hungary,
Latvia, Lithuania, Malta, Poland, the Slovak Republic and Slovenia.
The EU in 2007:
The following are EU applicant countries: Bulgaria, Romania and Turkey.
Bulgaria and Romania are expected to join the EU in 2007.
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AUSTRIA	 vage I or
I. Total population : 8 015 000 pannuary 1994)
1Children(0-14) 
725 800 
i	 687 500	 I
1 413 300 
Working age(15-64Elderly(over
2 736 000 
2 667 800
65)
425 200
1	 Total 
3 887 000 
1 ,4 128 000 
18 015 0001
Male 
[Female 
Total 
I	 772 700 
1 197 9005 403 800
II.Total visually impaired population : 139 300 (identified)
Percentage(compared to total population) : 1,72
Children Working age Elderly Total 1
Male 1 11 1I
Female >7 334*
I Total r 2 700 I 13 600 1123 0001139 3001
*This figure excludes Vienna, Salzburg and Carinthia
11.1 Blind population :
Legal definition of blindness :
jphi1drenliworking agellEiderly ITotail
I	 Mal.= I
'Female I I I
I Total 	 1	 I	   II	 1
11.2 Partially sighted population :
Legal definition of partially sighted :
I 'Children 'Working age] Elderly 'Total
Male 1 1L
	
1_1-1
,
liFernalei 11
I Total  	 II	 I	 I
http.//www.euroblind.orgifichiersGB1statAUS.htm	 7/3/2003
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III. Number of visually impaired people with additional handicap(s) :
IV. Total handicapped population (all handicaps) :
lifttiwkiiikriki RifRti1iii1.eF61-1EH1040111§idf4t4.1itiii 	 7/1/jOtt;
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Female' 893 100 3 322 900 944 400 5 160 400
Male I I 937 700 1	 3 375 200
Elderly(over 65)
627 300
Total
4 940 200 I
Children(0-14) !working age(15-64)
I. Total population : 10 100 600 (Jannuary 1994)
I Total 1 830 800 11	 6 698 100 I	 1 571 700 110 100 600 
11. Total visually impaired population : Between 12 and 15 000
(identified)
Percentage(compared to total population) : 0,1210,13
1Childrcin ilWorkin r, anedtP l rukrlv1	 it	 -	 -	 ii	 . Total	 11
1	 Male	 I I 11
IFernalejj 1 I	 I
1 Total li	 112 000/15 000,
11.1 Blind population :
Legal definition of blindness : (White cane)
After correction and in both eyes : visual acuity less than 1/10 of normal sight or visual field inferior to
20°
phildrectWorking.	 fakCII
I Male I
(Female I
I Total  	 I I	
I
i	
es	 "H. rtri u3;ey el." • 	 "*".'"""1":'"":"1
Legal definition of partially sighted: (Yellow cane)
- Central visual acuity in both eyes less than 0,6 of normal sight - after correction
http://www.euroblind.org/fichiersGB/statBEL.htm	 7/3/2003
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	 ilphild7e-il  [Working ag_ejtElderlygotaill
I Male  I 		 —Ir	 II	 11
I Total  	
[Female J
I
or global vision impairment in both eyes, with absolute sensitivity reduction to 1/10Utn or iess or
normal sight at equivaieni age
or loss of penpherical vision, with residual visual field in both eyes infenor to 40°
Number of visually impaired people with additional handicap(s) :
V. Totm l h f-I ndir =ppad population (all —1.-ts•-7=rre
ers( i EL'statBF.L htm	 7/3,-1( )0 ;
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Male 515 664 1 804 632
489 539 41 763 935
1 005 203 3 568 567
	
[Female  
12,,t
 
	
ale 1 	   	
lic	Total 11	 1 721 	 11 613	 it	 34366
DEN, Ni A
Data provided by the Danish Association of the Blind, March 2002
I. Total population : 5 368 354 January (2002)
16hildren(0-14)1 Working ade(15-64)}[Elder1y(over 65)
Jr-333 850
460 734
794 584
Total  II
')I 714 9014
‘-'11
15 368 35411
2 654 146
Total visually impaired population : 53 700
Percentage of total population : 1 %
• In Denmark, only visually impaired children between U anci 18 are registered. Theleiute, tiguies
provided for the tither egc groups are only estimates.
• Whereas the visually impaired population is evenly distnbuted between women ario men up to
60 years of age, there are significantly more women in the age gioup above 60.
• Estimates by health researchers and disability experts indicate that the visually impaired
population is evenly dintribilted between the blind and the partially sighted
(0-18)11Working age (19-6O)1 Elderly (over 65)LTtal 
HA Blind population : 26 850
Definition of blindness - Visual acuity lower than or equal to 6/60
	
liChildrenlIworkino agellElderlyji Totall
	
ji male	 17-11	lr	 ii	 II	
	 IIFernai
26 850
11\
	
11 Total it			
11.2 Partially sighted population : 26 850
http l!www eurnhiind org i fichiersGB/statDEN htm 	 ]13/2003
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DENMARK
	
Fin OP rlf
Definition of partial sight : Visual acuity between 6/18 and 6/60, but with complications that cause
the "value" of vision to be considered lower than or equal to 6160
I Children 'Working age l Elderly] Total .
I	 Male I I 1
Female I	 I	
I	 1 	 26 850 I Total II	
Ill. Number of visually impaired people with additional disabiiities
966 chikiien with additional disabilities (0-18 years of age).
No figures available for the other age groups for same reason as above.
IV. Total disabled population : 536 800 approx.
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Children(0-14)111Norking age(15-64)liElderly(ovar 55)1 Total
481 142 1 749 103
461 859 1 712 030
943 001 3 461 133
I_'Male (0-14)
IFemale
I Total
	
I
292 781 -2 523 026
474 387 12 648 276
767 168 [5 171 302
I
Male 11 700 
,Femalell 600
Total II 1 300
1	 4 500
10 ow I 70 0001181 3001
150 0001155 1001
tWorking ages iEldertyl Total
5 500 1 20 000
iChildrenN.Vorking agellEldertyli Total 11
fiTi5-0-11_ 5 300
11, :10-0710 1! 5 200	 1\
Male 1 300 2 000
[Female; 200 1 000
1 Total 11 500 3 000 11 7 000 1110	 5001\
FINLAND
	
1	 1 •.1.
I. Total population : 5 171 302 (2000)
II. Total visually impaired population : 81 300 (identified)
Percentage of total population : 1,57
11.1 Blind population : 10 SOO (estimated)
Definition r-sf blindness	 's definition, group 3, 4 and 5
11.2 Partially sig hted population : 70 800
Definition of partial sight : WHO's definition, group 1 and 2
1
1	 liChildreniNVorking ageliElderiyit Total 11
1 Male 11	 400	 13 500	 ----117 000_ 20 9001
(Female' 400	 r	 3 500 1146 000149 90011
Total 800	 - r	 7 000 163 000170 8001
http://www.euroblmd.org/fichiersGBistatFIN.htm
	
7317003
228
FINLAND	 Pagc 2 of 2
HI. Number of visually impaired people with additionaldisabilities:
0-5ycars old children 75 ‘3.4.• mill.tirtnelicapped
la/inn:mu! rtfirtn
v • p %JINX IA Ca SI • gr 4.4	 d
http://www.euroblind.orgitichiersGrilstatFIN.hun
	 7/3r001
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Total IIFCTIildren (0-14) ,RiVorking age (15-64Elderly (over 65)
Male 1
Female]
19 424 018 3 900 579 29 023 201
19 399 588 5 701 600 30 628 026
38 823 606 9 602 179 159 651 227Total 1
5 698 604
5 526 838
I 11 225 442
Female'
Total 2 000 18 000
1617-11167-el !Working age Elderly Total
Male 
35 0001155 000
I. Total population : 59 651 227 (July 2001)
II. Total visually impaired population : 140 000 *
Percentage of total population : 0,23
Children *orking age 
II	
L
[Elderly I	 Total	 I
Male
	 I 	 1
000
Female 1
Total 	 68 000 	 1140 
• estimated at 1 200 000 if taking visual acuity less than 3/10 as criterium (percentage fs then 2)
11.1 Blind population : 55 000
Definition of blindness C;entrai visual acuity in the better eye les:0- than tin f normal sight, after
correction
112 Partially sighted population : 85 000
Definition of partial sight :
According to a November 1993 new scale, any person can obtain a disablement card when
. his/her view is inferior or equal to 1/10 for each eye
http.//www.euroblind.org/tictuersUB/statERA.htm	 7!3/2001
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. nil at one eye and inferior or equal to 2/10 at the other
Children !Working age Elderly Total
Male 11 I
Female!' I	 I II 	
85 0061I Total I 	 Il	 50000 I	 1
ilL Number of visually impaired people with additional disabilities :
IV. Total disabled population :
http://www.euroblind.org/fichiersGE/statFRA.htm
	
7/3/2003
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!Working age.] Elderly [ Total .1
11295 0001
11360 0001
465 00011655 000;
Children
Total
Male 11
Female!
GERMANY
•	 -1/4. )1,, A b,	 11
	 •••:,	 rk, • ;I 4 1 	 es'
,-e	 , •f.'„, 	 1	 ,	 J	 g	 n
L Total population : 81 338 100 (Jannuary 1994)
traFfildren(0-14)1Working ane(15-64)11Elderly(over 65)11 Total
I	 Male 11 6 827 000 1 28 374 600 4 316 900 139 518 5001
1Fernale I	 6 480 700 I 27 295 500 8 043 400 41 
181 
819
338
6001
100]I Total 11 13 307 700	 	I 55 670 100 L12 360 300
II. Total visually impaired population : 656 000 (identifiedr
Percentage(compared to total population) : 0,8
* Projected from 1990 figures (since 1990 partially sighted people are no longer entitled to any special
allowance and thus no longer registered ; but in the former GDR they were granted a fixed allowance
and could thus be numbered)
cult of these 655 000, 155 000 five in the former Federal Republic of Germany.
11.1 Blind population : 155 000
Legal definition of blindness : Visual acuity of 2 % or less of normal sight, and other impairments of
visual acuity of the same gravity (i.e decreasing visual field size)
iChildren (1-18)111Norking age (18-65)jiEiderly (over 65)1i 	 Total
Male 1 I I I	 58 900
iFetnalei I I 1	 96 100	 I
I Total II 9 300 11	 43 989 II	 	 102 aoo 11155 000 approxli
11.2 Partially sighted population : 500 000*
Projected from 1990 figures (since 1990 they are no longer entitled to any special allowance and
thus no longer registered ; but in The former C-DR they were granted a fixed allowance and could thus
be numbered).
7/3/2003http://www.euroblind.orgifichiersGBIstattiER.htm
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Legal definition of partial sight : Visual acuity of 5 % or less of normal sight, and other impairments
of visual acuity of the same gravity (i.e decreasing visual field size)
I Children [Working ageliElderly1
[
Total
Male I 1225 000
Female' 1 1275 000 
1500 000 Total I	   
HI. Number of visually impaired people with additional disabilities :
7/10 babies born blind had additional handicaps in 1992
IV. Total disabled population :
http://www.euroblind.org/fichiersGB/statGER.htm
	 7/3/2003
1•4_,T	 1—cille 1 01 .L
r • eb. r-	 •"
/A,
.;	 %.
I. Total population : 10 409 700 (Jannuary 1994)
Children(0-14)1Working age(15-64)11Fiderly(over 65)
691 000
Total 	 1
I 5 140 900--_
5 268 800]
110 409 700"
Male I 941 800	 If	 3 508 100
Female 889 100	 ll	 3 512 000 867 700
I Total 1 830 900 	 I	 7 020 100 1 558 700 
IL Total visually impaired population : 22 000 (identified)
Percentage(compared to total population) : 0,21
1Children 'Working age Elderly! Total
Male li II h 1 000I
Femalell 11 11 000
[ Total II	 i	 7 000 	 1122 000 
11.1 Blind population :
Legal definition of blindness : Visual acuity less than 1120 of normal sight in both eyes - after
correction.
There is no legal definition for low vision and there are no people registered as partially sighted in
Greece.
I	 Children Working age Elderly ITotall
Male	 ] I I
IFemalel I I
I Total	 il  	 1	 II 
11.2 Partially sighted population :
See 11.1 above
Legal definition of partially sighted : See 11.1
II —II
http://www.euroblind.orgjfichiersGB/statGRE.htm
	
7/3/2003
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I Male
'Female
I Total
	1}ChildrenliWorking agellElderlyilTotall
GREECE
	
Page 2 of 2
Number of visually impaired people with additional handicap(s) :
400 - 500 (adults and children)
IV. Total handicapped population (all handicaps) :
http://www.euroblind.org/fichierstaiistateRE:htm
	 713/2003
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rtigz
Data provided by the National Council of the Blind of Ireland, March 2002
I. Total population : 3 626 087
I Children(0-14)UWorking age(15-64)E1derly(over 65)11	 Total
I Male 1 441 452 1 1 181 528 I 177 252 1 800 232
'Female ' 417 972 11 1 171 253 236 630 111 825 8551
I Total 	 859 424 1	 	 2 352 781 413 882 3 626 087
II. Total visually impaired population* : 17 000 approx.
Percentage (compared to total population) : 0,47
Children Working age Elderlyf	 Total
Male II I I I	 I
IFemalell I 1	 I
i Total - I	   	 1117 000 approx.11
" The National Council for the Blind of Ireland conservatively estimates that there are approximately 30
000 persons in the Republic of Ireland who are or may be eligible to be registered as blind or partially
sighted.
11.1 Blind population : 6 448
Definition of blindness "Best vision must be equal to or less than 6/60 in the better eye or the field
of vision is limited, the widest diameter of vision subtending an angle of not greater than 20
degrees" (Certificate of Visual Acuity)
I 'Children Working age Elderly -Total
Male I	 I
!Female I I	 ll
1 500  	 '	 116
11	 i
448 I Total I	 li
11.2 Partially sighted population. 11 000 approx.
Definition of partial sight :
http://www.eurobiind.org/fichiersGB/statIRE.htm
	
713/2003
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[Children Working age Elderly I	 Total
Male i 11
Female I I
, Total I	 I	 _	 1111 000 approx. 
Ill. Number of visually impaired people with additional disabilities :
IV. Total disabled population
http://www.euroblind.org/fichiersGBistatIRE.htm
	 7/312003
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1.1 AL
Page 1 of 2
,
Data provided by the Italian Union of the Blind, January 2001
I. Total population : 57 138 500
I Children(0-14) Working age(15-64) lElderly(over 65)
27
Total	 1
738 7001Male 4 465 000 19 548 100 3 725 600
Female! 4 223 000 19 744 300 I 5 432 500 29 399 8001
[ Total I 8 688 000 39 292 400	 - 9 158 100 57 138 500
U. Total visually impaired population : 110 793* / 368 000**
Percentage of total population :0 ,19* !0.64**
* Source : Institute for Social Security (July 2000)
This figure only includes the blind and partially sighted whose residual vision is not more than 1/20 in
both eyes with lenses receiving an economic allowance according to the ltafian legislation.
** Source : Institute for Statistics (1990/1993)
This flame includes, besides the blind and partially sighted whose residual vision is not more than 1/20
in both eyes with lenses receiving an economic allowance according to the Italian legislation, all the
visually impaired who do not receive an economic allowance : namely those whose residual vision is
more than 1/20 but suffer from such a severe visual impairment that they cannot see or count the
fingers of a hand (provisional criterion). All the data of this surveying are assumed to be provisional.
ilChildren 'Working agel Elderly I	 Total
1 Male	 I	 4 000
	
I 69 000	 I 77 000 j150 000
IFernalelL 6 000	 II 63 000 11149 00011 218 000 1
FT4:7•Clal  i 10 000 11 132 WO 226 00:3435a CIQU'' 
11.1 Blind population : 58 370*** (December 1991)
*** Source : Ministry of Intenor. Data from Institute for Social Security : none
Definition of blindness :
The current legislation provides that persons defined as suffering from total blindness are :
a) those with no sight at all in both eyes with lenses
b) those who have mere perception of light and shade
The Parliament will soon complete the evaluation of a bill which provides that persons defined as
suffering from total blindness are :
c) those with no sight at all in both eyes
d) those who have mere perception of light and shade or the movement of a hand in both eyes or in
the eye with better vision
e) those whose residual binocular peripheral vision is less than 3 per cent
http://www.euroblind.org/fichiersGB/statITA.htm	 7/3/2003
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Total
ChildrenIAlorking agei Elderly Total 1
Male I
57 388***
1i AL Y
11.2 Partially sighted population : 57 388*** (December 1991)
". Source : Ministry of Interior Data from Institute for Social Security : none
Definition of partial sight **** :
The current legislation provides that persons defined as suffering from partial blindness are :
a) those whose residual vision is not more than 1120 in both eyes, even with lenses
The Parliament will soon complete the evaluation of a bill which provides that persons defined
suffering from partial blindness are.
b) those whose residual vision is not more than 1/20 in both eyes or in the eye with better vision, even
with lenses
c) those whose residual binocular peripheral vision is less than 10 per cent
**** Besides this category, the Italian legislation also recognises another category of partially sighted :
those whose residual vision is not more than 1/10 in both eyes with correction lenses. The latter is not
entitled to any economic allowance, but it is included in other protection schemes (such as compulsory
employment).
Number of visually impaired people with additional disabilitie(s) :16 640 ....*
***4-* Source : institute for Social Security (July 2000)
This figure shows the number of the visually impaired who receive economic allowances also for other
impairment(s).
IV. Total disabled population :
7/3/2003http://www.euroblind ,org/fichiersCiBistatITA.htm
LUXEMBOURG
	
Page 1 of 2
X P	 3R
L Total population : 400 900 (Jannuary 1994)
1iChildren(0-14Working age(15-64)1 Elderly(over 64 Total 1
Male 1 37 300 138 800 1 20 800 [196 9001
Female I 35 400 [---- 134 200 7 34 40 [204 000
Total i 72 700 	  273 000 I	 55 200 1300 900 
II. Total visually impaired population :550 (identified),
Percentage (compared to total population) : 0,14
I	 'Children Working age Elderly* Total
Male I I I 1 200
Female' I 1 1 350
' Total 1 69—]	 80 I 	 401 11 550 
11.1 Blind population :
Legal definition of blindness : Visual acuity in better eye after correction less than 1/10 of normal
sight, or visual field inferior to 10°.
IChildrenliWorking ageliElderlyiiTotaii
I	 Male It
:I [	 11
Female I
, Total i I
1
I
11.2 Partially sighted population :
Legal definition of partially sighted :
I	 liChildren Working agellElderly Totall
1	 Male	 it I
IFemaleil I
1 Total  	 	 I	
http://www.euroblind.org/fichiersGB/statLUX.htm	 7/3/2003
240
H. Number of visually impaired people with additional handicap(s) :
IV. Total handicapped population (all handicaps) :
http://www.euroblind.org/fichiersGB/statLUX.htni
	 7/3/2003
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Children(0-14)11Working age(15-64)1lEiderly(over 65)1I Total
Male 1 439 300 5 343 800
Female 1 376 400 5 174 100
Total 2 815 700 10 517 900
802 800 7 585 900
1 205 200 I 7 755 700
1
	
2 008 000 	 15 341 6001
llchildrenl Working age
Elderly* Total 
Male
Female'
Total I 2 200 I 158 OON
11ChildrenliWorking age 
1
1 Male I 	
Total 
I Total I
1116 0001
Elderly'
NETHERLANDS
	 Page 1 of 2
T	 r)';:,	 I	
I. Total population : 15 341 600 (Jannuary 1994)
II. Total visually impaired population : 158 000 (identified),
Percentage (compared to total population) : 1,03
11.1 Blind population : 16 000 (1988 survey)
Legal definition of blindness Criteria used by the Act on Sheltered Employment (WSW):
"Anyone obliged to read braille or make use of the spoken word".
II.2 Partially sighted population : 142 000 (1988 survey)
Legal definition of partially sighted : Criteria used by the Dutch Union of the Blind and the Dutch
Railways for delivery of a "guidance permit" (free circulation - on Public Transport - for the guide) :
"People who, in spite of the use of glasses or contact lenses, have the disposal over less than 10 % of
their normal visual field, and/or who have the disposal of a visual field that forms an imaginary corner
in the largest id (bore) of no bigger than 20".
http://www.euroblind.org/fichiersGB/statNET.htrn 	 7/3/2003
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	 11ChildrenilWorking agellElderlyll Total I
Male
IiFeum.e 
Total 142 000'
NETHERLANDS
	
rage 2 or 2
HI Number of visually impaired people withadditional handicap(s) :
90 000
IV. Total handicapped population (all handicaps) :
Approx. 1 500 000 (physical handicap), 100 000 (mental handicap)
http://www.euroblind.org/fichiersGB/statNET.htm
	 7/31'2003
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!Children (0-16
5 500
}Working age (17-64)
46 000
Elderly (over 64)
17 500
Total
69 000Male
5 500 46 000 25 500 77 000
II LI
',UK I UCiAL	 ragc ot
Data provided by ACAPO, March 2002
I. Total population : 10 355 824 (2001 Census)
Children (0-14) Working age (15-64) Elderly (over 64)1 Total
Male 849 162 3 435 729 715 073 14 999 9641
Female 810 399 3 558 414	 II 987 047 I 5 355 860 i
Total 1 659 561 6 994 143 1 702 120 _110 355 824
cnt:Total visually impaired population : 163 .,„. approx. (2001 Census)
Percentage of total population : 1,6
1 'Children (0-16)1FINorking age (17-64)jlEiderly (over 64)11 Total I
I Male 6 100 1	 51 600 I	 19 600 177 300
1Female 6 200 I	 51 500 I	 28 500 86 200
I Total I	 12 300 I	 103 100 I	 48 100 (163 500 
11.1 Blind population : 17 500 approx.
Definition of blindness :
Visual acuity less than 1/10
Visual field less than 200
I liChildren (016) Working age (17-64) Elderly (over 64)1 Total 1
18 300I Male I	 600 I	 5 600	 I 2 100
'Female I	 700	 .1 5 500 3 000 (9200 
(17500'i Total 1	 1 300 11 100 [	 	 5 100
11.2 Partially sighted population : 146 000 approx.
Definition of partial sight : None (ophthalmologists apply old WHO definitions)
http://www.euroblind.org/fichiersGB/statPOR.htm
	 7/3/2003
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ruts. I. LA-I.M.L.,
	 ax-Au
Total II	 11 000	 j1	 92 000	 II	 43 000	 11146 00011
D. Number of visually impaired people with additional disabilities ; 31
000
IV. Total disabled population : 634 408 people - 6,1 per cent (2001
census)
(The figure of 905 500 people suggested in 1995 survey is disputed by many)
http://www.euroblind.org/fichiersGB/statPOR.htm
	
7/3/2003
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[Children Working age! Elderly Total
Male I
!Female
1 Total I 150 000 - 200 000
Male
'Female
ChildrenilWorking agejElderlyl Total
SPAIN	 Page 1 of 2
r; A
41
I. Total population : 39 852 652 (November 2000)
Children(0-14)IIWorking age(15-64)I Elderly(over 65)1
	 Total
I Male 3 098 043 13 667 147 2 723 277	 119 488 467
(Female ' 2 945 082 13 638 614 3 780 489 120 364 1851
i Total 6 043 125 li 27 305 761 1 6 503 766 139 852 652
H. Total visually impaired population : 150 000 -200 000 estimated
Percentage of total population : 0,38 - 0,5
Ill Blind population : 59 186 (registered)
Definition of blindness :
Visual acuity less than 1/10th on the Wecker scale in both eyes, after the best possible optical
correction,
or visual field not exceeding 10 0
 in both eyes.
11ChildrenliWorking191 Elderly Total 1
I	 Male II 2 436	 I 18 429 9 297 1130 
3941129
162
024'Female I	 1 904	 I 14
33
726
155
1112
i Total I 4 340 j 121 691159 186
11.2 Partially sighted population : 100 000 - 150 000
Legal definition of partial sight :
http://www.euroblind
 org/fichiersGB/statSP.htm
	 7/3/2003
Jr rt.' IN
11 Total II
	 II
	
II	 11100 000 - 150 00011
UI Number of visually impaired people with additional 	 :
10 355 (out of the 59 186 blind people)
IV. Total disabl szd populntion :
3 498 353 (estimate)
http://www.euroblind.orgifichiersGB/statSP.htn
	 7/3/2003
247
Female L 1 300 I[ 9000 I(44 000 I 54 300
I Male 1 300 9 000 [25 000 I 35 3001
SWEDEN
	 nagu 1 i.J1
I. Total population : 8 745 100 (January 1994)
1	 I Children(0-14)11Workin9
839 200 I	 2 830 600	 I
age(15-64)Ila riey(m., 65 ) 1
651 100	 114
Total	 1
320 900I Male
[Female 796 300 2 742 900 885 000 14 424 2001
(Total I , 1 635 500 I	 	 5 573 500 1 536 100 8 745 1001
II.Total visually impaired population : 103 000 approx. (identified)
Percentage (compared to total population) : 1,17
I	 (Children Working age Elderly t Total I
I Male	 1	 1 500 I 10 300 129 00011 40 800 I
IFemalell	 1 500 I 10 300 1 50 000 I 61 800 1
I Total	 3 000	 II 20 600 (79 000(103 000 approxl
Ill Blind population : 13 000
Legal definition of blindness : There is no legal definition different criteria are applied by different
authorities.
The Swedish Association of the Visually Impaired (SRF) defines visual impairment as follows : "A
person is visually impaired when his/her sight is reduced to such an extent that it leads to difficulties in
reading ordinary script or orientating with the help of sight".
liChildrenl*orking age 'Elderly( Total
[ Male 200	 I 1 300 1 4 000 1 5 500
female ' 200	 ll 1 300 I 6 000 II 7 500
Total I 400 	 I	 	 260C) 110 0001113 0001
11.2 Partially sighted population : 90 000 approx.
Legal definition of partial sight : See above
IChildrenitWorking agejlEiderly I	 Total
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III.Number of visually impaired people with additional disabilities :
- One third of the visually handicapped have at least one additional disability.
IV. Total disabled population :
Not available.
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Working age (16-
611) 
166 140
Elderly (overElderly (65-1
74)
	 I	 75) 
ii-
I'Thifriren (0-
15)
1 Male
IFemale
125 940 750 460 I  1
	 II 
066
740 Total 24 200
[Children 'Working agel Elderly I Total
I Male
II	
	 II	 II
II
	 II	
rage I 01 L
UNITED KINGDOM
v./	 L	 ; 4 t	 '"'"'
1. Total population : 58 801 500 (2001)
I	 ]IChildren(C-14)IEWrnting ags--(15-54)119clerly(over 654	 Total
I Male 11	 5 787 000 [	 18 838 000	 3 692 000	 128 317 000
Femalell. 	 5 485 000	 1 18 710 000	 11 5 447 000	 [29 642 000i
i Total 1 	 11 272 000	 II 37 548 000 9 139 000	 P7 959 000
(Distribution in above table as of 1993)
IL Total visually impaired population :
1 066 740 (identified) ; 1,8 per cent of total population
354 153 (registered)
• 82 % of visually impaired people are 65 or over
• 1 in 7 over 75 and i in 3 over 85 have severe vision loss
• The number of blind adults (includes the elderly, as opposed to "children") living in private
households is estimated to be 300 000, with 41 000 of working age
• The number of partially sighted adults (includes the elderly, as opposed to "children") living in
private households is estimated to be 457 000, with 50 000 of working age
Ili Blind population : 1 93 956 (registered)
Definition of blindness : Individuals are registered hfind if they have :
a) a visual acuity of less than 3160 Snellen
or b) a visual acuity of between 3160 and 6160 Snellen and a consideraoie contraction of their
field of vision
or c) a visual acuity greater than 6/60 Snellen and a field contraction covering majority of the
field.
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UNITED KINGDOM
	 Page .1 ot "'
1Femaleil 	 11	 11	
Total 193 956
,1.2 Partially si raviclra p--••in4;—n • i An 1(47 franicfaradl.	 I
Definition of partial sight- Individuals are registered as partially sighted if they have :
a) Visual acuity of between 3/60 and 6160 Snellen and a full field of vision
or b) a visual acuity of between 6160 and 6/24 Snelien and a moderate contraction of their field
of vision
or c) a visual acuity up to 6/15 Snellen, or even better, with a gross field defect.
I
r•s,;1.-4.-.Esx4lititsin-W.nti nru-slic irip-ivi
... ...	 .......1.11•• n.	 ,P1 •••••.........1p...=••=-•t 5 ., 1 T ofl,
1 Male I I I	 1
Ifernale I I
I Total 
, 	 I	 II 160 197 
Ill. Number of visually impaired people with additional disabilities :
- 67 % of visually impaired people have another permanent illness or disability. Most frequently
mentioned are :
arthritis (25 %), heart conditions (16 %), mobility problems (14%) and diabetes (9 %).
- 35 % of visually impaired people experience some difficulty in hearing normal speech (round
50 0/0 of those over 75)
-56 % of visually impaired children have at least one over disability.
IV. Total disabled population :
http://www.euroblind.org/fi chi ersGB/statUK.htrn
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Established Market Economies	 Formeriy Socialist Economies of Europe
India	 China
C.ataract 51.2%1
Other Asian and Islands	 Sub-Saharan Africa
Oth GM 69.0%
Others 84.9%
Trachoma 23.6%
Glaucoma 16.7%
Latin America and the Caribbean
Cataract 57.6%
Middle-Eastern Crescent
(IncludIng mod, lotegardent stales in A.I.
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